HCA Healthcare (HCA) 10-K 26 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Jan. 31, 2014	Jun. 30, 2013
Document And Entity Information [Abstract]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Registrant Name	'HCA HOLDINGS, INC.	'	'
Entity Central Index Key	'0000860730	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	440,512,800	'
Entity Public Float	'	'	$9,867

Consolidated_Income_Statements

Consolidated Income Statements (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

In Millions, except Share data in Thousands, unless otherwise specified

Mar. 31, 2013

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Income Statement [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues before the provision for doubtful accounts

'

'

'

'

'

'

'

'

'

$38,040

$36,783

$32,506

Provision for doubtful accounts

'

'

'

'

'

'

'

'

'

3,858

3,770

2,824

Revenues

'

8,836

8,456

8,450

8,440

8,434

8,062

8,112

8,405

34,182

33,013

29,682

Salaries and benefits

'

'

'

'

'

'

'

'

'

15,646

15,089

13,440

Supplies

'

'

'

'

'

'

'

'

'

5,970

5,717

5,179

Other operating expenses

'

'

'

'

'

'

'

'

'

6,237

6,048

5,470

Electronic health record incentive income

'

'

'

'

'

'

'

'

'

-216

-336

-210

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-29

-36

-258

Depreciation and amortization

'

'

'

'

'

'

'

'

'

1,753

1,679

1,465

Interest expense

'

'

'

'

'

'

'

'

'

1,848

1,798

2,037

Losses (gains) on sales of facilities

'

-2

1

-3

11

-6

-5

1

1

10

-15

-142

Losses on retirement of debt

17

'

'

'

11

'

'

'

'

17

'

481

Legal claim costs

'

'

'

'

'

110

'

'

'

'

175

'

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

-1,522

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

181

Total expenses including equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

31,236

30,119

26,121

Income before income taxes

'

'

'

'

'

'

'

'

'

2,946

2,894

3,561

Provision for income taxes

'

'

'

'

'

'

'

'

'

950

888

719

Net income

'

554

467

537

438

427

455

485

639

1,996

2,006

2,842

Net income attributable to noncontrolling interests

'

'

'

'

'

'

'

'

'

440

401

377

Net income attributable to HCA Holdings, Inc.

'

$424

$365

$423

$344

$314

$360

$391

$540

$1,556

$1,605

$2,465

Per share data:

'

'

'

'

'

'

'

'

'

'

'

'

Basic earnings per share

'

$0.96

$0.82

$0.95

$0.77

$0.71

$0.82

$0.89

$1.23

$3.50

$3.65

$5.17

Diluted earnings per share

'

$0.92

$0.79

$0.91

$0.74

$0.68

$0.78

$0.85

$1.18

$3.37

$3.49

$4.97

Shares used in earnings per share calculations (in thousands):

'

'

'

'

'

'

'

'

'

'

'

'

Basic

'

'

'

'

'

'

'

'

'

445,066

440,178

476,609

Diluted

'

'

'

'

'

'

'

'

'

461,913

459,403

495,943

Consolidated_Comprehensive_Inc

Consolidated Comprehensive Income Statements (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statement Of Income And Comprehensive Income [Abstract]	'	'	'
Net income	$1,996	$2,006	$2,842
Other comprehensive income (loss) before taxes:	'	'	'
Foreign currency translation	18	37	-9
Unrealized (losses) gains on available-for-sale securities	-7	6	2
Defined benefit plans	134	-89	-67
Pension costs included in salaries and benefits	38	46	25
Total defined benefit plans	172	-43	-42
Change in fair value of derivative financial instruments	3	-151	-311
Interest costs included in interest expense	131	122	341
Total change in fair value of derivative financial instruments	134	-29	30
Other comprehensive income (loss) before taxes	317	-29	-19
Income taxes (benefits) related to other comprehensive income items	117	-12	-7
Other comprehensive income (loss)	200	-17	-12
Comprehensive income	2,196	1,989	2,830
Comprehensive income attributable to noncontrolling interests	440	401	377
Comprehensive income attributable to HCA Holdings, Inc.	$1,756	$1,588	$2,453

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$414	$705
Accounts receivable, less allowance for doubtful accounts of $5,488 and $4,846	5,208	4,672
Inventories	1,179	1,086
Deferred income taxes	489	385
Other	747	915
Total current assets	8,037	7,763
Property and equipment, at cost:	'	'
Land	1,487	1,429
Buildings	11,211	10,720
Equipment	17,519	16,430
Construction in progress	856	948
Property and equipment, at cost	31,073	29,527
Accumulated depreciation	-17,454	-16,342
Property and equipment, net	13,619	13,185
Investments of insurance subsidiaries	448	515
Investments in and advances to affiliates	121	104
Goodwill and other intangible assets	5,903	5,539
Deferred loan costs	237	290
Other	466	679
Total assets	28,831	28,075
Current liabilities:	'	'
Accounts payable	1,803	1,768
Accrued salaries	1,193	1,120
Other accrued expenses	1,913	1,849
Long-term debt due within one year	786	1,435
Total current liabilities	5,695	6,172
Long-term debt	27,590	27,495
Professional liability risks	949	973
Income taxes and other liabilities	1,525	1,776
Stockholders' deficit:	'	'
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 439,604,000 shares - 2013 and 443,200,200 shares - 2012	4	4
Capital in excess of par value	1,386	1,753
Accumulated other comprehensive loss	-257	-457
Retained deficit	-9,403	-10,960
Stockholders' deficit attributable to HCA Holdings, Inc.	-8,270	-9,660
Noncontrolling interests	1,342	1,319
Total stockholders' deficit	-6,928	-8,341
Total liabilities and stockholders' deficit	$28,831	$28,075

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, except Share data, unless otherwise specified
Statement Of Financial Position [Abstract]	'	'
Allowance for Accounts receivable	$5,488	$4,846
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, shares outstanding	439,604,000	443,200,200

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Deficit (USD $)	Total	Common Stock [Member]	Capital in Excess of Par Value [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Deficit [Member]	Equity Attributable to Noncontrolling Interests [Member]
In Millions, except Share data
Balance at Dec. 31, 2010	($10,794)	$4	$386	($428)	($11,888)	$1,132
Balance, shares at Dec. 31, 2010	'	427,459,000	'	'	'	'
Comprehensive income	2,830	'	'	-12	2,465	377
Issuance of common stock	2,506	1	2,505	'	'	'
Issuance of common stock, shares	'	87,719,000	'	'	'	'
Repurchase of common stock	-1,503	-1	-1,502	'	'	'
Repurchase of common stock, shares	'	-80,771,000	'	'	'	'
Share-based benefit plans	35	'	35	'	'	'
Share-based benefit plans, shares	'	3,071,000	'	'	'	'
Distributions	-378	'	'	'	'	-378
Adjustment to the acquired controlling interest in equity investment	93	'	'	'	'	93
Reclassification of equity securities with contingent redemption rights	141	'	141	'	'	'
Other	56	'	36	'	'	20
Balance at Dec. 31, 2011	-7,014	4	1,601	-440	-9,423	1,244
Balance, shares at Dec. 31, 2011	'	437,478,000	'	'	'	'
Comprehensive income	1,989	'	'	-17	1,605	401
Share-based benefit plans	169	'	169	'	'	'
Share-based benefit plans, shares	'	5,722,000	'	'	'	'
Distributions	-3,543	'	'	'	-3,142	-401
Adjustment to the acquired controlling interest in equity investment	30	'	'	'	'	30
Other	28	'	-17	'	'	45
Balance at Dec. 31, 2012	-8,341	4	1,753	-457	-10,960	1,319
Balance, shares at Dec. 31, 2012	'	443,200,000	'	'	'	'
Comprehensive income	2,196	'	'	200	1,556	440
Repurchase of common stock	-500	'	-500	'	'	'
Repurchase of common stock, shares	'	-10,656,000	'	'	'	'
Share-based benefit plans	139	'	139	'	'	'
Share-based benefit plans, shares	'	7,060,000	'	'	'	'
Distributions	-435	'	'	'	'	-435
Other	13	'	-6	'	1	18
Balance at Dec. 31, 2013	($6,928)	$4	$1,386	($257)	($9,403)	$1,342
Balance, shares at Dec. 31, 2013	'	439,604,000	'	'	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net income	$1,996	$2,006	$2,842
Increase (decrease) in cash from operating assets and liabilities:	'	'	'
Accounts receivable	-4,395	-3,896	-3,248
Inventories and other assets	-19	-122	-18
Accounts payable and accrued expenses	142	355	313
Provision for doubtful accounts	3,858	3,770	2,824
Depreciation and amortization	1,753	1,679	1,465
Income taxes	143	96	912
Losses (gains) on sales of facilities	10	-15	-142
Losses on retirement of debt	17	'	481
Legal claim costs	'	175	'
Gain on acquisition of controlling interest in equity investment	'	'	-1,522
Amortization of deferred loan costs	55	62	70
Share-based compensation	113	56	26
Pay-in-kind interest	'	'	-78
Other	7	9	8
Net cash provided by (used in) operating activities	3,680	4,175	3,933
Cash flows from investing activities:	'	'	'
Purchase of property and equipment	-1,943	-1,862	-1,679
Acquisition of hospitals and health care entities	-481	-258	-1,682
Disposal of hospitals and health care entities	33	30	281
Change in investments	36	16	80
Other	9	11	5
Net cash used in investing activities	-2,346	-2,063	-2,995
Cash flows from financing activities:	'	'	'
Issuances of long-term debt	'	4,850	5,500
Net change in revolving bank credit facilities	970	-685	-449
Repayment of long-term debt	-1,662	-2,441	-6,640
Distributions to noncontrolling interests	-435	-401	-378
Payment of debt issuance costs	-5	-62	-92
Issuance of common stock	'	'	2,506
Repurchase of common stock	-500	'	-1,503
Distributions to stockholders	-16	-3,148	-31
Income tax benefits	113	174	63
Other	-90	-67	48
Net cash (used in) provided by financing activities	-1,625	-1,780	-976
Change in cash and cash equivalents	-291	332	-38
Cash and cash equivalents at beginning of period	705	373	411
Cash and cash equivalents at end of period	414	705	373
Interest payments	1,832	1,723	1,987
Income tax payments (refunds), net	$694	$618	($256)

Accounting_Policies

Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Accounting Policies	'
	NOTE 1 — ACCOUNTING POLICIES
	Reporting Entity and Corporate Reorganization
	On November 17, 2006, HCA Inc. was acquired by a private investor group, including affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners and HCA founder, Dr. Thomas F. Frist Jr. (collectively, the “Investors”) and by members of management and certain other investors. The transaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities.
	On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s 100% owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. As a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities Exchange Act of 1934.
	During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock. Upon the completion of a secondary offering in February 2013, we no longer qualify as a “controlled company” under the applicable New York Stock Exchange (“NYSE”) listing standards and were required to appoint a board of directors comprised of a majority of independent members within one year of such date. Our common stock is traded on the NYSE (symbol “HCA”).
	HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At December 31, 2013, these affiliates owned and operated 165 hospitals, 115 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The term “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.
	Basis of Presentation
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
	The consolidated financial statements include all subsidiaries and entities controlled by HCA. We generally define “control” as ownership of a majority of the voting interest of an entity. The consolidated financial statements include entities in which we absorb a majority of the entity’s expected losses, receive a majority of the entity’s expected residual returns, or both, as a result of ownership, contractual or other financial interests in the entity. Significant intercompany transactions have been eliminated. Investments in entities we do not control, but in which we have a substantial ownership interest and can exercise significant influence, are accounted for using the equity method.
	We have completed various acquisitions and joint venture transactions. The accounts of these entities have been included in our consolidated financial statements for periods subsequent to our acquisition of controlling interests. The majority of our expenses are “cost of revenue” items. Costs that could be classified as general and administrative include our corporate office costs, which were $287 million, $248 million and $228 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Revenues
	Revenues consist primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts (based primarily on historical collection experience) related to these uninsured accounts to record net self pay revenues at the estimated amounts we expect to collect. Our revenues from third party payers and the uninsured for the years ended December 31, are summarized in the following table (dollars in millions):
		2013			Ratio			2012			Ratio			2011			Ratio
	Medicare	$	7,951			23.3	%	$	8,292			25.1	%	$	7,653			25.8	%
	Managed Medicare		3,279			9.6			2,954			8.9			2,442			8.2
	Medicaid		1,480			4.3			1,464			4.4			1,845			6.2
	Managed Medicaid		1,570			4.6			1,504			4.6			1,265			4.3
	Managed care and other insurers		18,654			54.6			17,998			54.5			15,703			52.9
	International (managed care and other insurers)		1,175			3.4			1,060			3.2			938			3.2
			34,109			99.8			33,272			100.7			29,846			100.6
	Uninsured		2,677			7.8			2,580			7.8			1,846			6.2
	Other		1,254			3.7			931			2.8			814			2.7
	Revenues before provision for doubtful accounts		38,040			111.3			36,783			111.3			32,506			109.5
	Provision for doubtful accounts		(3,858	)		(11.3	)		(3,770	)		(11.3	)		(2,824	)		(9.5	)
	Revenues	$	34,182			100	%	$	33,013			100	%	$	29,682			100	%
	Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. As a result, there is at least a reasonable possibility recorded estimates will change by a material amount. Estimated reimbursement amounts are adjusted in subsequent periods as cost reports are prepared and filed and as final settlements are determined (in relation to certain government programs, primarily Medicare, this is generally referred to as the “cost report” filing and settlement process). The adjustments to estimated Medicare and Medicaid reimbursement amounts and disproportionate-share funds, which resulted in net increases to revenues, related primarily to cost reports filed during the respective year were $41 million, $50 million and $40 million in 2013, 2012 and 2011, respectively. The adjustments to estimated reimbursement amounts, which resulted in net increases to revenues, related primarily to cost reports filed during previous years were $68 million, $242 million and $30 million in 2013, 2012 and 2011, respectively. The 2012 amount related to cost reports filed during previous years includes two adjustments to Medicare revenues that affected multiple annual cost report periods for the majority of our hospitals (the Rural Floor Provision Settlement increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios reduced revenues by approximately $75 million). Excluding the effect of these Medicare adjustments, the 2012 amount related to previous years would have been $46 million.
	The Emergency Medical Treatment and Labor Act (“EMTALA”) requires any hospital participating in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize the condition or make an appropriate transfer of the individual to a facility able to handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. Federal and state laws and regulations require, and our commitment to providing quality patient care encourages, us to provide services to patients who are financially unable to pay for the health care services they receive. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Patients treated at hospitals for nonelective care, who have income at or below 200% of the federal poverty level, are eligible for charity care. The federal poverty level is established by the federal government and is based on income and family size. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. In implementing the uninsured discount policy, we first attempt to qualify uninsured patients for Medicaid, other federal or state assistance or charity care. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.
	To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view charity care, uninsured discounts and the provision for doubtful accounts in combination, rather than each separately. A summary of these amounts for the years ended December 31, follows (dollars in millions):
		2013			Ratio			2012			Ratio			2011			Ratio
	Charity care	$	3,497			22	%	$	3,093			22	%	$	2,683			24	%
	Uninsured discounts		8,210			53			6,978			51			5,707			51
	Provision for doubtful accounts		3,858			25			3,770			27			2,824			25
	Total uncompensated care	$	15,565			100	%	$	13,841			100	%	$	11,214			100	%
	A summary of the estimated cost of total uncompensated care for the years ended December 31, follows (dollars in millions):
		2013			2012			2011
	Gross patient charges	$	181,141		$	165,614		$	141,516
	Patient care costs (salaries and benefits, supplies, other operating expenses and depreciation and amortization)		29,606			28,533			25,554
	Cost-to-charges ratio		16.3	%		17.2	%		18.1	%
	Total uncompensated care	$	15,565		$	13,841		$	11,214
	Multiply by the cost-to-charges ratio		16.3	%		17.2	%		18.1	%
	Estimated cost of total uncompensated care	$	2,537		$	2,381		$	2,030
	The sum of charity care, uninsured discounts and the provision for doubtful accounts, as a percentage of the sum of revenues, charity care, uninsured discounts and the provision for doubtful accounts increased from 27.4% for 2011, to 29.5% for 2012 and to 31.3% for 2013.
	Cash and Cash Equivalents
	Cash and cash equivalents include highly liquid investments with a maturity of three months or less when purchased. Our insurance subsidiaries’ cash equivalent investments in excess of the amounts required to pay estimated professional liability claims during the next twelve months are not included in cash and cash equivalents as these funds are not available for general corporate purposes. Carrying values of cash and cash equivalents approximate fair value due to the short-term nature of these instruments.
	Our cash management system provides for daily investment of available balances and the funding of outstanding checks when presented for payment. Outstanding, but unpresented, checks totaling $461 million and $437 million at December 31, 2013 and 2012, respectively, have been included in “accounts payable” in the consolidated balance sheets. Upon presentation for payment, these checks are funded through available cash balances or our credit facility.
	Accounts Receivable
	We receive payments for services rendered from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. We recognize that revenues and receivables from government agencies are significant to our operations, but do not believe there are significant credit risks associated with these government agencies. We do not believe there are any other significant concentrations of revenues from any particular payer that would subject us to any significant credit risks in the collection of our accounts receivable.
	Additions to the allowance for doubtful accounts are made by means of the provision for doubtful accounts. Accounts written off as uncollectible are deducted from the allowance for doubtful accounts and subsequent recoveries are added. The amount of the provision for doubtful accounts is based upon management’s assessment of historical and expected net collections, business and economic conditions, trends in federal, state and private employer health care coverage and other collection indicators. The provision for doubtful accounts and the allowance for doubtful accounts relate to “uninsured” amounts due directly from patients (including copayment and deductible amounts from patients who have health care coverage). Accounts are written off when all reasonable internal and external collection efforts have been performed. We consider the return of an account from the secondary collection agency to be the culmination of our reasonable collection efforts and the timing basis for writing off the account balance. Writeoffs are based upon specific identification and the writeoff process requires a writeoff adjustment entry to the patient accounting system. Management relies on the results of detailed reviews of historical writeoffs and recoveries at facilities that represent a majority of our revenues and accounts receivable (the “hindsight analysis”) as a primary source of information to utilize in estimating the collectibility of our accounts receivable. We perform the hindsight analysis quarterly, utilizing rolling twelve-months accounts receivable collection and writeoff data. At both December 31, 2013 and 2012, the allowance for doubtful accounts represented approximately 93% of the $5.927 billion and $5.228 billion, respectively, patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured portion of our accounts receivable. The estimated uninsured portion of Medicaid pending and uninsured discount pending accounts is included in our patient due accounts receivable balance. Days revenues in accounts receivable were 54 days, 51 days and 52 days at December 31, 2013, 2012 and 2011, respectively. Adverse changes in general economic conditions, patient accounting service center operations, payer mix or trends in federal or state governmental health care coverage could affect our collection of accounts receivable, cash flows and results of operations.
	Inventories
	Inventories are stated at the lower of cost (first-in, first-out) or market.
	Property and Equipment
	Depreciation expense, computed using the straight-line method, was $1.733 billion in 2013, $1.673 billion in 2012 and $1.461 billion in 2011. Buildings and improvements are depreciated over estimated useful lives ranging generally from 10 to 40 years. Estimated useful lives of equipment vary generally from four to 10 years.
	When events, circumstances or operating results indicate the carrying values of certain long-lived assets expected to be held and used, might be impaired, we prepare projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value. Fair value may be estimated based upon internal evaluations that include quantitative analyses of revenues and cash flows, reviews of recent sales of similar facilities and independent appraisals.
	Long-lived assets to be disposed of are reported at the lower of their carrying amounts or fair value less costs to sell or close. The estimates of fair value are usually based upon recent sales of similar assets and market responses based upon discussions with and offers received from potential buyers.
	Investments of Insurance Subsidiaries
	At December 31, 2013 and 2012, the investments of our 100% owned insurance subsidiaries were classified as “available-for-sale” as defined in Accounting Standards Codification (“ASC”) No. 320, Investments — Debt and Equity Securities and are recorded at fair value. The investment securities are held for the purpose of providing a funding source to pay liability claims covered by the insurance subsidiaries. We perform a quarterly assessment of individual investment securities to determine whether declines in market value are temporary or other-than-temporary. Our investment securities evaluation process involves multiple subjective judgments, often involves estimating the outcome of future events, and requires a significant level of professional judgment in determining whether an impairment has occurred. We evaluate, among other things, the financial position and near term prospects of the issuer, conditions in the issuer’s industry, liquidity of the investment, changes in the amount or timing of expected future cash flows from the investment, and recent downgrades of the issuer by a rating agency, to determine if, and when, a decline in the fair value of an investment below amortized cost is considered other-than-temporary. The length of time and extent to which the fair value of the investment is less than amortized cost and our ability and intent to retain the investment, to allow for any anticipated recovery of the investment’s fair value, are important components of our investment securities evaluation process.
	Goodwill and Intangible Assets
	Goodwill is not amortized but is subject to annual impairment tests. In addition to the annual impairment review, impairment reviews are performed whenever circumstances indicate a possible impairment may exist. Impairment testing for goodwill is done at the reporting unit level. Reporting units are one level below the business segment level, and our impairment testing is performed at the operating division or market level. We compare the fair value of the reporting unit assets to the carrying amount, on at least an annual basis, to determine if there is potential impairment. If the fair value of the reporting unit assets is less than their carrying value, we compare the fair value of the goodwill to its carrying value. If the fair value of the goodwill is less than its carrying value, an impairment loss is recognized. Fair value of goodwill is estimated based upon internal evaluations of the related long-lived assets for each reporting unit that include quantitative analyses of market multiples, revenues and cash flows and reviews of recent sales of similar facilities. No goodwill impairments were recognized during 2013, 2012 and 2011. Since January 1, 2000, we have recognized total goodwill impairments of $102 million in the aggregate. None of the goodwill impairments related to evaluations of goodwill at the reporting unit level, as all recognized goodwill impairments during this period related to goodwill allocated to asset disposal groups.
	During 2013, goodwill increased by $265 million related to acquisitions, declined by $1 million related to facility sales and declined by $13 million related to foreign currency translation and other adjustments. During 2012, goodwill increased by $288 million related to acquisitions, declined by $3 million related to facility sales and increased by $3 million related to foreign currency translation and other adjustments.
	During 2013, identifiable intangible assets increased by $113 million and are being amortized over estimated lives ranging generally from three to 15 years. During 2012, there were no changes in identifiable intangible assets. During 2011, indefinite-lived identifiable intangible assets increased by $269 million. Indefinite-lived identifiable intangible assets are not amortized, but all identifiable intangible assets are subject to annual impairment tests, and impairment reviews are performed whenever circumstances indicate a possible impairment may exist.
	Deferred Loan Costs
	Debt issuance costs are amortized based upon the terms of the respective debt obligations. The gross carrying amount of deferred loan costs at December 31, 2013 and 2012 was $542 million and $571 million, respectively, and accumulated amortization was $305 million and $281 million, respectively. Amortization of deferred loan costs is included in interest expense and was $55 million, $62 million and $70 million for 2013, 2012 and 2011, respectively.
	Physician Recruiting Agreements
In order to recruit physicians to meet the needs of our hospitals and the communities they serve, we enter into minimum revenue guarantee arrangements to assist the recruited physicians during the period they are relocating and establishing their practices. A guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the stand-ready obligation undertaken in issuing the guarantee. We expense the total estimated guarantee liability amount at the time the physician recruiting agreement becomes effective as we are not able to justify recording a contract-based asset based upon our analysis of the related control, regulatory and legal considerations.
The physician recruiting liability amount of $15 million at both December 31, 2013 and 2012 represents the amount of expense recognized in excess of payments made through December 31, 2013 and 2012. At December 31, 2013 the maximum amount we could have to pay under all effective minimum revenue guarantees was $39 million.
Professional Liability Claims
Reserves for professional liability risks were $1.279 billion and $1.297 billion at December 31, 2013 and 2012, respectively. The current portion of the reserves, $331 million and $324 million at December 31, 2013 and 2012, respectively, is included in “other accrued expenses” in the consolidated balance sheets. Provisions for losses related to professional liability risks were $314 million, $331 million and $244 million for 2013, 2012 and 2011, respectively, and are included in “other operating expenses” in our consolidated income statements. Provisions for losses related to professional liability risks are based upon actuarially determined estimates. Loss and loss expense reserves represent the estimated ultimate net cost of all reported and unreported losses incurred through the respective consolidated balance sheet dates. The reserves for unpaid losses and loss expenses are estimated using individual case-basis valuations and actuarial analyses. Those estimates are subject to the effects of trends in loss severity and frequency. The estimates are continually reviewed and adjustments are recorded as experience develops or new information becomes known. Adjustments to the estimated reserve amounts are included in current operating results. The reserves for professional liability risks cover approximately 2,600 individual claims and 2,700 individual claims at December 31, 2013 and 2012, respectively, and estimates for unreported potential claims. The time period required to resolve these claims can vary depending upon the jurisdiction and whether the claim is settled or litigated. During 2013 and 2012, $307 million and $335 million, respectively, of net payments were made for professional and general liability claims. The estimation of the timing of payments beyond a year can vary significantly. Although considerable variability is inherent in professional liability reserve estimates, we believe the reserves for losses and loss expenses are adequate; however, there can be no assurance the ultimate liability will not exceed our estimates.
A portion of our professional liability risks is insured through a 100% owned insurance subsidiary. Subject to a $5 million per occurrence self-insured retention, our facilities are insured by our 100% owned insurance subsidiary for losses up to $50 million per occurrence. The insurance subsidiary has obtained reinsurance for professional liability risks generally above a retention level of $15 million per occurrence. We also maintain professional liability insurance with unrelated commercial carriers for losses in excess of amounts insured by our insurance subsidiary.
The obligations covered by reinsurance and excess insurance contracts are included in the reserves for professional liability risks, as we remain liable to the extent the reinsurers and excess insurance carriers do not meet their obligations under the reinsurance and excess insurance contracts. The amounts receivable under the reinsurance contracts include $19 million and $17 million at December 31, 2013 and 2012, respectively, recorded in “other assets”, and $5 million and $32 million at December 31, 2013 and 2012, respectively, recorded in “other current assets”.
Financial Instruments
Derivative financial instruments are employed to manage risks, including interest rate and foreign currency exposures, and are not used for trading or speculative purposes. We recognize derivative instruments, such as interest rate swap agreements and foreign exchange contracts, in the consolidated balance sheets at fair value. Changes in the fair value of derivatives are recognized periodically either in earnings or in stockholders’ equity, as a component of other comprehensive income (loss), depending on whether the derivative financial instrument qualifies for hedge accounting, and if so, whether it qualifies as a fair value hedge or a cash flow hedge. Generally, changes in fair values of derivatives accounted for as fair value hedges are recorded in earnings, along with the changes in the fair value of the hedged items related to the hedged risk. Gains and losses on derivatives designated as cash flow hedges, to the extent they are effective, are recorded in other comprehensive income (loss), and subsequently reclassified to earnings to offset the impact of the forecasted transactions when they occur. In the event the forecasted transaction to which a cash flow hedge relates is no longer likely, the amount in other comprehensive income (loss) is recognized in earnings and generally the derivative is terminated. Changes in the fair value of derivatives not qualifying as hedges, and for any portion of a hedge that is ineffective, are reported in earnings.
The net interest paid or received on interest rate swaps is recognized as interest expense. Gains and losses resulting from the early termination of interest rate swap agreements are deferred and amortized as adjustments to interest expense over the remaining term of the debt originally associated with the terminated swap.
Electronic Health Record Incentive Payments
The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments for eligible hospitals and professionals that adopt and meaningfully use certified electronic health record (“EHR”) technology. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.
Medicaid EHR incentive calculations and related payment amounts are based upon prior period cost report information available at the time our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, and are not subject to revision for cost report data filed for a subsequent period. Thus, incentive income recognition occurs at the point our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, as the cost report information for the full cost report year that will determine the final calculation of the incentive payment is known at that time.
Medicare EHR incentive calculations and related initial payment amounts are based upon the most current filed cost report information available at the time our eligible hospitals demonstrate meaningful use of certified EHR technology for the applicable period. However, unlike Medicaid, this initial payment amount will be adjusted based upon an updated calculation using the annual cost report information for the cost report period that began during the applicable payment year. Thus, incentive income recognition occurs at the point our eligible hospitals demonstrate meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.
We recognized $216 million ($183 million Medicare and $33 million Medicaid), $336 million ($252 million Medicare and $84 million Medicaid) and $210 million ($123 million Medicare and $87 million Medicaid) of electronic health record incentive income during the years ended December 31, 2013, 2012 and 2011, respectively. At December 31, 2013 and 2012, we had $78 million and $113 million, respectively, of deferred EHR incentive income, which represent initial incentive payments received for which EHR incentive income has not been recognized.
Noncontrolling Interests in Consolidated Entities
The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned entities that we control. Accordingly, we have recorded noncontrolling interests in the earnings and equity of such entities.
Related Party Transactions — Management Agreement
The Investors provided management and advisory services to the Company pursuant to a management agreement among HCA Inc. and the Investors executed in connection with the Investors’ acquisition of HCA Inc. in November 2006. The management agreement was terminated pursuant to its terms upon completion of the initial public offering of our common stock during March 2011, and the Company paid the Investors a final fee of $181 million. The management agreement also provided that the Company pay a 1% fee in connection with certain financing, acquisition, divestiture and change of control transactions. The Company paid the Investors a fee of $26 million related to the initial public offering of our common stock, and this fee was recorded as a cost of the stock offering.
Reclassifications
Certain prior year amounts have been reclassified to conform to the 2013 presentation.

ShareBased_Compensation

Share-Based Compensation	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Share-Based Compensation	'
	NOTE 2 — SHARE-BASED COMPENSATION
	Stock Incentive Plan
	The 2006 Stock Incentive Plan for Key Employees of HCA Holdings Inc. and its Affiliates, as Amended and Restated (the “Stock Incentive Plan”) is designed to promote the long term financial interests and growth of the Company by attracting and retaining management and other personnel and to motivate them to achieve long range goals and further the alignment of interests of participants with those of our stockholders through opportunities for increased stock, or stock-based, ownership in the Company. Portions of the options, stock appreciation rights (“SARs”) and restricted share units (“RSUs”) granted under the Stock Incentive Plan vest solely based upon continued employment over a specific period of time, and portions of the options, SARs and RSUs vest based both upon continued employment over a specific period of time and upon the achievement of predetermined financial targets over time. We granted 4,864,000 and 6,348,000 SARs and 4,858,800 and 4,647,400 RSUs under the Stock Incentive Plan during 2013 and 2012, respectively. At December 31, 2013, there were 25,088,200 stock options and SARs outstanding and exercisable, and there were 32,269,100 shares available for future grants under the Stock Incentive Plan.
	Stock Option, SAR and RSU Activity
	The fair value of each stock option and SAR award is estimated on the grant date, using valuation models and the weighted average assumptions indicated in the following table. Awards under the Stock Incentive Plan generally vest based on continued employment (“Time Stock Options and SARs” and “Time RSUs”) and based upon achievement of certain financial targets (“Performance Stock Options and SARs” and “Performance RSUs”). Each grant is valued as a single award with an expected term equal to the average expected term of the component vesting tranches. We use historical exercise behavior data and other factors to estimate the expected term of the options and SARs. The expected term of the share-based award is limited by the contractual term, and employee post-vesting termination behavior is incorporated in the historical exercise behavior data.
	Compensation cost is recognized on the straight-line attribution method. The straight-line attribution method requires that total compensation expense recognized must at least equal the vested portion of the grant-date fair value. The expected volatility is derived using historical stock price information for our common stock and that of certain peer group companies. The risk-free interest rate is the approximate yield on United States Treasury Strips having a life equal to the expected share-based award life on the date of grant. The expected life is an estimate of the number of years a share-based award will be held before it is exercised.
		2013			2012			2011
	Risk-free interest rate		1.2	%		1.18	%		0.89	%
	Expected volatility		45	%		50	%		41	%
	Expected life, in years		6.25			6.25			5
	Expected dividend yield		—			—			—
	Information regarding Time Stock Options and SARs and Performance Stock Options and SARs activity during 2013, 2012 and 2011 is summarized below (share amounts in thousands):
		Time			Performance			Total			Weighted		Weighted		Aggregate
		Stock			Stock			Stock			Average		Average		Intrinsic Value
		Options			Options and			Options			Exercise		Remaining		(dollars in millions)
		and			SARs			and			Price		Contractual Term
		SARs						SARs
	Options outstanding, December 31, 2010		24,517			26,009			50,526		$	8.58
	Granted		644			644			1,288			23.35
	Exercised		(3,312	)		(1,732	)		(5,044	)		6.31
	Cancelled		(110	)		(348	)		(458	)		5.88
	Options outstanding, December 31, 2011		21,739			24,573			46,312			9.26
	Granted		3,174			3,174			6,348			27.03
	Exercised		(5,530	)		(5,128	)		(10,658	)		7.6
	Cancelled		(192	)		(568	)		(760	)		9.49
	Options and SARs outstanding, December 31, 2012		19,191			22,051			41,242			11.56
	Granted		2,432			2,432			4,864			37.49
	Exercised		(4,498	)		(5,843	)		(10,341	)		8.49
	Cancelled		(316	)		(263	)		(579	)		25.5
	Options and SARs outstanding, December 31, 2013		16,809			18,377			35,186			15.82		5.4 years	$	1,122
	Options and SARs exercisable, December 31, 2013		11,960			13,527			25,487		$	10.55		4.1 years	$	947
	The weighted average fair values of stock options and SARs granted during 2013, 2012 and 2011 were $16.68, $13.16 and $8.53 per share, respectively. The total intrinsic value of stock options and SARs exercised in the year ended December 31, 2013 was $334 million. As of December 31, 2013, the unrecognized compensation cost related to nonvested stock options and SARs was $104 million.
	Information regarding Time RSUs and Performance RSUs activity during 2013, 2012 and 2011 is summarized below (share amounts in thousands):
		Time RSUs			Performance			Total RSUs			Weighted
					RSUs						Average
											Grant
											Date Fair
											Value
	RSUs outstanding, December 31, 2010		—			—			—			—
	Granted		80			—			80		$	30
	Vested		—			—			—			—
	Cancelled		—			—			—			—
	RSUs outstanding, December 31, 2011		80			—			80			30
	Granted		3,162			1,485			4,647			26.98
	Vested		(4	)		—			(4	)		30
	Cancelled		(164	)		(75	)		(239	)		26.99
	RSUs outstanding, December 31, 2012		3,074			1,410			4,484			27.03
	Granted		3,305			1,554			4,859			37.43
	Vested		(831	)		(352	)		(1,183	)		27.3
	Cancelled		(449	)		(213	)		(662	)		31.91
	RSUs outstanding, December 31, 2013		5,099			2,399			7,498			33.3
	As of December 31, 2013, the unrecognized compensation cost related to RSUs was $185 million.
	During 2012, our Board of Directors declared three distributions to the Company’s stockholders and holders of certain vested share-based awards. The distributions totaled $6.50 per share and vested share-based award (subject to limitations for certain awards), or $3.142 billion in the aggregate. Pursuant to the terms of our share-based award plans, the holders of nonvested stock options and SARs received $6.50 per share reductions to the exercise price of the applicable share-based awards (subject to certain limitations for certain share-based awards that resulted in deferred distributions for a portion of the declared distribution, which will be paid upon the vesting of the applicable share-based award). The holders of any nonvested RSUs will be paid the applicable distribution amounts upon the vesting of the applicable RSUs. There were no distributions declared during 2013 and 2011.

Acquisitions_and_Dispositions

Acquisitions and Dispositions	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Acquisitions and Dispositions	'
	NOTE 3 — ACQUISITIONS AND DISPOSITIONS
	HealthONE Acquisition
	During October 2011, we completed the acquisition of the Colorado Health Foundation’s (“Foundation”) approximate 40% remaining ownership interest in the HCA-HealthONE LLC (“HealthONE”) joint venture for $1.450 billion. HealthONE’s assets included seven hospitals and 12 freestanding surgery centers in the Denver area. We accounted for our investment in HealthONE using the equity method through October 2011 with our share of their operations all recorded in the line item “Equity in earnings of affiliates” in our consolidated income statements, and we began consolidating HealthONE’s operations in our consolidated income statements beginning November 2011.
	The total cost of the HealthONE acquisition has been allocated to the assets acquired and liabilities assumed based upon their respective fair values in accordance with ASC No. 805, Business Combinations. The purchase price represented a premium over the fair value of the net tangible and identifiable intangible assets acquired due to the value of the expected cash flows and HealthONE’s assembled workforce.
	We identified and analyzed the acquired fixed assets, contracts, contractual commitments and legal contingencies to record the fair value of all assets acquired and liabilities assumed, resulting in goodwill of $2.261 billion being recorded as of December 31, 2011. We also recorded a gain of $1.522 billion related to this acquisition due to the remeasurement of our previous equity investment in HealthONE, based upon our acquisition of the Foundation’s ownership interest and the resulting consolidation of the entire enterprise at estimated fair value. During 2012, we recorded final adjustments to the purchase price allocation which resulted in a $30 million increase to noncontrolling interests, a $26 million reduction to property and equipment and a $56 million increase to goodwill. The amount of tax deductible goodwill is $981 million.
	A summary of the final purchase price allocation, including assumed liabilities, follows (dollars in millions):
	Current assets	$	400
	Property and equipment		1,014
	Identifiable intangible asset (trade name)		269
	Goodwill		2,317
	Other assets		7
	Liabilities		152
	Noncontrolling interests		123
	The acquired HealthONE operating results have been included in our consolidated income statements since the acquisition date. The revenues and net income attributable to HCA Holdings, Inc. related to the acquired HealthONE operations for the period from November 1, 2011 through December 31, 2011 were $347 million and $15 million, respectively. The following unaudited pro forma combined summary of operations data gives effect to including the acquired HealthONE operating results in our operating results as if the acquisition had occurred as of January 1, 2011 (dollars in millions):
		Year Ended
		December  31,
		2011
	Pro forma revenues	$	31,383
	Pro forma net income attributable to HCA Holdings, Inc.		2,507
	Pro forma adjustments to net income attributable to HCA Holdings, Inc. include adjustments to record HealthONE’s operating results on a consolidated basis and eliminate the equity method operating results, to record depreciation expense based on the estimated fair value assigned to the long-lived assets acquired, to record interest expense assuming the increase in long-term debt used to fund the acquisition had occurred as of January 1, 2011 and to record the related tax effects. This pro forma result is not necessarily indicative of the actual results of operations that would have occurred if the acquisition had occurred on January 1, 2011.
	Other Acquisitions and Dispositions
	During 2013, we paid $277 million and recorded goodwill and identifiable intangible assets of $183 million and $113 million, respectively, related to the acquisition of The Outsource Group, which was acquired by our Parallon affiliate and is included in the Corporate and other Group. During 2013, we also paid $146 million and recorded goodwill of $58 million related to the acquisition of three hospitals, and we paid $57 million to acquire nonhospital health care entities. During 2012, we paid $58 million and assumed liabilities of $33 million to acquire a hospital and paid $200 million to acquire other nonhospital health care entities. During 2011, we paid $136 million to acquire a hospital and $96 million to acquire other nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. The purchase price paid in excess of the fair value of identifiable net assets of these acquired entities aggregated $265 million, $232 million and $68 million in 2013, 2012 and 2011, respectively. The consolidated financial statements include the accounts and operations of the acquired entities subsequent to the respective acquisition dates. The pro forma effects of these acquired entities on our results of operations for periods prior to the respective acquisition dates were not significant.
	During 2013, we received proceeds of $33 million and recognized a net pretax loss of $10 million ($7 million after tax) related to the sale of a hospital facility in the American Group and other real estate investments. During 2012, we received proceeds of $30 million and recognized a net pretax gain of $15 million ($9 million after tax) related to the sales of real estate investments. During 2011, we received proceeds of $281 million and recognized a net pretax gain of $142 million ($80 million after tax) related to the sales of a hospital facility in the National Group and our investment in a hospital joint venture.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	NOTE 4 — INCOME TAXES
	The provision for income taxes consists of the following (dollars in millions):
		2013			2012			2011
	Current:
	Federal	$	827		$	604		$	(119	)
	State		86			58			(12	)
	Foreign		44			43			44
	Deferred:
	Federal		(53	)		167			714
	State		20			(8	)		71
	Foreign		26			24			21
		$	950		$	888		$	719
	The provision for income taxes reflects $4 million, $53 million and $100 million ($3 million, $33 million and $63 million net of tax, respectively) reductions in interest related to taxing authority examinations for the years ended December 31, 2013, 2012 and 2011, respectively. Our foreign income before income taxes was $187 million, $178 million and $173 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	A reconciliation of the federal statutory rate to the effective income tax rate follows:
		2013			2012			2011
	Federal statutory rate		35	%		35	%		35	%
	State income taxes, net of federal tax benefit		2.3			2.2			2
	Change in liability for uncertain tax positions		0.5			—			1
	Nontaxable gain on acquisition of controlling interest in equity investment		—			—			(13.8	)
	Tax exempt interest income		(0.2	)		(0.2	)		(0.2	)
	Other items, net		0.3			(1.4	)		(1.4	)
	Effective income tax rate on income applicable to HCA Holdings, Inc.		37.9			35.6			22.6
	Income attributable to noncontrolling interests from consolidated partnerships		(5.7	)		(4.9	)		(2.4	)
	Effective income tax rate on income before income taxes		32.2	%		30.7	%		20.2	%
	A summary of the items comprising the deferred tax assets and liabilities at December 31 follows (dollars in millions):
		2013						2012
		Assets			Liabilities			Assets			Liabilities
	Depreciation and fixed asset basis differences	$	—		$	229		$	—		$	292
	Allowances for professional liability and other risks		365			—			355			—
	Accounts receivable		423			—			405			—
	Compensation		240			—			237			—
	Other		638			698			744			595
		$	1,666		$	927		$	1,741		$	887
	At December 31, 2013, state net operating loss carryforwards (expiring in years 2014 through 2033) available to offset future taxable income approximated $17 million. Utilization of net operating loss carryforwards in any one year may be limited. Net deferred tax assets related to such carryforwards are not significant.
	We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2011 federal income tax return in 2014.
	The following table summarizes the activity related to our unrecognized tax benefits (dollars in millions):
		2013			2012
	Balance at January 1	$	425		$	445
	Additions based on tax positions related to the current year		21			16
	Additions for tax positions of prior years		25			92
	Reductions for tax positions of prior years		(18	)		(19	)
	Settlements		(5	)		(103	)
	Lapse of applicable statutes of limitations		(3	)		(6	)
	Balance at December 31	$	445		$	425
	During 2013, we finalized settlements with the IRS resolving all outstanding issues for HCA Inc.’s 2007, 2008 and 2009 tax years. During 2012, we finalized settlements with the IRS for our 2005 and 2006 tax years resolving all outstanding issues, including the timing of recognition of certain patient service revenues, the deductibility of certain debt retirement costs and our method for calculating the tax allowance for doubtful accounts.
	Our liability for unrecognized tax benefits was $462 million, including accrued interest of $30 million and excluding $13 million that was recorded as reductions of the related deferred tax assets, as of December 31, 2013 ($426 million, $14 million and $13 million, respectively, as of December 31, 2012). Unrecognized tax benefits of $160 million ($125 million as of December 31, 2012) would affect the effective rate, if recognized.
	Depending on the resolution of any IRS disputes, the completion of examinations by federal, state or international taxing authorities, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible that our liability for unrecognized tax benefits may significantly increase or decrease within the next 12 months. However, we are currently unable to estimate the range of any possible change.

Earnings_Per_Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	NOTE 5 — EARNINGS PER SHARE
	We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding plus the dilutive effect of outstanding stock options, SARs and RSUs, computed using the treasury stock method. During September 2011, we repurchased 80,771,143 shares of our common stock. During November 2013, we repurchased 10,656,436 shares of our common stock. The following table sets forth the computations of basic and diluted earnings per share for the years ended December 31, 2013, 2012 and 2011 (dollars in millions, except per share amounts, and shares in thousands):
		2013		2012		2011
	Net income attributable to HCA Holdings, Inc	$	1,556	$	1,605	$	2,465
	Weighted average common shares outstanding		445,066		440,178		476,609
	Effect of dilutive incremental shares		16,847		19,225		19,334
	Shares used for diluted earnings per share		461,913		459,403		495,943
	Earnings per share:
	Basic earnings per share	$	3.5	$	3.65	$	5.17
	Diluted earnings per share	$	3.37	$	3.49	$	4.97

Investments_of_Insurance_Subsi

Investments of Insurance Subsidiaries	12 Months Ended
	Dec. 31, 2013
Investments Debt And Equity Securities [Abstract]	'
Investments of Insurance Subsidiaries	'
	NOTE 6 — INVESTMENTS OF INSURANCE SUBSIDIARIES
	A summary of the insurance subsidiaries’ investments at December 31 follows (dollars in millions):
		2013
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	385	$	11	$	(3	)	$	393
	Auction rate securities		7		—		—			7
	Asset-backed securities		12		—		—			12
	Money market funds		94		—		—			94
			498		11		(3	)		506
	Equity securities		2		2		—			4
		$	500	$	13	$	(3	)		510
	Amounts classified as current assets									(62	)
	Investment carrying value								$	448
		2012
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	395	$	23	$	—		$	418
	Auction rate securities		74		—		(6	)		68
	Asset-backed securities		14		—		—			14
	Money market funds		67		—		—			67
			550		23		(6	)		567
	Equity securities		2		1		—			3
		$	552	$	24	$	(6	)		570
	Amounts classified as current assets									(55	)
	Investment carrying value								$	515
	At December 31, 2013 and 2012, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income (loss). At December 31, 2013 and 2012, $1 million and $9 million, respectively, of our investments were subject to the restrictions included in insurance bond collateralization and assumed reinsurance contracts.
	Scheduled maturities of investments in debt securities at December 31, 2013 were as follows (dollars in millions):
		Amortized		Fair
		Cost		Value
	Due in one year or less	$	110	$	110
	Due after one year through five years		180		186
	Due after five years through ten years		100		102
	Due after ten years		89		89
			479		487
	Auction rate securities		7		7
	Asset-backed securities		12		12
		$	498	$	506
	The average expected maturity of the investments in debt securities at December 31, 2013 was 3.8 years, compared to the average scheduled maturity of 5.4 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to their scheduled maturity date.

Financial_Instruments

Financial Instruments	12 Months Ended
	Dec. 31, 2013
Derivative Instruments And Hedging Activities Disclosure [Abstract]	'
Financial Instruments	'
	NOTE 7 — FINANCIAL INSTRUMENTS
	Interest Rate Swap Agreements
	We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities, for the interest rate swap agreements which have been designated as cash flow hedges. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.
	The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at December 31, 2013 (dollars in millions):
		Notional		Maturity Date		Fair
		Amount				Value
	Pay-fixed interest rate swaps	$	500		December 2014	$	(5	)
	Pay-fixed interest rate swaps		3,000		December 2016		(248	)
	Pay-fixed interest rate swaps		1,000		December 2017		(42	)
	During the next 12 months, we estimate $127 million will be reclassified from other comprehensive income (“OCI”) to interest expense.
	Cross Currency Swaps
	The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into various cross currency swaps. At December 31, 2013, we are not party to any cross currency swaps.
	Derivatives — Results of Operations
	The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the year ended December 31, 2013 (dollars in millions):
	Derivatives in Cash Flow Hedging Relationships	Amount of Gain		Location of Loss		Amount of Loss
		Recognized in OCI on		Reclassified from		Reclassified from
		Derivatives, Net of  Tax		Accumulated OCI		Accumulated OCI
				into Operations		into Operations
	Interest rate swaps	$	2		Interest expense	$	131
	Derivatives Not Designated as Hedging Instruments	Location of Gain		Amount of Gain
		Recognized in		Recognized in
		Operations on		Operations on
		Derivatives		Derivatives
	Cross currency swap (matured November 2013)		Other operating expenses	$	13
	Credit-risk-related Contingent Features
	We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of December 31, 2013, we have not been required to post any collateral related to these agreements. If we had breached these provisions at December 31, 2013, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $308 million.

Assets_and_Liabilities_Measure

Assets and Liabilities Measured at Fair Value	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Assets and Liabilities Measured at Fair Value	'
	NOTE 8 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE
	Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 utilizes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
	Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.
	Cash Traded Investments
	Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The valuation of these securities involves management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived fair market values compared to tax-equivalent yields of other securities of similar credit worthiness and similar effective maturities.
	Derivative Financial Instruments
	We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. To comply with the provisions of ASC 820, we incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.
	Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at December 31, 2013 and 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.
	The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):
		December 31, 2013
		Fair Value			Fair Value Measurements Using
					Quoted Prices in			Significant Other		Significant
					Active Markets for			Observable Inputs		Unobservable Inputs
					Identical Assets			(Level 2)		(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	393		$	—		$	393	$	—
	Auction rate securities		7			—			—		7
	Asset-backed securities		12			—			12		—
	Money market funds		94			94			—		—
			506			94			405		7
	Equity securities		4			3			—		1
	Investments of insurance subsidiaries		510			97			405		8
	Less amounts classified as current assets		(62	)		(62	)		—		—
		$	448		$	35		$	405	$	8
	Liabilities:
	Interest rate swaps (Income taxes and other liabilities)	$	295		$	—		$	295	$	—
		December 31, 2012
					Fair Value Measurements Using
		Fair Value			Quoted Prices in			Significant Other		Significant
					Active Markets for			Observable Inputs		Unobservable Inputs
					Identical Assets			(Level 2)		(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	418		$	—		$	418	$	—
	Auction rate securities		68			—			—		68
	Asset-backed securities		14			—			14		—
	Money market funds		67			67			—		—
			567			67			432		68
	Equity securities		3			1			—		2
	Investments of insurance subsidiaries		570			68			432		70
	Less amounts classified as current assets		(55	)		(55	)		—		—
		$	515		$	13		$	432	$	70
	Liabilities:
	Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
	Interest rate swaps (Income taxes and other liabilities)		429			—			429		—
	The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the year ended December 31, 2013 (dollars in millions):
	Asset balances at December 31, 2012	$	70
	Unrealized gains included in other comprehensive income		6
	Settlements		(68	)
	Asset balances at December 31, 2013	$	8
	The estimated fair value of our long-term debt was $29.603 billion and $30.781 billion at December 31, 2013 and 2012, respectively, compared to carrying amounts aggregating $28.376 billion and $28.930 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

LongTerm_Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Long-Term Debt	'
	NOTE 9 — LONG-TERM DEBT
	A summary of long-term debt at December 31, including related interest rates at December 31, 2013, follows (dollars in millions):
			2013		2012
	Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)		$	2,440	$	1,470
	Senior secured revolving credit facility			—		—
	Senior secured term loan facilities (effective interest rate of 5.3%)			5,598		5,958
	Senior secured first lien notes (effective interest rate of 7.1%)			9,695		9,688
	Other senior secured debt (effective interest rate of 6.8%)			448		423
	First lien debt			18,181		17,539
	Senior secured second lien notes			—		197
	Senior unsecured notes (effective interest rate of 7.2%)			10,195		11,194
	Total debt (average life of 6.3 years, rates averaging 6.3%)			28,376		28,930
	Less amounts due within one year			786		1,435
			$	27,590	$	27,495
	2013 Activity
	During March 2013, we redeemed all $201 million aggregate principal amount of our 9 7/8% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.
	During November 2013, our $329 million senior secured European term loan facility matured.
	2012 Activity
	During February 2012, we issued $1.350 billion aggregate principal amount of 5.875% senior secured first lien notes due 2022. After the payment of related fees and expenses, we used the proceeds for general corporate purposes.
	During October 2012, we replaced our $2.000 billion senior secured revolving credit facility maturing on November 17, 2015, with a new facility on substantially the same terms other than foregoing a scheduled increase in interest rates and extending the maturity date to November 17, 2016.
	During October 2012, we issued $2.500 billion aggregate principal amount of notes, comprised of $1.250 billion of 4.75% senior secured first lien notes due 2023 and $1.250 billion of 5.875% senior unsecured notes due 2023. After the payment of related fees and expenses, we used the proceeds for general corporate purposes.
	During December 2012, we issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. After the payment of related fees and expenses, we used the proceeds to pay a distribution to our stockholders and holders of certain vested stock awards.
	Senior Secured Credit Facilities And Other First Lien Debt
	We have entered into the following senior secured credit facilities: (i) a $2.500 billion asset-based revolving credit facility maturing on September 30, 2016 with a borrowing base of 85% of eligible accounts receivable, subject to customary reserves and eligibility criteria ($2.440 billion outstanding at December 31, 2013) (the “ABL credit facility”); (ii) a $2.000 billion senior secured revolving credit facility maturing on November 17, 2016 (none outstanding at December 31, 2013 without giving effect to certain outstanding letters of credit); (iii) a $512 million senior secured term loan A-2 facility maturing on May 2, 2016; (iv) a $724 million senior secured term loan A-4 facility maturing on February 2, 2016; (v) a $2.367 billion senior secured term loan B-4 facility maturing on May 1, 2018; and (vi) a $1.995 billion senior secured term loan B-5 facility maturing on March 31, 2017. We refer to the facilities described under (ii) through (vi) above, collectively, as the “cash flow credit facility” and, together with the ABL credit facility, the “senior secured credit facilities.”
	Borrowings under the senior secured credit facilities bear interest at a rate equal to, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% or (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period, plus, in each case, an applicable margin. The applicable margin for borrowings under the senior secured credit facilities may be reduced subject to attaining certain leverage ratios.
	The senior secured credit facilities contain a number of covenants that restrict, subject to certain exceptions, our (and some or all of our subsidiaries’) ability to incur additional indebtedness, repay subordinated indebtedness, create liens on assets, sell assets, make investments, loans or advances, engage in certain transactions with affiliates, pay dividends and distributions, and enter into sale and leaseback transactions. In addition, we are required to satisfy and maintain a maximum total leverage ratio covenant under the cash flow credit facility and, in certain situations under the ABL credit facility, a minimum interest coverage ratio covenant.
	Senior secured first lien notes consist of (i) $1.500 billion aggregate principal amount of 8 1/2% senior secured first lien notes due 2019; (ii) $1.250 billion aggregate principal amount of 7 7/8% senior secured first lien notes due 2020; (iii) $1.400 billion aggregate principal amount of 7 1/4% senior secured first lien notes due 2020; (iv) $3.000 billion aggregate principal amount of 6.50% senior secured first lien notes due 2020; (v) $1.350 billion aggregate principal amount of 5.875% first lien notes due 2022; (vi) $1.250 billion aggregate principal amount of 4.75% first lien notes due 2023; and (vii) $55 million of unamortized debt discounts that reduce the senior secured first lien indebtedness. Capital leases and other secured debt totaled $448 million at December 31, 2013.
	We use interest rate swap agreements to manage the variable rate exposure of our debt portfolio. At December 31, 2013, we had entered into effective interest rate swap agreements, in a total notional amount of $4.500 billion, in order to hedge a portion of our exposure to variable rate interest payments associated with the senior secured credit facilities. The effect of the interest rate swaps is reflected in the effective interest rates for the senior secured credit facilities.
	Senior Unsecured Notes
	Senior unsecured notes consist of (i) $6.541 billion aggregate principal amount of senior notes with maturities ranging from 2014 to 2033; (ii) an aggregate principal amount of $246 million medium-term notes with maturities ranging from 2014 to 2025; (iii) an aggregate principal amount of $886 million debentures with maturities ranging from 2015 to 2095; (iv) an aggregate principal amount of $1.525 billion senior notes due 2021 issued by HCA Holdings, Inc.; (v) an aggregate principal amount of $1.000 billion senior notes due 2021 issued by HCA Holdings, Inc.; and (vi) $3 million of unamortized debt discounts that reduce the indebtedness.
	General Debt Information
	The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, 100% owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture (the “1993 Indenture”) dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our ABL credit facility).
	All obligations under the ABL credit facility, and the guarantees of those obligations, are secured, subject to permitted liens and other exceptions, by a first-priority lien on substantially all of the receivables of the borrowers and each guarantor under such ABL credit facility (the “Receivables Collateral”).
	All obligations under the cash flow credit facility and the guarantees of such obligations are secured, subject to permitted liens and other exceptions, by:
		•		a first-priority lien on the capital stock owned by HCA Inc., or by any U.S. guarantor, in each of their respective first-tier subsidiaries;
		•		a first-priority lien on substantially all present and future assets of HCA Inc. and of each U.S. guarantor other than (i) “Principal Properties” (as defined in the 1993 Indenture), (ii) certain other real properties and (iii) deposit accounts, other bank or securities accounts, cash, leaseholds, motor-vehicles and certain other exceptions; and
		•		a second-priority lien on certain of the Receivables Collateral.
	Our senior secured first lien notes and the related guarantees are secured by first-priority liens, subject to permitted liens, on our and our subsidiary guarantors’ assets, subject to certain exceptions, that secure our cash flow credit facility on a first-priority basis and are secured by second-priority liens, subject to permitted liens, on our and our subsidiary guarantors’ assets that secure our ABL credit facility on a first-priority basis and our other cash flow credit facility on a second-priority basis.
	Maturities of long-term debt in years 2015 through 2018, excluding amounts under the ABL credit facility, are $1.065 million, $2.282 billion, $2.028 billion and $2.803 billion, respectively.

Contingencies_and_Legal_Claim_

Contingencies and Legal Claim Costs	12 Months Ended
	Dec. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Contingencies and Legal Claim Costs	'
	NOTE 10 — CONTINGENCIES AND LEGAL CLAIM COSTS
	We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.
	Government Investigations, Claims and Litigation
	Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.
	As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.
	In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and has produced medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.
	Securities Class Action Litigation
	On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims.
	In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action had also been stayed pending developments in the shareholder class actions, but that stay has expired. The plaintiff in the state derivative action subsequently filed an amended complaint on September 9, 2013 that added additional allegations made in the shareholder class actions. On September 24, 2013, an additional state derivative action, Steinberg v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court. This action against our board of directors has been consolidated with the earlier filed state derivative action. The plaintiffs in the consolidated action filed a consolidated complaint on December 4, 2013. The Company has filed a motion to again stay the state derivative action pending developments in the class action, but the Court has not yet acted on that motion.
	Health Midwest Litigation
	In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling. The accounting for HCA’s capital expenditures and charity and uncompensated care is ongoing and will likely not be concluded before the fourth quarter of 2014. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters final judgment.

Leases

Leases	12 Months Ended
	Dec. 31, 2013
Leases [Abstract]	'
Leases	'
	NOTE 11 — LEASES
	We lease medical office buildings and certain equipment under operating lease agreements. Commitments relating to noncancellable operating leases for each of the next five years and thereafter are as follows (dollars in millions):
	For the Year Ended December 31,
	2014	$	293
	2015		267
	2016		215
	2017		175
	2018		132
	Thereafter		740
			1,822
	Less sublease income		(30	)
		$	1,792

Capital_Stock

Capital Stock	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Capital Stock	'
	NOTE 12 — CAPITAL STOCK
	The amended and restated certificate of incorporation authorizes the Company to issue up to 1,800,000,000 shares of common stock, and our amended and restated by-laws set the number of directors constituting the board of directors of the Company at not less than three members, the exact number to be determined from time to time by resolution adopted by the affirmative vote of a majority of the total number of directors then in office.
	During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock at a price of $30.00 per share and realized net proceeds (after costs of the offering) of $2.506 billion. During September 2011, we repurchased 80,771,143 shares of our common stock beneficially owned by affiliates of Bank of America Corporation at a purchase price of $18.61 per share, the closing price of the Company’s common stock on the New York Stock Exchange on September 14, 2011. The shares repurchased represented approximately 15.6% of our total shares outstanding at the time of the repurchase. During November 2013, we repurchased 10,656,436 shares of our common stock at a price of $46.92 per share.
	Distributions
	During 2012, our Board of Directors declared three distributions to the Company’s stockholders and holders of certain vested share-based awards. The distributions totaled $6.50 per share and vested share-based award (subject to limitations for certain awards), or $3.142 billion in the aggregate. Pursuant to the terms of our share-based award plans, the holders of nonvested stock options and SARs received $6.50 per share reductions to the exercise price of the applicable share-based awards (subject to certain limitations for certain share-based awards that resulted in deferred distributions for a portion of the declared distribution, which will be paid upon the vesting of the applicable share-based award). The holders of nonvested RSUs will be paid the applicable distribution amounts upon the vesting of the applicable RSUs. There were no distributions declared during 2013 and 2011.

Employee_Benefit_Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2013
Compensation And Retirement Disclosure [Abstract]	'
Employee Benefit Plans	'
	NOTE 13 — EMPLOYEE BENEFIT PLANS
	We maintain contributory, defined contribution benefit plans that are available to employees who meet certain minimum requirements. Certain of the plans require that we match specified percentages of participant contributions up to certain maximum levels (generally, 100% of the first 3% to 9%, depending upon years of vesting service, of compensation deferred by participants). The cost of these plans totaled $374 million for 2013, $371 million for 2012 and $322 million for 2011. Our contributions are funded periodically during each year.
	We maintain the noncontributory, nonqualified Restoration Plan to provide certain retirement benefits for eligible employees. Eligibility for the Restoration Plan is based upon earning eligible compensation in excess of the Social Security Wage Base and attaining 1,000 or more hours of service during the plan year. Company credits to participants’ account balances (the Restoration Plan is not funded) depend upon participants’ compensation, years of vesting service and certain IRS limitations related to the HCA 401(k) plan. Benefits expense under this plan was $29 million for 2013, $20 million for 2012 and $25 million for 2011. Accrued benefits liabilities under this plan totaled $137 million at December 31, 2013 and $120 million at December 31, 2012.
	We maintain a Supplemental Executive Retirement Plan (“SERP”) for certain executives. The plan is designed to ensure that upon retirement the participant receives the value of a prescribed life annuity from the combination of the SERP and our other benefit plans. Benefits expense under the plan was $43 million for 2013, $51 million for 2012 and $33 million for 2011. Accrued benefits liabilities under this plan totaled $214 million at December 31, 2013 and $242 million at December 31, 2012.
	We maintain defined benefit pension plans which resulted from certain hospital acquisitions in prior years. Benefits expense under these plans was $37 million for 2013, $49 million for 2012, and $39 million for 2011. Accrued benefits liabilities under these plans totaled $81 million at December 31, 2013 and $196 million at December 31, 2012.

Segment_and_Geographic_Informa

Segment and Geographic Information	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Segment and Geographic Information	'
	NOTE 14 — SEGMENT AND GEOGRAPHIC INFORMATION
	We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The acquired HealthONE operating results have been included in the American Group operating results for periods subsequent to November 1, 2011. Prior to November 1, 2011, the American Group recorded its share of the HealthONE operating results in equity in earnings of affiliates.
	At December 31, 2013, the National Group included 82 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group included 77 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.
	Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses (gains) on sales of facilities, losses on retirement of debt, legal claim costs, gain on acquisition of controlling interest in equity investment, termination of management agreement, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA, depreciation and amortization, assets and goodwill and other intangible assets are summarized in the following table (dollars in millions):
		For the Years Ended December 31,
		2013			2012			2011
	Revenues:
	National Group	$	15,968		$	15,505		$	14,741
	American Group		16,487			16,115			13,714
	Corporate and other		1,727			1,393			1,227
		$	34,182		$	33,013		$	29,682
	Equity in earnings of affiliates:
	National Group	$	(9	)	$	(9	)	$	(7	)
	American Group		(24	)		(28	)		(251	)
	Corporate and other		4			1			—
		$	(29	)	$	(36	)	$	(258	)
	Adjusted segment EBITDA:
	National Group	$	3,301		$	3,325		$	3,052
	American Group		3,662			3,575			3,141
	Corporate and other		(389	)		(369	)		(132	)
		$	6,574		$	6,531		$	6,061
	Depreciation and amortization:
	National Group	$	718		$	694		$	639
	American Group		835			816			680
	Corporate and other		200			169			146
		$	1,753		$	1,679		$	1,465
		For the Years Ended December 31,
		2013			2012			2011
	Adjusted segment EBITDA	$	6,574		$	6,531		$	6,061
	Depreciation and amortization		1,753			1,679			1,465
	Interest expense		1,848			1,798			2,037
	Losses (gains) on sales of facilities		10			(15	)		(142	)
	Losses on retirement of debt		17			—			481
	Legal claim costs		—			175			—
	Gain on acquisition of controlling interest in equity investment		—			—			(1,522	)
	Termination of management agreement		—			—			181
	Income before income taxes	$	2,946		$	2,894		$	3,561
		As of December 31,
		2013			2012
	Assets:
	National Group	$	10,206		$	9,451
	American Group		13,911			13,744
	Corporate and other		4,714			4,880
		$	28,831		$	28,075
		National			American			Corporate			Total
		Group			Group			and Other
	Goodwill and other intangible assets:
	Balance at December 31, 2012	$	1,035		$	4,189		$	315		$	5,539
	Acquisitions		68			13			297			378
	Dispositions		—			(1	)		—			(1	)
	Foreign currency translation and other		1			(11	)		(3	)		(13	)
	Balance at December 31, 2013	$	1,104		$	4,190		$	609		$	5,903

Other_Comprehensive_Loss

Other Comprehensive Loss	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Other Comprehensive Loss	'
	NOTE 15 — OTHER COMPREHENSIVE LOSS
	The components of accumulated other comprehensive loss are as follows (dollars in millions):
		Unrealized			Foreign			Defined			Change			Total
		Gains on			Currency			Benefit			in Fair
		Available-			Translation			Plans			Value of
		for-Sale			Adjustments						Derivative
		Securities									Instruments
	Balances at December 31, 2010	$	6		$	(19	)	$	(143	)	$	(272	)	$	(428	)
	Unrealized gains on available-for-sale securities, net of $1 of income taxes		1			—			—			—			1
	Foreign currency translation adjustments, net of $3 income tax benefit		—			(6	)		—			—			(6	)
	Defined benefit plans, net of $25 income tax benefit		—			—			(42	)		—			(42	)
	Change in fair value of derivative instruments, net of $114 income tax benefit		—			—			—			(197	)		(197	)
	Expense reclassified into operations from other comprehensive income, net of $9 and $125, respectively, income tax benefits		—			—			16			216			232
	Balances at December 31, 2011		7			(25	)		(169	)		(253	)		(440	)
	Unrealized gains on available-for-sale securities, net of $2 of income taxes		4			—			—			—			4
	Foreign currency translation adjustments, net of $13 of income taxes		—			24			—			—			24
	Defined benefit plans, net of $33 income tax benefit		—			—			(56	)		—			(56	)
	Change in fair value of derivative instruments, net of $55 income tax benefit		—			—			—			(96	)		(96	)
	Expense reclassified into operations from other comprehensive income, net of $17 and $44, respectively, income tax benefits		—			—			29			78			107
	Balances at December 31, 2012		11			(1	)		(196	)		(271	)		(457	)
	Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(4	)		—			—			—			(4	)
	Foreign currency translation adjustments, net of $6 of income taxes		—			12			—			—			12
	Defined benefit plans, net of $50 of income taxes		—			—			84			—			84
	Change in fair value of derivative instruments, net of $1 of income taxes		—			—			—			2			2
	Expense reclassified into operations from other comprehensive income, net of $14 and $49, respectively, income tax benefits		—			—			24			82			106
	Balances at December 31, 2013	$	7		$	11		$	(88	)	$	(187	)	$	(257	)

Accrued_Expenses_and_Allowance

Accrued Expenses and Allowance for Doubtful Accounts	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Accrued Expenses and Allowance for Doubtful Accounts	'
	NOTE 16 — ACCRUED EXPENSES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
	A summary of other accrued expenses at December 31 follows (dollars in millions):
		2013		2012
	Professional liability risks	$	331	$	324
	Interest		392		409
	Taxes other than income		252		235
	Legal claim costs		189		175
	Other		749		706
		$	1,913	$	1,849
	A summary of activity for the allowance of doubtful accounts follows (dollars in millions):
		Balance		Provision		Accounts			Balance
		at		for		Written			at End
		Beginning		Doubtful		off,			of Year
		of Year		Accounts		Net of
						Recoveries
	Allowance for doubtful accounts:
	Year ended December 31, 2011	$	3,939	$	2,824	$	(2,657	)	$	4,106
	Year ended December 31, 2012		4,106		3,770		(3,030	)		4,846
	Year ended December 31, 2013		4,846		3,858		(3,216	)		5,488

Supplemental_Condensed_Consoli

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information	'
	NOTE 17 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION
	On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s 100% owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7 3/4% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.
	The senior secured credit facilities and senior secured notes described in Note 9 are jointly and severally, and fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, 100% owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our ABL credit facility).
	Our condensed consolidating balance sheets at December 31, 2013 and 2012 and condensed consolidating statements of comprehensive income and cash flows for each of the three years in the period ended December 31, 2013, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow.
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE YEAR ENDED DECEMBER 31, 2013
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	Revenues before provision for doubtful accounts		$	—		$	—		$	20,042		$	17,998		$	—		$	38,040
	Provision for doubtful accounts			—			—			2,262			1,596			—			3,858
	Revenues			—			—			17,780			16,402			—			34,182
	Salaries and benefits			—			—			8,387			7,259			—			15,646
	Supplies			—			—			3,158			2,812			—			5,970
	Other operating expenses			8			(2	)		2,998			3,233			—			6,237
	Electronic health record incentive income			—			—			(142	)		(74	)		—			(216	)
	Equity in earnings of affiliates			(1,875	)		—			(2	)		(27	)		1,875			(29	)
	Depreciation and amortization			—			—			855			898			—			1,753
	Interest expense			184			2,253			(523	)		(66	)		—			1,848
	Losses (gains) on sales of facilities			—			—			20			(10	)		—			10
	Loss on retirement of debt			—			17			—			—			—			17
	Management fees			—			—			(632	)		632			—			—
				(1,683	)		2,268			14,119			14,657			1,875			31,236
	Income (loss) before income taxes			1,683			(2,268	)		3,661			1,745			(1,875	)		2,946
	Provision (benefit) for income taxes			(73	)		(860	)		1,362			521			—			950
	Net income (loss)			1,756			(1,408	)		2,299			1,224			(1,875	)		1,996
	Net income attributable to noncontrolling interests			—			—			69			371			—			440
	Net income (loss) attributable to HCA Holdings, Inc.		$	1,756		$	(1,408	)	$	2,230		$	853		$	(1,875	)	$	1,556
	Comprehensive income (loss) attributable to HCA Holdings, Inc.		$	1,756		$	(1,324	)	$	2,338		$	861		$	(1,875	)	$	1,756
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE YEAR ENDED DECEMBER 31, 2012
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	Revenues before provision for doubtful accounts		$	—		$	—		$	19,415		$	17,368		$	—		$	36,783
	Provision for doubtful accounts			—			—			2,144			1,626			—			3,770
	Revenues			—			—			17,271			15,742			—			33,013
	Salaries and benefits			—			—			7,959			7,130			—			15,089
	Supplies			—			—			2,995			2,722			—			5,717
	Other operating expenses			3			5			3,013			3,027			—			6,048
	Electronic health record incentive income			—			—			(219	)		(117	)		—			(336	)
	Equity in earnings of affiliates			(1,668	)		—			(5	)		(31	)		1,668			(36	)
	Depreciation and amortization			—			—			821			858			—			1,679
	Interest expense			123			2,167			(468	)		(24	)		—			1,798
	Losses (gains) on sales of facilities			—			—			3			(18	)		—			(15	)
	Legal claim costs			—			175			—			—			—			175
	Management fees			—			—			(569	)		569			—			—
				(1,542	)		2,347			13,530			14,116			1,668			30,119
	Income (loss) before income taxes			1,542			(2,347	)		3,741			1,626			(1,668	)		2,894
	Provision (benefit) for income taxes			(46	)		(839	)		1,313			460			—			888
	Net income (loss)			1,588			(1,508	)		2,428			1,166			(1,668	)		2,006
	Net income attributable to noncontrolling interests			—			—			62			339			—			401
	Net income (loss) attributable to HCA Holdings, Inc.		$	1,588		$	(1,508	)	$	2,366		$	827		$	(1,668	)	$	1,605
	Comprehensive income (loss) attributable to HCA Holdings, Inc.		$	1,588		$	(1,526	)	$	2,339		$	855		$	(1,668	)	$	1,588
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE YEAR ENDED DECEMBER 31, 2011
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
Holdings, Inc.			Issuer			Guarantors			Non-			Consolidated
Issuer									Guarantors
Revenues before provision for doubtful accounts		$	—		$	—		$	18,126		$	14,380		$	—		$	32,506
Provision for doubtful accounts			—			—			1,644			1,180			—			2,824
Revenues			—			—			16,482			13,200			—			29,682
Salaries and benefits			—			—			7,584			5,856			—			13,440
Supplies			—			—			2,851			2,328			—			5,179
Other operating expenses			—			4			2,741			2,725			—			5,470
Electronic health record incentive income			—			—			(126	)		(84	)		—			(210	)
Equity in earnings of affiliates			(2,531	)		—			(86	)		(172	)		2,531			(258	)
Depreciation and amortization			—			—			777			688			—			1,465
Interest expense			120			2,390			(342	)		(131	)		—			2,037
Gains on sales of facilities			—			—			(127	)		(15	)		—			(142	)
Gain on acquisition of controlling interest in equity investment			—			—			—			(1,522	)		—			(1,522	)
Losses on retirement of debt			—			481			—			—			—			481
Termination of management agreement			—			181			—			—			—			181
Management fees			—			—			(491	)		491			—			—
			(2,411	)		3,056			12,781			10,164			2,531			26,121
Income (loss) before income taxes			2,411			(3,056	)		3,701			3,036			(2,531	)		3,561
Provision (benefit) for income taxes			(42	)		(1,068	)		1,271			558			—			719
Net income (loss)			2,453			(1,988	)		2,430			2,478			(2,531	)		2,842
Net income attributable to noncontrolling interests			—			—			63			314			—			377
Net income (loss) attributable to HCA Holdings, Inc.		$	2,453		$	(1,988	)	$	2,367		$	2,164		$	(2,531	)	$	2,465
Comprehensive income (loss) attributable to HCA Holdings, Inc.		$	2,453		$	(1,969	)	$	2,341		$	2,159		$	(2,531	)	$	2,453
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
31-Dec-13
(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
ASSETS
Current assets:
Cash and cash equivalents		$	—		$	—		$	112		$	302		$	—		$	414
Accounts receivable, net			—			—			2,565			2,643			—			5,208
Inventories			—			—			692			487			—			1,179
Deferred income taxes			489			—			—			—			—			489
Other			—			—			301			446			—			747
			489			—			3,670			3,878			—			8,037
Property and equipment, net			—			—			7,504			6,115			—			13,619
Investments of insurance subsidiaries			—			—			—			448			—			448
Investments in and advances to affiliates			20,356			—			13			108			(20,356	)		121
Goodwill and other intangible assets			—			—			1,695			4,208			—			5,903
Deferred loan costs			30			207			—			—			—			237
Other			250			—			48			168			—			466
		$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable		$	1		$	—		$	1,169		$	633		$	—		$	1,803
Accrued salaries			—			—			694			499			—			1,193
Other accrued expenses			272			353			464			824			—			1,913
Long-term debt due within one year			—			702			45			39			—			786
			273			1,055			2,372			1,995			—			5,695
Long-term debt			2,525			24,701			181			183			—			27,590
Intercompany balances			26,107			(10,513	)		(19,428	)		3,834			—			—
Professional liability risks			—			—			—			949			—			949
Income taxes and other liabilities			490			296			521			218			—			1,525
			29,395			15,539			(16,354	)		7,179			—			35,759
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.			(8,270	)		(15,332	)		29,185			6,503			(20,356	)		(8,270	)
Noncontrolling interests			—			—			99			1,243			—			1,342
			(8,270	)		(15,332	)		29,284			7,746			(20,356	)		(6,928	)
		$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
31-Dec-12
(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
ASSETS
Current assets:
Cash and cash equivalents		$	22		$	—		$	383		$	300		$	—		$	705
Accounts receivable, net			—			—			2,448			2,224			—			4,672
Inventories			—			—			629			457			—			1,086
Deferred income taxes			385			—			—			—			—			385
Other			122			—			342			451			—			915
			529			—			3,802			3,432			—			7,763
Property and equipment, net			—			—			7,417			5,768			—			13,185
Investments of insurance subsidiaries			—			—			—			515			—			515
Investments in and advances to affiliates			18,481			—			16			88			(18,481	)		104
Goodwill and other intangible assets			—			—			1,697			3,842			—			5,539
Deferred loan costs			32			258			—			—			—			290
Other			469			—			31			179			—			679
		$	19,511		$	258		$	12,963		$	13,824		$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable		$	—		$	—		$	1,203		$	565		$	—		$	1,768
Accrued salaries			—			—			638			482			—			1,120
Other accrued expenses			30			567			464			788			—			1,849
Long-term debt due within one year			—			1,360			39			36			—			1,435
			30			1,927			2,344			1,871			—			6,172
Long-term debt			2,525			24,304			173			493			—			27,495
Intercompany balances			26,131			(12,407	)		(17,130	)		3,406			—			—
Professional liability risks			—			—			—			973			—			973
Income taxes and other liabilities			485			442			629			220			—			1,776
			29,171			14,266			(13,984	)		6,963			—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.			(9,660	)		(14,008	)		26,847			5,642			(18,481	)		(9,660	)
Noncontrolling interests			—			—			100			1,219			—			1,319
			(9,660	)		(14,008	)		26,947			6,861			(18,481	)		(8,341	)
		$	19,511		$	258		$	12,963		$	13,824		$	(18,481	)	$	28,075
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED DECEMBER 31, 2013
(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
Cash flows from operating activities:
Net income (loss)		$	1,756		$	(1,408	)	$	2,299		$	1,224		$	(1,875	)	$	1,996
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Change in operating assets and liabilities			(11	)		17			(2,320	)		(1,958	)		—			(4,272	)
Provision for doubtful accounts			—			—			2,262			1,596			—			3,858
Depreciation and amortization			—			—			855			898			—			1,753
Income taxes			143			—			—			—			—			143
Losses (gains) on sales of facilities			—			—			20			(10	)		—			10
Loss on retirement of debt			—			17			—			—			—			17
Amortization of deferred loan costs			3			52			—			—			—			55
Share-based compensation			113			—			—			—			—			113
Equity in earnings of affiliates			(1,875	)		—			—			—			1,875			—
Other			—			9			2			(4	)		—			7
Net cash provided by (used in) operating activities			129			(1,313	)		3,118			1,746			—			3,680
Cash flows from investing activities:
Purchase of property and equipment			—			—			(921	)		(1,022	)		—			(1,943	)
Acquisition of hospitals and health care entities			—			—			—			(481	)		—			(481	)
Disposal of hospitals and health care entities			—			—			17			16			—			33
Change in investments			—			—			(16	)		52			—			36
Other			—			—			—			9			—			9
Net cash used in investing activities			—			—			(920	)		(1,426	)		—			(2,346	)
Cash flows from financing activities:
Net change in revolving bank credit facilities			—			970			—			—			—			970
Repayment of long-term debt			—			(1,254	)		(34	)		(374	)		—			(1,662	)
Distributions to noncontrolling interests			—			—			(71	)		(364	)		—			(435	)
Payment of debt issuance costs			—			(5	)		—			—			—			(5	)
Repurchase of common stock			(500	)		—			—			—			—			(500	)
Distributions to stockholders			(16	)		—			—			—			—			(16	)
Income tax benefits			113			—			—			—			—			113
Changes in intercompany balances with affiliates, net			342			1,602			(2,364	)		420			—			—
Other			(90	)		—			—			—			—			(90	)
Net cash (used in) provided by financing activities			(151	)		1,313			(2,469	)		(318	)		—			(1,625	)
Change in cash and cash equivalents			(22	)		—			(271	)		2			—			(291	)
Cash and cash equivalents at beginning of period			22			—			383			300			—			705
Cash and cash equivalents at end of period		$	—		$	—		$	112		$	302		$	—		$	414
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED DECEMBER 31, 2012
(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
Cash flows from operating activities:
Net income (loss)		$	1,588		$	(1,508	)	$	2,428		$	1,166		$	(1,668	)	$	2,006
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Change in operating assets and liabilities			57			(28	)		(1,927	)		(1,765	)		—			(3,663	)
Provision for doubtful accounts			—			—			2,144			1,626			—			3,770
Depreciation and amortization			—			—			821			858			—			1,679
Income taxes			96			—			—			—			—			96
Losses (gains) on sales of facilities			—			—			3			(18	)		—			(15	)
Legal claim costs			—			175			—			—			—			175
Amortization of deferred loan costs			2			60			—			—			—			62
Share-based compensation			56			—			—			—			—			56
Equity in earnings of affiliates			(1,668	)		—			—			—			1,668			—
Other			—			14			(1	)		(4	)		—			9
Net cash provided by (used in) operating activities			131			(1,287	)		3,468			1,863			—			4,175
Cash flows from investing activities:
Purchase of property and equipment			—			—			(1,039	)		(823	)		—			(1,862	)
Acquisition of hospitals and health care entities			—			—			(110	)		(148	)		—			(258	)
Disposal of hospitals and health care entities			—			—			2			28			—			30
Change in investments			—			—			(11	)		27			—			16
Other			—			—			(2	)		13			—			11
Net cash used in investing activities			—			—			(1,160	)		(903	)		—			(2,063	)
Cash flows from financing activities:
Issuances of long-term debt			1,000			3,850			—			—			—			4,850
Net change in revolving bank credit facilities			—			(685	)		—			—			—			(685	)
Repayment of long-term debt			—			(2,309	)		(20	)		(112	)		—			(2,441	)
Distributions to noncontrolling interests			—			—			(60	)		(341	)		—			(401	)
Payment of debt issuance costs			(12	)		(50	)		—			—			—			(62	)
Distributions to stockholders			(3,148	)		—			—			—			—			(3,148	)
Income tax benefits			174			—			—			—			—			174
Changes in intercompany balances with affiliates, net			1,938			481			(1,960	)		(459	)		—			—
Other			(61	)		—			—			(6	)		—			(67	)
Net cash (used in) provided by financing activities			(109	)		1,287			(2,040	)		(918	)		—			(1,780	)
Change in cash and cash equivalents			22			—			268			42			—			332
Cash and cash equivalents at beginning of period			—			—			115			258			—			373
Cash and cash equivalents at end of period		$	22		$	—		$	383		$	300		$	—		$	705
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED DECEMBER 31, 2011
(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
Cash flows from operating activities:
Net income (loss)		$	2,453		$	(1,988	)	$	2,430		$	2,478		$	(2,531	)	$	2,842
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Change in operating assets and liabilities			6			71			(1,755	)		(1,275	)		—			(2,953	)
Provision for doubtful accounts			—			—			1,644			1,180			—			2,824
Depreciation and amortization			—			—			777			688			—			1,465
Income taxes			912			—			—			—			—			912
Gains on sales of facilities			—			—			(127	)		(15	)		—			(142	)
Gain on acquisition of controlling interest in equity investment			—			—			—			(1,522	)		—			(1,522	)
Losses on retirement of debt			—			481			—			—			—			481
Amortization of deferred loan costs			—			70			—			—			—			70
Share-based compensation			26			—			—			—			—			26
Pay-in-kind interest			—			(78	)		—			—			—			(78	)
Equity in earnings of affiliates			(2,531	)		—			—			—			2,531			—
Other			—			9			—			(1	)		—			8
Net cash provided by (used in) operating activities			866			(1,435	)		2,969			1,533			—			3,933
Cash flows from investing activities:
Purchase of property and equipment			—			—			(910	)		(769	)		—			(1,679	)
Acquisition of hospitals and health care entities			—			—			(142	)		(1,540	)		—			(1,682	)
Disposal of hospitals and health care entities			—			—			200			81			—			281
Change in investments			—			—			34			46			—			80
Other			—			—			—			5			—			5
Net cash used in investing activities			—			—			(818	)		(2,177	)		—			(2,995	)
Cash flows from financing activities:
Issuances of long-term debt			—			5,500			—			—			—			5,500
Net change in revolving bank credit facilities			—			(449	)		—			—			—			(449	)
Repayment of long-term debt			—			(6,577	)		(17	)		(46	)		—			(6,640	)
Distributions to noncontrolling interests			—			—			(77	)		(301	)		—			(378	)
Payment of debt issuance costs			—			(92	)		—			—			—			(92	)
Issuance of common stock			2,506			—			—			—			—			2,506
Repurchase of common stock			(1,503	)		—			—			—			—			(1,503	)
Distributions to stockholders			(31	)		—			—			—			—			(31	)
Income tax benefits			63			—			—			—			—			63
Changes in intercompany balances with affiliates, net			(1,918	)		3,053			(2,098	)		963			—			—
Other			11			—			—			37			—			48
Net cash provided by (used in) financing activities			(872	)		1,435			(2,192	)		653			—			(976	)
Change in cash and cash equivalents			(6	)		—			(41	)		9			—			(38	)
Cash and cash equivalents at beginning of period			6			—			156			249			—			411
Cash and cash equivalents at end of period		$	—		$	—		$	115		$	258		$	—		$	373
Healthtrust, Inc. — The Hospital Company (“Healthtrust”) is the first-tier subsidiary of HCA Inc. The common stock of Healthtrust has been pledged as collateral for the senior secured credit facilities and senior secured notes described in Note 9. Rule 3-16 of Regulation S-X under the Securities Act requires the filing of separate financial statements for any affiliate of the registrant whose securities constitute a substantial portion of the collateral for any class of securities registered or being registered. We believe the separate financial statements requirement applies to Healthtrust due to the pledge of its common stock as collateral for the senior secured notes. Due to the corporate structure relationship of HCA and Healthtrust, HCA’s operating subsidiaries are also the operating subsidiaries of Healthtrust. The corporate structure relationship, combined with the application of push-down accounting in Healthtrust’s consolidated financial statements related to HCA’s debt and financial instruments, results in the consolidated financial statements of Healthtrust being substantially identical to the consolidated financial statements of HCA. The consolidated financial statements of HCA and Healthtrust present the identical amounts for revenues, expenses, net income, assets, liabilities, total stockholders’ deficit, net cash provided by operating activities, net cash used in investing activities and net cash used in financing activities. Certain individual line items in the HCA consolidated statements of stockholders’ deficit are combined into one line item in the Healthtrust consolidated statements of stockholder’s deficit.
Reconciliations of the HCA Holdings, Inc. Consolidated Statements of Stockholders’ Deficit presentation to the Healthtrust, Inc. — The Hospital Company Consolidated Statements of Stockholder’s Deficit presentation for the years ended December 31, 2013, 2012 and 2011 are as follows (dollars in millions):
		2013			2012			2011
Presentation in HCA Holdings, Inc. Consolidated Statements of Stockholders’ Deficit:
Share-based benefit plans		$	139		$	169		$	35
Reclassification of certain equity securities with contingent redemption rights			—			—			141
Other			(6	)		(17	)		36
Presentation in Healthtrust, Inc. — The Hospital Company Consolidated Statements of Stockholder’s Deficit:
Distributions from HCA Holdings, Inc., net of contributions to HCA Holdings, Inc.		$	133		$	152		$	212
Due to the consolidated financial statements of Healthtrust being substantially identical to the consolidated financial statements of HCA, except for the items presented in the table above, the separate consolidated financial statements of Healthtrust are not presented.
HCA HOLDINGS, INC.
QUARTERLY CONSOLIDATED FINANCIAL INFORMATION
(UNAUDITED)
(Dollars in millions)
		2013
		First			Second			Third			Fourth
Revenues		$	8,440		$	8,450		$	8,456		$	8,836
Net income		$	438	(a)	$	537	(b)	$	467	(c)	$	554	(d)
Net income attributable to HCA Holdings, Inc.		$	344	(a)	$	423	(b)	$	365	(c)	$	424	(d)
Basic earnings per share		$	0.77		$	0.95		$	0.82		$	0.96
Diluted earnings per share		$	0.74		$	0.91		$	0.79		$	0.92
		2012
		First			Second			Third			Fourth
Revenues		$	8,405		$	8,112		$	8,062		$	8,434
Net income		$	639	(e)	$	485	(f)	$	455	(g)	$	427	(h)
Net income attributable to HCA Holdings, Inc.		$	540	(e)	$	391	(f)	$	360	(g)	$	314	(h)
Basic earnings per share		$	1.23		$	0.89		$	0.82		$	0.71
Diluted earnings per share		$	1.18		$	0.85		$	0.78		$	0.68
(a)	First quarter results include $11 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $11 million of loss on retirement of debt (See NOTE 9 of the notes to consolidated financial statements).
(b)	Second quarter results include $3 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
(c)	Third quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
(d)	Fourth quarter results include $2 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
(e)	First quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
(f)	Second quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
(g)	Third quarter results include $5 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
(h)	Fourth quarter results include $6 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $110 million of legal claim costs (See NOTE 10 of the notes to consolidated financial statements).

Accounting_Policies_Policies

Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
	The consolidated financial statements include all subsidiaries and entities controlled by HCA. We generally define “control” as ownership of a majority of the voting interest of an entity. The consolidated financial statements include entities in which we absorb a majority of the entity’s expected losses, receive a majority of the entity’s expected residual returns, or both, as a result of ownership, contractual or other financial interests in the entity. Significant intercompany transactions have been eliminated. Investments in entities we do not control, but in which we have a substantial ownership interest and can exercise significant influence, are accounted for using the equity method.
	We have completed various acquisitions and joint venture transactions. The accounts of these entities have been included in our consolidated financial statements for periods subsequent to our acquisition of controlling interests. The majority of our expenses are “cost of revenue” items. Costs that could be classified as general and administrative include our corporate office costs, which were $287 million, $248 million and $228 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Revenues	'
	Revenues
	Revenues consist primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts (based primarily on historical collection experience) related to these uninsured accounts to record net self pay revenues at the estimated amounts we expect to collect. Our revenues from third party payers and the uninsured for the years ended December 31, are summarized in the following table (dollars in millions):
		2013			Ratio			2012			Ratio			2011			Ratio
	Medicare	$	7,951			23.3	%	$	8,292			25.1	%	$	7,653			25.8	%
	Managed Medicare		3,279			9.6			2,954			8.9			2,442			8.2
	Medicaid		1,480			4.3			1,464			4.4			1,845			6.2
	Managed Medicaid		1,570			4.6			1,504			4.6			1,265			4.3
	Managed care and other insurers		18,654			54.6			17,998			54.5			15,703			52.9
	International (managed care and other insurers)		1,175			3.4			1,060			3.2			938			3.2
			34,109			99.8			33,272			100.7			29,846			100.6
	Uninsured		2,677			7.8			2,580			7.8			1,846			6.2
	Other		1,254			3.7			931			2.8			814			2.7
	Revenues before provision for doubtful accounts		38,040			111.3			36,783			111.3			32,506			109.5
	Provision for doubtful accounts		(3,858	)		(11.3	)		(3,770	)		(11.3	)		(2,824	)		(9.5	)
	Revenues	$	34,182			100	%	$	33,013			100	%	$	29,682			100	%
	Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. As a result, there is at least a reasonable possibility recorded estimates will change by a material amount. Estimated reimbursement amounts are adjusted in subsequent periods as cost reports are prepared and filed and as final settlements are determined (in relation to certain government programs, primarily Medicare, this is generally referred to as the “cost report” filing and settlement process). The adjustments to estimated Medicare and Medicaid reimbursement amounts and disproportionate-share funds, which resulted in net increases to revenues, related primarily to cost reports filed during the respective year were $41 million, $50 million and $40 million in 2013, 2012 and 2011, respectively. The adjustments to estimated reimbursement amounts, which resulted in net increases to revenues, related primarily to cost reports filed during previous years were $68 million, $242 million and $30 million in 2013, 2012 and 2011, respectively. The 2012 amount related to cost reports filed during previous years includes two adjustments to Medicare revenues that affected multiple annual cost report periods for the majority of our hospitals (the Rural Floor Provision Settlement increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios reduced revenues by approximately $75 million). Excluding the effect of these Medicare adjustments, the 2012 amount related to previous years would have been $46 million.
	The Emergency Medical Treatment and Labor Act (“EMTALA”) requires any hospital participating in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize the condition or make an appropriate transfer of the individual to a facility able to handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. Federal and state laws and regulations require, and our commitment to providing quality patient care encourages, us to provide services to patients who are financially unable to pay for the health care services they receive. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Patients treated at hospitals for nonelective care, who have income at or below 200% of the federal poverty level, are eligible for charity care. The federal poverty level is established by the federal government and is based on income and family size. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. In implementing the uninsured discount policy, we first attempt to qualify uninsured patients for Medicaid, other federal or state assistance or charity care. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.
	To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view charity care, uninsured discounts and the provision for doubtful accounts in combination, rather than each separately. A summary of these amounts for the years ended December 31, follows (dollars in millions):
		2013			Ratio			2012			Ratio			2011			Ratio
	Charity care	$	3,497			22	%	$	3,093			22	%	$	2,683			24	%
	Uninsured discounts		8,210			53			6,978			51			5,707			51
	Provision for doubtful accounts		3,858			25			3,770			27			2,824			25
	Total uncompensated care	$	15,565			100	%	$	13,841			100	%	$	11,214			100	%
	A summary of the estimated cost of total uncompensated care for the years ended December 31, follows (dollars in millions):
		2013			2012			2011
	Gross patient charges	$	181,141		$	165,614		$	141,516
	Patient care costs (salaries and benefits, supplies, other operating expenses and depreciation and amortization)		29,606			28,533			25,554
	Cost-to-charges ratio		16.3	%		17.2	%		18.1	%
	Total uncompensated care	$	15,565		$	13,841		$	11,214
	Multiply by the cost-to-charges ratio		16.3	%		17.2	%		18.1	%
	Estimated cost of total uncompensated care	$	2,537		$	2,381		$	2,030
	The sum of charity care, uninsured discounts and the provision for doubtful accounts, as a percentage of the sum of revenues, charity care, uninsured discounts and the provision for doubtful accounts increased from 27.4% for 2011, to 29.5% for 2012 and to 31.3% for 2013.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	Cash and cash equivalents include highly liquid investments with a maturity of three months or less when purchased. Our insurance subsidiaries’ cash equivalent investments in excess of the amounts required to pay estimated professional liability claims during the next twelve months are not included in cash and cash equivalents as these funds are not available for general corporate purposes. Carrying values of cash and cash equivalents approximate fair value due to the short-term nature of these instruments.
	Our cash management system provides for daily investment of available balances and the funding of outstanding checks when presented for payment. Outstanding, but unpresented, checks totaling $461 million and $437 million at December 31, 2013 and 2012, respectively, have been included in “accounts payable” in the consolidated balance sheets. Upon presentation for payment, these checks are funded through available cash balances or our credit facility.
Accounts Receivable	'
	Accounts Receivable
	We receive payments for services rendered from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. We recognize that revenues and receivables from government agencies are significant to our operations, but do not believe there are significant credit risks associated with these government agencies. We do not believe there are any other significant concentrations of revenues from any particular payer that would subject us to any significant credit risks in the collection of our accounts receivable.
	Additions to the allowance for doubtful accounts are made by means of the provision for doubtful accounts. Accounts written off as uncollectible are deducted from the allowance for doubtful accounts and subsequent recoveries are added. The amount of the provision for doubtful accounts is based upon management’s assessment of historical and expected net collections, business and economic conditions, trends in federal, state and private employer health care coverage and other collection indicators. The provision for doubtful accounts and the allowance for doubtful accounts relate to “uninsured” amounts due directly from patients (including copayment and deductible amounts from patients who have health care coverage). Accounts are written off when all reasonable internal and external collection efforts have been performed. We consider the return of an account from the secondary collection agency to be the culmination of our reasonable collection efforts and the timing basis for writing off the account balance. Writeoffs are based upon specific identification and the writeoff process requires a writeoff adjustment entry to the patient accounting system. Management relies on the results of detailed reviews of historical writeoffs and recoveries at facilities that represent a majority of our revenues and accounts receivable (the “hindsight analysis”) as a primary source of information to utilize in estimating the collectibility of our accounts receivable. We perform the hindsight analysis quarterly, utilizing rolling twelve-months accounts receivable collection and writeoff data. At both December 31, 2013 and 2012, the allowance for doubtful accounts represented approximately 93% of the $5.927 billion and $5.228 billion, respectively, patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured portion of our accounts receivable. The estimated uninsured portion of Medicaid pending and uninsured discount pending accounts is included in our patient due accounts receivable balance. Days revenues in accounts receivable were 54 days, 51 days and 52 days at December 31, 2013, 2012 and 2011, respectively. Adverse changes in general economic conditions, patient accounting service center operations, payer mix or trends in federal or state governmental health care coverage could affect our collection of accounts receivable, cash flows and results of operations.
Inventories	'
	Inventories
	Inventories are stated at the lower of cost (first-in, first-out) or market.
Property and Equipment	'
	Property and Equipment
	Depreciation expense, computed using the straight-line method, was $1.733 billion in 2013, $1.673 billion in 2012 and $1.461 billion in 2011. Buildings and improvements are depreciated over estimated useful lives ranging generally from 10 to 40 years. Estimated useful lives of equipment vary generally from four to 10 years.
	When events, circumstances or operating results indicate the carrying values of certain long-lived assets expected to be held and used, might be impaired, we prepare projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value. Fair value may be estimated based upon internal evaluations that include quantitative analyses of revenues and cash flows, reviews of recent sales of similar facilities and independent appraisals.
	Long-lived assets to be disposed of are reported at the lower of their carrying amounts or fair value less costs to sell or close. The estimates of fair value are usually based upon recent sales of similar assets and market responses based upon discussions with and offers received from potential buyers.
Investments of Insurance Subsidiaries	'
	Investments of Insurance Subsidiaries
	At December 31, 2013 and 2012, the investments of our 100% owned insurance subsidiaries were classified as “available-for-sale” as defined in Accounting Standards Codification (“ASC”) No. 320, Investments — Debt and Equity Securities and are recorded at fair value. The investment securities are held for the purpose of providing a funding source to pay liability claims covered by the insurance subsidiaries. We perform a quarterly assessment of individual investment securities to determine whether declines in market value are temporary or other-than-temporary. Our investment securities evaluation process involves multiple subjective judgments, often involves estimating the outcome of future events, and requires a significant level of professional judgment in determining whether an impairment has occurred. We evaluate, among other things, the financial position and near term prospects of the issuer, conditions in the issuer’s industry, liquidity of the investment, changes in the amount or timing of expected future cash flows from the investment, and recent downgrades of the issuer by a rating agency, to determine if, and when, a decline in the fair value of an investment below amortized cost is considered other-than-temporary. The length of time and extent to which the fair value of the investment is less than amortized cost and our ability and intent to retain the investment, to allow for any anticipated recovery of the investment’s fair value, are important components of our investment securities evaluation process.
Goodwill and Intangible Assets	'
	Goodwill and Intangible Assets
	Goodwill is not amortized but is subject to annual impairment tests. In addition to the annual impairment review, impairment reviews are performed whenever circumstances indicate a possible impairment may exist. Impairment testing for goodwill is done at the reporting unit level. Reporting units are one level below the business segment level, and our impairment testing is performed at the operating division or market level. We compare the fair value of the reporting unit assets to the carrying amount, on at least an annual basis, to determine if there is potential impairment. If the fair value of the reporting unit assets is less than their carrying value, we compare the fair value of the goodwill to its carrying value. If the fair value of the goodwill is less than its carrying value, an impairment loss is recognized. Fair value of goodwill is estimated based upon internal evaluations of the related long-lived assets for each reporting unit that include quantitative analyses of market multiples, revenues and cash flows and reviews of recent sales of similar facilities. No goodwill impairments were recognized during 2013, 2012 and 2011. Since January 1, 2000, we have recognized total goodwill impairments of $102 million in the aggregate. None of the goodwill impairments related to evaluations of goodwill at the reporting unit level, as all recognized goodwill impairments during this period related to goodwill allocated to asset disposal groups.
	During 2013, goodwill increased by $265 million related to acquisitions, declined by $1 million related to facility sales and declined by $13 million related to foreign currency translation and other adjustments. During 2012, goodwill increased by $288 million related to acquisitions, declined by $3 million related to facility sales and increased by $3 million related to foreign currency translation and other adjustments.
	During 2013, identifiable intangible assets increased by $113 million and are being amortized over estimated lives ranging generally from three to 15 years. During 2012, there were no changes in identifiable intangible assets. During 2011, indefinite-lived identifiable intangible assets increased by $269 million. Indefinite-lived identifiable intangible assets are not amortized, but all identifiable intangible assets are subject to annual impairment tests, and impairment reviews are performed whenever circumstances indicate a possible impairment may exist.
Deferred Loan Costs	'
	Deferred Loan Costs
	Debt issuance costs are amortized based upon the terms of the respective debt obligations. The gross carrying amount of deferred loan costs at December 31, 2013 and 2012 was $541 million and $571 million, respectively, and accumulated amortization was $305 million and $281 million, respectively. Amortization of deferred loan costs is included in interest expense and was $55 million, $62 million and $70 million for 2013, 2012 and 2011, respectively.
Physician Recruiting Agreements	'
	Physician Recruiting Agreements
	In order to recruit physicians to meet the needs of our hospitals and the communities they serve, we enter into minimum revenue guarantee arrangements to assist the recruited physicians during the period they are relocating and establishing their practices. A guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the stand-ready obligation undertaken in issuing the guarantee. We expense the total estimated guarantee liability amount at the time the physician recruiting agreement becomes effective as we are not able to justify recording a contract-based asset based upon our analysis of the related control, regulatory and legal considerations.
	The physician recruiting liability amount of $15 million at both December 31, 2013 and 2012 represents the amount of expense recognized in excess of payments made through December 31, 2013 and 2012. At December 31, 2013 the maximum amount we could have to pay under all effective minimum revenue guarantees was $39 million.
Professional Liability Claims	'
	Professional Liability Claims
	Reserves for professional liability risks were $1.279 billion and $1.297 billion at December 31, 2013 and 2012, respectively. The current portion of the reserves, $331 million and $324 million at December 31, 2013 and 2012, respectively, is included in “other accrued expenses” in the consolidated balance sheets. Provisions for losses related to professional liability risks were $314 million, $331 million and $244 million for 2013, 2012 and 2011, respectively, and are included in “other operating expenses” in our consolidated income statements. Provisions for losses related to professional liability risks are based upon actuarially determined estimates. Loss and loss expense reserves represent the estimated ultimate net cost of all reported and unreported losses incurred through the respective consolidated balance sheet dates. The reserves for unpaid losses and loss expenses are estimated using individual case-basis valuations and actuarial analyses. Those estimates are subject to the effects of trends in loss severity and frequency. The estimates are continually reviewed and adjustments are recorded as experience develops or new information becomes known. Adjustments to the estimated reserve amounts are included in current operating results. The reserves for professional liability risks cover approximately 2,600 individual claims and 2,700 individual claims at December 31, 2013 and 2012, respectively, and estimates for unreported potential claims. The time period required to resolve these claims can vary depending upon the jurisdiction and whether the claim is settled or litigated. During 2013 and 2012, $307 million and $335 million, respectively, of net payments were made for professional and general liability claims. The estimation of the timing of payments beyond a year can vary significantly. Although considerable variability is inherent in professional liability reserve estimates, we believe the reserves for losses and loss expenses are adequate; however, there can be no assurance the ultimate liability will not exceed our estimates.
	A portion of our professional liability risks is insured through a 100% owned insurance subsidiary. Subject to a $5 million per occurrence self-insured retention, our facilities are insured by our 100% owned insurance subsidiary for losses up to $50 million per occurrence. The insurance subsidiary has obtained reinsurance for professional liability risks generally above a retention level of $15 million per occurrence. We also maintain professional liability insurance with unrelated commercial carriers for losses in excess of amounts insured by our insurance subsidiary.
	The obligations covered by reinsurance and excess insurance contracts are included in the reserves for professional liability risks, as we remain liable to the extent the reinsurers and excess insurance carriers do not meet their obligations under the reinsurance and excess insurance contracts. The amounts receivable under the reinsurance contracts include $19 million and $17 million at December 31, 2013 and 2012, respectively, recorded in “other assets”, and $5 million and $32 million at December 31, 2013 and 2012, respectively, recorded in “other current assets”.
Financial Instruments	'
	Financial Instruments
	Derivative financial instruments are employed to manage risks, including interest rate and foreign currency exposures, and are not used for trading or speculative purposes. We recognize derivative instruments, such as interest rate swap agreements and foreign exchange contracts, in the consolidated balance sheets at fair value. Changes in the fair value of derivatives are recognized periodically either in earnings or in stockholders’ equity, as a component of other comprehensive income (loss), depending on whether the derivative financial instrument qualifies for hedge accounting, and if so, whether it qualifies as a fair value hedge or a cash flow hedge. Generally, changes in fair values of derivatives accounted for as fair value hedges are recorded in earnings, along with the changes in the fair value of the hedged items related to the hedged risk. Gains and losses on derivatives designated as cash flow hedges, to the extent they are effective, are recorded in other comprehensive income (loss), and subsequently reclassified to earnings to offset the impact of the forecasted transactions when they occur. In the event the forecasted transaction to which a cash flow hedge relates is no longer likely, the amount in other comprehensive income (loss) is recognized in earnings and generally the derivative is terminated. Changes in the fair value of derivatives not qualifying as hedges, and for any portion of a hedge that is ineffective, are reported in earnings.
	The net interest paid or received on interest rate swaps is recognized as interest expense. Gains and losses resulting from the early termination of interest rate swap agreements are deferred and amortized as adjustments to interest expense over the remaining term of the debt originally associated with the terminated swap.
Electronic Health Record Incentive Payments	'
	Electronic Health Record Incentive Payments
	The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments for eligible hospitals and professionals that adopt and meaningfully use certified electronic health record (“EHR”) technology. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.
	Medicaid EHR incentive calculations and related payment amounts are based upon prior period cost report information available at the time our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, and are not subject to revision for cost report data filed for a subsequent period. Thus, incentive income recognition occurs at the point our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, as the cost report information for the full cost report year that will determine the final calculation of the incentive payment is known at that time.
	Medicare EHR incentive calculations and related initial payment amounts are based upon the most current filed cost report information available at the time our eligible hospitals demonstrate meaningful use of certified EHR technology for the applicable period. However, unlike Medicaid, this initial payment amount will be adjusted based upon an updated calculation using the annual cost report information for the cost report period that began during the applicable payment year. Thus, incentive income recognition occurs at the point our eligible hospitals demonstrate meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.
	We recognized $216 million ($183 million Medicare and $33 million Medicaid), $336 million ($252 million Medicare and $84 million Medicaid) and $210 million ($123 million Medicare and $87 million Medicaid) of electronic health record incentive income during the years ended December 31, 2013, 2012 and 2011, respectively. At December 31, 2013 and 2012, we had $78 million and $113 million, respectively, of deferred EHR incentive income, which represent initial incentive payments received for which EHR incentive income has not been recognized.
Noncontrolling Interests in Consolidated Entities	'
	Noncontrolling Interests in Consolidated Entities
	The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned entities that we control. Accordingly, we have recorded noncontrolling interests in the earnings and equity of such entities.
Related Party Transactions - Management Agreement	'
	Related Party Transactions — Management Agreement
	The Investors provided management and advisory services to the Company pursuant to a management agreement among HCA Inc. and the Investors executed in connection with the Investors’ acquisition of HCA Inc. in November 2006. The management agreement was terminated pursuant to its terms upon completion of the initial public offering of our common stock during March 2011, and the Company paid the Investors a final fee of $181 million. The management agreement also provided that the Company pay a 1% fee in connection with certain financing, acquisition, divestiture and change of control transactions. The Company paid the Investors a fee of $26 million related to the initial public offering of our common stock, and this fee was recorded as a cost of the stock offering.
Reclassifications	'
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the 2013 presentation.
Fair Value Measurements and Disclosures	'
	Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 utilizes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
	Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.
Cash Traded Investments	'
	Cash Traded Investments
	Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The valuation of these securities involves management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived fair market values compared to tax-equivalent yields of other securities of similar credit worthiness and similar effective maturities.
Derivative Financial Instruments	'
	Derivative Financial Instruments
	We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. To comply with the provisions of ASC 820, we incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.
	Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at December 31, 2013 and 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

Accounting_Policies_Tables

Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Schedule of Revenues from Third Party Payers and Uninsured	'
	Our revenues from third party payers and the uninsured for the years ended December 31, are summarized in the following table (dollars in millions):
		2013			Ratio			2012			Ratio			2011			Ratio
	Medicare	$	7,951			23.3	%	$	8,292			25.1	%	$	7,653			25.8	%
	Managed Medicare		3,279			9.6			2,954			8.9			2,442			8.2
	Medicaid		1,480			4.3			1,464			4.4			1,845			6.2
	Managed Medicaid		1,570			4.6			1,504			4.6			1,265			4.3
	Managed care and other insurers		18,654			54.6			17,998			54.5			15,703			52.9
	International (managed care and other insurers)		1,175			3.4			1,060			3.2			938			3.2
			34,109			99.8			33,272			100.7			29,846			100.6
	Uninsured		2,677			7.8			2,580			7.8			1,846			6.2
	Other		1,254			3.7			931			2.8			814			2.7
	Revenues before provision for doubtful accounts		38,040			111.3			36,783			111.3			32,506			109.5
	Provision for doubtful accounts		(3,858	)		(11.3	)		(3,770	)		(11.3	)		(2,824	)		(9.5	)
	Revenues	$	34,182			100	%	$	33,013			100	%	$	29,682			100	%
Schedule of Revenue Deductions Related to Uninsured Accounts	'
	A summary of these amounts for the years ended December 31, follows (dollars in millions):
		2013			Ratio			2012			Ratio			2011			Ratio
	Charity care	$	3,497			22	%	$	3,093			22	%	$	2,683			24	%
	Uninsured discounts		8,210			53			6,978			51			5,707			51
	Provision for doubtful accounts		3,858			25			3,770			27			2,824			25
	Total uncompensated care	$	15,565			100	%	$	13,841			100	%	$	11,214			100	%
Schedule of Estimated Cost of Uncompensated Care	'
	A summary of the estimated cost of total uncompensated care for the years ended December 31, follows (dollars in millions):
		2013			2012			2011
	Gross patient charges	$	181,141		$	165,614		$	141,516
	Patient care costs (salaries and benefits, supplies, other operating expenses and depreciation and amortization)		29,606			28,533			25,554
	Cost-to-charges ratio		16.3	%		17.2	%		18.1	%
	Total uncompensated care	$	15,565		$	13,841		$	11,214
	Multiply by the cost-to-charges ratio		16.3	%		17.2	%		18.1	%
	Estimated cost of total uncompensated care	$	2,537		$	2,381		$	2,030

ShareBased_Compensation_Tables

Share-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Schedule of Fair Value of Each Stock Option Award is Estimated on Grant Date, Using Option Valuation Models	'
	The expected life is an estimate of the number of years a share-based award will be held before it is exercised.
		2013			2012			2011
	Risk-free interest rate		1.2	%		1.18	%		0.89	%
	Expected volatility		45	%		50	%		41	%
	Expected life, in years		6.25			6.25			5
	Expected dividend yield		—			—			—
Schedule of Stock Option Activity	'
	Information regarding Time Stock Options and SARs and Performance Stock Options and SARs activity during 2013, 2012 and 2011 is summarized below (share amounts in thousands):
		Time			Performance			Total			Weighted		Weighted		Aggregate
		Stock			Stock			Stock			Average		Average		Intrinsic Value
		Options			Options and			Options			Exercise		Remaining		(dollars in millions)
		and			SARs			and			Price		Contractual Term
		SARs						SARs
	Options outstanding, December 31, 2010		24,517			26,009			50,526		$	8.58
	Granted		644			644			1,288			23.35
	Exercised		(3,312	)		(1,732	)		(5,044	)		6.31
	Cancelled		(110	)		(348	)		(458	)		5.88
	Options outstanding, December 31, 2011		21,739			24,573			46,312			9.26
	Granted		3,174			3,174			6,348			27.03
	Exercised		(5,530	)		(5,128	)		(10,658	)		7.6
	Cancelled		(192	)		(568	)		(760	)		9.49
	Options and SARs outstanding, December 31, 2012		19,191			22,051			41,242			11.56
	Granted		2,432			2,432			4,864			37.49
	Exercised		(4,498	)		(5,843	)		(10,341	)		8.49
	Cancelled		(316	)		(263	)		(579	)		25.5
	Options and SARs outstanding, December 31, 2013		16,809			18,377			35,186			15.82		5.4 years	$	1,122
	Options and SARs exercisable, December 31, 2013		11,960			13,527			25,487		$	10.55		4.1 years	$	947
Schedule of Restricted Stock Units Activity	'
	Information regarding Time RSUs and Performance RSUs activity during 2013, 2012 and 2011 is summarized below (share amounts in thousands):
		Time RSUs			Performance			Total RSUs			Weighted
					RSUs						Average
											Grant
											Date Fair
											Value
	RSUs outstanding, December 31, 2010		—			—			—			—
	Granted		80			—			80		$	30
	Vested		—			—			—			—
	Cancelled		—			—			—			—
	RSUs outstanding, December 31, 2011		80			—			80			30
	Granted		3,162			1,485			4,647			26.98
	Vested		(4	)		—			(4	)		30
	Cancelled		(164	)		(75	)		(239	)		26.99
	RSUs outstanding, December 31, 2012		3,074			1,410			4,484			27.03
	Granted		3,305			1,554			4,859			37.43
	Vested		(831	)		(352	)		(1,183	)		27.3
	Cancelled		(449	)		(213	)		(662	)		31.91
	RSUs outstanding, December 31, 2013		5,099			2,399			7,498			33.3

Acquisitions_and_Dispositions_

Acquisitions and Dispositions (Tables)	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Schedule of Allocation of Purchase Price, Including Assumed Liabilities	'
	A summary of the final purchase price allocation, including assumed liabilities, follows (dollars in millions):
	Current assets	$	400
	Property and equipment		1,014
	Identifiable intangible asset (trade name)		269
	Goodwill		2,317
	Other assets		7
	Liabilities		152
	Noncontrolling interests		123
Schedule of Pro Forma Summary of Operations	'
	The following unaudited pro forma combined summary of operations data gives effect to including the acquired HealthONE operating results in our operating results as if the acquisition had occurred as of January 1, 2011 (dollars in millions):
		Year Ended
		December  31,
		2011
	Pro forma revenues	$	31,383
	Pro forma net income attributable to HCA Holdings, Inc.		2,507

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Provision for Income Taxes	'
	The provision for income taxes consists of the following (dollars in millions):
		2013			2012			2011
	Current:
	Federal	$	827		$	604		$	(119	)
	State		86			58			(12	)
	Foreign		44			43			44
	Deferred:
	Federal		(53	)		167			714
	State		20			(8	)		71
	Foreign		26			24			21
		$	950		$	888		$	719
Schedule of Reconciliation of Federal Statutory Rate to Effective Income Tax Rate	'
	A reconciliation of the federal statutory rate to the effective income tax rate follows:
		2013			2012			2011
	Federal statutory rate		35	%		35	%		35	%
	State income taxes, net of federal tax benefit		2.3			2.2			2
	Change in liability for uncertain tax positions		0.5			—			1
	Nontaxable gain on acquisition of controlling interest in equity investment		—			—			(13.8	)
	Tax exempt interest income		(0.2	)		(0.2	)		(0.2	)
	Other items, net		0.3			(1.4	)		(1.4	)
	Effective income tax rate on income applicable to HCA Holdings, Inc.		37.9			35.6			22.6
	Income attributable to noncontrolling interests from consolidated partnerships		(5.7	)		(4.9	)		(2.4	)
	Effective income tax rate on income before income taxes		32.2	%		30.7	%		20.2	%
Schedule of Deferred Tax Assets and Liabilities	'
	A summary of the items comprising the deferred tax assets and liabilities at December 31 follows (dollars in millions):
		2013						2012
		Assets			Liabilities			Assets			Liabilities
	Depreciation and fixed asset basis differences	$	—		$	229		$	—		$	292
	Allowances for professional liability and other risks		365			—			355			—
	Accounts receivable		423			—			405			—
	Compensation		240			—			237			—
	Other		638			698			744			595
		$	1,666		$	927		$	1,741		$	887
Schedule of Activity Related to Unrecognized Tax Benefits	'
	The following table summarizes the activity related to our unrecognized tax benefits (dollars in millions):
		2013			2012
	Balance at January 1	$	425		$	445
	Additions based on tax positions related to the current year		21			16
	Additions for tax positions of prior years		25			92
	Reductions for tax positions of prior years		(18	)		(19	)
	Settlements		(5	)		(103	)
	Lapse of applicable statutes of limitations		(3	)		(6	)
	Balance at December 31	$	445		$	425

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Schedule of Computations of Basic and Diluted Earnings Per Share	'
	The following table sets forth the computations of basic and diluted earnings per share for the years ended December 31, 2013, 2012 and 2011 (dollars in millions, except per share amounts, and shares in thousands):
		2013		2012		2011
	Net income attributable to HCA Holdings, Inc	$	1,556	$	1,605	$	2,465
	Weighted average common shares outstanding		445,066		440,178		476,609
	Effect of dilutive incremental shares		16,847		19,225		19,334
	Shares used for diluted earnings per share		461,913		459,403		495,943
	Earnings per share:
	Basic earnings per share	$	3.5	$	3.65	$	5.17
	Diluted earnings per share	$	3.37	$	3.49	$	4.97

Investments_of_Insurance_Subsi1

Investments of Insurance Subsidiaries (Tables)	12 Months Ended
	Dec. 31, 2013
Investments Debt And Equity Securities [Abstract]	'
Schedule of Investments	'
	A summary of the insurance subsidiaries’ investments at December 31 follows (dollars in millions):
		2013
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	385	$	11	$	(3	)	$	393
	Auction rate securities		7		—		—			7
	Asset-backed securities		12		—		—			12
	Money market funds		94		—		—			94
			498		11		(3	)		506
	Equity securities		2		2		—			4
		$	500	$	13	$	(3	)		510
	Amounts classified as current assets									(62	)
	Investment carrying value								$	448
		2012
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	395	$	23	$	—		$	418
	Auction rate securities		74		—		(6	)		68
	Asset-backed securities		14		—		—			14
	Money market funds		67		—		—			67
			550		23		(6	)		567
	Equity securities		2		1		—			3
		$	552	$	24	$	(6	)		570
	Amounts classified as current assets									(55	)
	Investment carrying value								$	515
Schedule of Maturities of Investments	'
	Scheduled maturities of investments in debt securities at December 31, 2013 were as follows (dollars in millions):
		Amortized		Fair
		Cost		Value
	Due in one year or less	$	110	$	110
	Due after one year through five years		180		186
	Due after five years through ten years		100		102
	Due after ten years		89		89
			479		487
	Auction rate securities		7		7
	Asset-backed securities		12		12
		$	498	$	506

Financial_Instruments_Tables

Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative Instruments And Hedging Activities Disclosure [Abstract]	'
Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges	'
	The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at December 31, 2013 (dollars in millions):
		Notional		Maturity Date		Fair
		Amount				Value
	Pay-fixed interest rate swaps	$	500		December 2014	$	(5	)
	Pay-fixed interest rate swaps		3,000		December 2016		(248	)
	Pay-fixed interest rate swaps		1,000		December 2017		(42	)
Effect of Interest Rate on Results of Operations	'
	The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the year ended December 31, 2013 (dollars in millions):
	Derivatives in Cash Flow Hedging Relationships	Amount of Gain		Location of Loss		Amount of Loss
		Recognized in OCI on		Reclassified from		Reclassified from
		Derivatives, Net of  Tax		Accumulated OCI		Accumulated OCI
				into Operations		into Operations
	Interest rate swaps	$	2		Interest expense	$	131
Effect of Interest Cross Currency Swaps on Results of Operations	'
	The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the year ended December 31, 2013 (dollars in millions):
	Derivatives Not Designated as Hedging Instruments	Location of Gain		Amount of Gain
		Recognized in		Recognized in
		Operations on		Operations on
		Derivatives		Derivatives
	Cross currency swap (matured November 2013)		Other operating expenses	$	13

Assets_and_Liabilities_Measure1

Assets and Liabilities Measured at Fair Value (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):
		December 31, 2013
		Fair Value			Fair Value Measurements Using
					Quoted Prices in			Significant Other		Significant
					Active Markets for			Observable Inputs		Unobservable Inputs
					Identical Assets			(Level 2)		(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	393		$	—		$	393	$	—
	Auction rate securities		7			—			—		7
	Asset-backed securities		12			—			12		—
	Money market funds		94			94			—		—
			506			94			405		7
	Equity securities		4			3			—		1
	Investments of insurance subsidiaries		510			97			405		8
	Less amounts classified as current assets		(62	)		(62	)		—		—
		$	448		$	35		$	405	$	8
	Liabilities:
	Interest rate swaps (Income taxes and other liabilities)	$	295		$	—		$	295	$	—
		December 31, 2012
					Fair Value Measurements Using
		Fair Value			Quoted Prices in			Significant Other		Significant
					Active Markets for			Observable Inputs		Unobservable Inputs
					Identical Assets			(Level 2)		(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	418		$	—		$	418	$	—
	Auction rate securities		68			—			—		68
	Asset-backed securities		14			—			14		—
	Money market funds		67			67			—		—
			567			67			432		68
	Equity securities		3			1			—		2
	Investments of insurance subsidiaries		570			68			432		70
	Less amounts classified as current assets		(55	)		(55	)		—		—
		$	515		$	13		$	432	$	70
	Liabilities:
	Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
	Interest rate swaps (Income taxes and other liabilities)		429			—			429		—
Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value	'
	The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the year ended December 31, 2013 (dollars in millions):
	Asset balances at December 31, 2012	$	70
	Unrealized gains included in other comprehensive income		6
	Settlements		(68	)
	Asset balances at December 31, 2013	$	8

LongTerm_Debt_Tables

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Long-Term Debt	'
	A summary of long-term debt at December 31, including related interest rates at December 31, 2013, follows (dollars in millions):
		2013		2012
	Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	2,440	$	1,470
	Senior secured revolving credit facility		—		—
	Senior secured term loan facilities (effective interest rate of 5.3%)		5,598		5,958
	Senior secured first lien notes (effective interest rate of 7.1%)		9,695		9,688
	Other senior secured debt (effective interest rate of 6.8%)		448		423
	First lien debt		18,181		17,539
	Senior secured second lien notes		—		197
	Senior unsecured notes (effective interest rate of 7.2%)		10,195		11,194
	Total debt (average life of 6.3 years, rates averaging 6.3%)		28,376		28,930
	Less amounts due within one year		786		1,435
		$	27,590	$	27,495

Leases_Tables

Leases (Tables)	12 Months Ended
	Dec. 31, 2013
Leases [Abstract]	'
Schedule of Commitments Relating to Noncancellable Operating Leases	'
	Commitments relating to noncancellable operating leases for each of the next five years and thereafter are as follows (dollars in millions):
	For the Year Ended December 31,
	2014	$	293
	2015		267
	2016		215
	2017		175
	2018		132
	Thereafter		740
			1,822
	Less sublease income		(30	)
		$	1,792

Segment_and_Geographic_Informa1

Segment and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA, Depreciation and Amortization and Assets	'
	The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA, depreciation and amortization, assets and goodwill and other intangible assets are summarized in the following table (dollars in millions):
		For the Years Ended December 31,
		2013			2012			2011
	Revenues:
	National Group	$	15,968		$	15,505		$	14,741
	American Group		16,487			16,115			13,714
	Corporate and other		1,727			1,393			1,227
		$	34,182		$	33,013		$	29,682
	Equity in earnings of affiliates:
	National Group	$	(9	)	$	(9	)	$	(7	)
	American Group		(24	)		(28	)		(251	)
	Corporate and other		4			1			—
		$	(29	)	$	(36	)	$	(258	)
	Adjusted segment EBITDA:
	National Group	$	3,301		$	3,325		$	3,052
	American Group		3,662			3,575			3,141
	Corporate and other		(389	)		(369	)		(132	)
		$	6,574		$	6,531		$	6,061
	Depreciation and amortization:
	National Group	$	718		$	694		$	639
	American Group		835			816			680
	Corporate and other		200			169			146
		$	1,753		$	1,679		$	1,465
		For the Years Ended December 31,
		2013			2012			2011
	Adjusted segment EBITDA	$	6,574		$	6,531		$	6,061
	Depreciation and amortization		1,753			1,679			1,465
	Interest expense		1,848			1,798			2,037
	Losses (gains) on sales of facilities		10			(15	)		(142	)
	Losses on retirement of debt		17			—			481
	Legal claim costs		—			175			—
	Gain on acquisition of controlling interest in equity investment		—			—			(1,522	)
	Termination of management agreement		—			—			181
	Income before income taxes	$	2,946		$	2,894		$	3,561
		As of December 31,
		2013			2012
	Assets:
	National Group	$	10,206		$	9,451
	American Group		13,911			13,744
	Corporate and other		4,714			4,880
		$	28,831		$	28,075
		National			American			Corporate			Total
		Group			Group			and Other
	Goodwill and other intangible assets:
	Balance at December 31, 2012	$	1,035		$	4,189		$	315		$	5,539
	Acquisitions		68			13			297			378
	Dispositions		—			(1	)		—			(1	)
	Foreign currency translation and other		1			(11	)		(3	)		(13	)
	Balance at December 31, 2013	$	1,104		$	4,190		$	609		$	5,903

Other_Comprehensive_Loss_Table

Other Comprehensive Loss (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Components of Accumulated Other Comprehensive Loss	'
	The components of accumulated other comprehensive loss are as follows (dollars in millions):
		Unrealized			Foreign			Defined			Change			Total
		Gains on			Currency			Benefit			in Fair
		Available-			Translation			Plans			Value of
		for-Sale			Adjustments						Derivative
		Securities									Instruments
	Balances at December 31, 2010	$	6		$	(19	)	$	(143	)	$	(272	)	$	(428	)
	Unrealized gains on available-for-sale securities, net of $1 of income taxes		1			—			—			—			1
	Foreign currency translation adjustments, net of $3 income tax benefit		—			(6	)		—			—			(6	)
	Defined benefit plans, net of $25 income tax benefit		—			—			(42	)		—			(42	)
	Change in fair value of derivative instruments, net of $114 income tax benefit		—			—			—			(197	)		(197	)
	Expense reclassified into operations from other comprehensive income, net of $9 and $125, respectively, income tax benefits		—			—			16			216			232
	Balances at December 31, 2011		7			(25	)		(169	)		(253	)		(440	)
	Unrealized gains on available-for-sale securities, net of $2 of income taxes		4			—			—			—			4
	Foreign currency translation adjustments, net of $13 of income taxes		—			24			—			—			24
	Defined benefit plans, net of $33 income tax benefit		—			—			(56	)		—			(56	)
	Change in fair value of derivative instruments, net of $55 income tax benefit		—			—			—			(96	)		(96	)
	Expense reclassified into operations from other comprehensive income, net of $17 and $44, respectively, income tax benefits		—			—			29			78			107
	Balances at December 31, 2012		11			(1	)		(196	)		(271	)		(457	)
	Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(4	)		—			—			—			(4	)
	Foreign currency translation adjustments, net of $6 of income taxes		—			12			—			—			12
	Defined benefit plans, net of $50 of income taxes		—			—			84			—			84
	Change in fair value of derivative instruments, net of $1 of income taxes		—			—			—			2			2
	Expense reclassified into operations from other comprehensive income, net of $14 and $49, respectively, income tax benefits		—			—			24			82			106
	Balances at December 31, 2013	$	7		$	11		$	(88	)	$	(187	)	$	(257	)

Accrued_Expenses_and_Allowance1

Accrued Expenses and Allowance for Doubtful Accounts (Tables)	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Summary of Other Accrued Expenses	'
	A summary of other accrued expenses at December 31 follows (dollars in millions):
		2013		2012
	Professional liability risks	$	331	$	324
	Interest		392		409
	Taxes other than income		252		235
	Legal claim costs		189		175
	Other		749		706
		$	1,913	$	1,849
Summary of Allowance of Doubtful Accounts	'
	A summary of activity for the allowance of doubtful accounts follows (dollars in millions):
		Balance		Provision		Accounts			Balance
		at		for		Written			at End
		Beginning		Doubtful		off,			of Year
		of Year		Accounts		Net of
						Recoveries
	Allowance for doubtful accounts:
	Year ended December 31, 2011	$	3,939	$	2,824	$	(2,657	)	$	4,106
	Year ended December 31, 2012		4,106		3,770		(3,030	)		4,846
	Year ended December 31, 2013		4,846		3,858		(3,216	)		5,488

Supplemental_Condensed_Consoli1

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information (Tables)	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Schedule of Condensed Consolidating Comprehensive Income Statement	'
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE YEAR ENDED DECEMBER 31, 2013
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	Revenues before provision for doubtful accounts		$	—		$	—		$	20,042		$	17,998		$	—		$	38,040
	Provision for doubtful accounts			—			—			2,262			1,596			—			3,858
	Revenues			—			—			17,780			16,402			—			34,182
	Salaries and benefits			—			—			8,387			7,259			—			15,646
	Supplies			—			—			3,158			2,812			—			5,970
	Other operating expenses			8			(2	)		2,998			3,233			—			6,237
	Electronic health record incentive income			—			—			(142	)		(74	)		—			(216	)
	Equity in earnings of affiliates			(1,875	)		—			(2	)		(27	)		1,875			(29	)
	Depreciation and amortization			—			—			855			898			—			1,753
	Interest expense			184			2,253			(523	)		(66	)		—			1,848
	Losses (gains) on sales of facilities			—			—			20			(10	)		—			10
	Loss on retirement of debt			—			17			—			—			—			17
	Management fees			—			—			(632	)		632			—			—
				(1,683	)		2,268			14,119			14,657			1,875			31,236
	Income (loss) before income taxes			1,683			(2,268	)		3,661			1,745			(1,875	)		2,946
	Provision (benefit) for income taxes			(73	)		(860	)		1,362			521			—			950
	Net income (loss)			1,756			(1,408	)		2,299			1,224			(1,875	)		1,996
	Net income attributable to noncontrolling interests			—			—			69			371			—			440
	Net income (loss) attributable to HCA Holdings, Inc.		$	1,756		$	(1,408	)	$	2,230		$	853		$	(1,875	)	$	1,556
	Comprehensive income (loss) attributable to HCA Holdings, Inc.		$	1,756		$	(1,324	)	$	2,338		$	861		$	(1,875	)	$	1,756
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE YEAR ENDED DECEMBER 31, 2012
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	Revenues before provision for doubtful accounts		$	—		$	—		$	19,415		$	17,368		$	—		$	36,783
	Provision for doubtful accounts			—			—			2,144			1,626			—			3,770
	Revenues			—			—			17,271			15,742			—			33,013
	Salaries and benefits			—			—			7,959			7,130			—			15,089
	Supplies			—			—			2,995			2,722			—			5,717
	Other operating expenses			3			5			3,013			3,027			—			6,048
	Electronic health record incentive income			—			—			(219	)		(117	)		—			(336	)
	Equity in earnings of affiliates			(1,668	)		—			(5	)		(31	)		1,668			(36	)
	Depreciation and amortization			—			—			821			858			—			1,679
	Interest expense			123			2,167			(468	)		(24	)		—			1,798
	Losses (gains) on sales of facilities			—			—			3			(18	)		—			(15	)
	Legal claim costs			—			175			—			—			—			175
	Management fees			—			—			(569	)		569			—			—
				(1,542	)		2,347			13,530			14,116			1,668			30,119
	Income (loss) before income taxes			1,542			(2,347	)		3,741			1,626			(1,668	)		2,894
	Provision (benefit) for income taxes			(46	)		(839	)		1,313			460			—			888
	Net income (loss)			1,588			(1,508	)		2,428			1,166			(1,668	)		2,006
	Net income attributable to noncontrolling interests			—			—			62			339			—			401
	Net income (loss) attributable to HCA Holdings, Inc.		$	1,588		$	(1,508	)	$	2,366		$	827		$	(1,668	)	$	1,605
	Comprehensive income (loss) attributable to HCA Holdings, Inc.		$	1,588		$	(1,526	)	$	2,339		$	855		$	(1,668	)	$	1,588
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE YEAR ENDED DECEMBER 31, 2011
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	Revenues before provision for doubtful accounts		$	—		$	—		$	18,126		$	14,380		$	—		$	32,506
	Provision for doubtful accounts			—			—			1,644			1,180			—			2,824
Revenues			—			—			16,482			13,200			—			29,682
Salaries and benefits			—			—			7,584			5,856			—			13,440
Supplies			—			—			2,851			2,328			—			5,179
Other operating expenses			—			4			2,741			2,725			—			5,470
Electronic health record incentive income			—			—			(126	)		(84	)		—			(210	)
Equity in earnings of affiliates			(2,531	)		—			(86	)		(172	)		2,531			(258	)
Depreciation and amortization			—			—			777			688			—			1,465
Interest expense			120			2,390			(342	)		(131	)		—			2,037
Gains on sales of facilities			—			—			(127	)		(15	)		—			(142	)
Gain on acquisition of controlling interest in equity investment			—			—			—			(1,522	)		—			(1,522	)
Losses on retirement of debt			—			481			—			—			—			481
Termination of management agreement			—			181			—			—			—			181
Management fees			—			—			(491	)		491			—			—
			(2,411	)		3,056			12,781			10,164			2,531			26,121
Income (loss) before income taxes			2,411			(3,056	)		3,701			3,036			(2,531	)		3,561
Provision (benefit) for income taxes			(42	)		(1,068	)		1,271			558			—			719
Net income (loss)			2,453			(1,988	)		2,430			2,478			(2,531	)		2,842
Net income attributable to noncontrolling interests			—			—			63			314			—			377
Net income (loss) attributable to HCA Holdings, Inc.		$	2,453		$	(1,988	)	$	2,367		$	2,164		$	(2,531	)	$	2,465
Comprehensive income (loss) attributable to HCA Holdings, Inc.		$	2,453		$	(1,969	)	$	2,341		$	2,159		$	(2,531	)	$	2,453
Schedule of Condensed Consolidating Balance Sheet	'
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING BALANCE SHEET
	31-Dec-13
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	ASSETS
	Current assets:
	Cash and cash equivalents		$	—		$	—		$	112		$	302		$	—		$	414
	Accounts receivable, net			—			—			2,565			2,643			—			5,208
	Inventories			—			—			692			487			—			1,179
	Deferred income taxes			489			—			—			—			—			489
	Other			—			—			301			446			—			747
				489			—			3,670			3,878			—			8,037
	Property and equipment, net			—			—			7,504			6,115			—			13,619
	Investments of insurance subsidiaries			—			—			—			448			—			448
	Investments in and advances to affiliates			20,356			—			13			108			(20,356	)		121
	Goodwill and other intangible assets			—			—			1,695			4,208			—			5,903
	Deferred loan costs			30			207			—			—			—			237
	Other			250			—			48			168			—			466
			$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
	LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
	Current liabilities:
	Accounts payable		$	1		$	—		$	1,169		$	633		$	—		$	1,803
	Accrued salaries			—			—			694			499			—			1,193
	Other accrued expenses			272			353			464			824			—			1,913
	Long-term debt due within one year			—			702			45			39			—			786
				273			1,055			2,372			1,995			—			5,695
	Long-term debt			2,525			24,701			181			183			—			27,590
	Intercompany balances			26,107			(10,513	)		(19,428	)		3,834			—			—
	Professional liability risks			—			—			—			949			—			949
	Income taxes and other liabilities			490			296			521			218			—			1,525
				29,395			15,539			(16,354	)		7,179			—			35,759
	Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.			(8,270	)		(15,332	)		29,185			6,503			(20,356	)		(8,270	)
	Noncontrolling interests			—			—			99			1,243			—			1,342
				(8,270	)		(15,332	)		29,284			7,746			(20,356	)		(6,928	)
			$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING BALANCE SHEET
	31-Dec-12
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	ASSETS
	Current assets:
	Cash and cash equivalents		$	22		$	—		$	383		$	300		$	—		$	705
	Accounts receivable, net			—			—			2,448			2,224			—			4,672
	Inventories			—			—			629			457			—			1,086
	Deferred income taxes			385			—			—			—			—			385
	Other			122			—			342			451			—			915
				529			—			3,802			3,432			—			7,763
	Property and equipment, net			—			—			7,417			5,768			—			13,185
	Investments of insurance subsidiaries			—			—			—			515			—			515
	Investments in and advances to affiliates			18,481			—			16			88			(18,481	)		104
	Goodwill and other intangible assets			—			—			1,697			3,842			—			5,539
	Deferred loan costs			32			258			—			—			—			290
	Other			469			—			31			179			—			679
			$	19,511		$	258		$	12,963		$	13,824		$	(18,481	)	$	28,075
	LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
	Current liabilities:
	Accounts payable		$	—		$	—		$	1,203		$	565		$	—		$	1,768
Accrued salaries			—			—			638			482			—			1,120
Other accrued expenses			30			567			464			788			—			1,849
Long-term debt due within one year			—			1,360			39			36			—			1,435
			30			1,927			2,344			1,871			—			6,172
Long-term debt			2,525			24,304			173			493			—			27,495
Intercompany balances			26,131			(12,407	)		(17,130	)		3,406			—			—
Professional liability risks			—			—			—			973			—			973
Income taxes and other liabilities			485			442			629			220			—			1,776
			29,171			14,266			(13,984	)		6,963			—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.			(9,660	)		(14,008	)		26,847			5,642			(18,481	)		(9,660	)
Noncontrolling interests			—			—			100			1,219			—			1,319
			(9,660	)		(14,008	)		26,947			6,861			(18,481	)		(8,341	)
		$	19,511		$	258		$	12,963		$	13,824		$	(18,481	)	$	28,075
Schedule of Condensed Consolidating Statement of Cash Flows	'
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	FOR THE YEAR ENDED DECEMBER 31, 2013
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	Cash flows from operating activities:
	Net income (loss)		$	1,756		$	(1,408	)	$	2,299		$	1,224		$	(1,875	)	$	1,996
	Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
	Change in operating assets and liabilities			(11	)		17			(2,320	)		(1,958	)		—			(4,272	)
	Provision for doubtful accounts			—			—			2,262			1,596			—			3,858
	Depreciation and amortization			—			—			855			898			—			1,753
	Income taxes			143			—			—			—			—			143
	Losses (gains) on sales of facilities			—			—			20			(10	)		—			10
	Loss on retirement of debt			—			17			—			—			—			17
	Amortization of deferred loan costs			3			52			—			—			—			55
	Share-based compensation			113			—			—			—			—			113
	Equity in earnings of affiliates			(1,875	)		—			—			—			1,875			—
	Other			—			9			2			(4	)		—			7
	Net cash provided by (used in) operating activities			129			(1,313	)		3,118			1,746			—			3,680
	Cash flows from investing activities:
	Purchase of property and equipment			—			—			(921	)		(1,022	)		—			(1,943	)
	Acquisition of hospitals and health care entities			—			—			—			(481	)		—			(481	)
	Disposal of hospitals and health care entities			—			—			17			16			—			33
	Change in investments			—			—			(16	)		52			—			36
	Other			—			—			—			9			—			9
	Net cash used in investing activities			—			—			(920	)		(1,426	)		—			(2,346	)
	Cash flows from financing activities:
	Net change in revolving bank credit facilities			—			970			—			—			—			970
	Repayment of long-term debt			—			(1,254	)		(34	)		(374	)		—			(1,662	)
	Distributions to noncontrolling interests			—			—			(71	)		(364	)		—			(435	)
	Payment of debt issuance costs			—			(5	)		—			—			—			(5	)
	Repurchase of common stock			(500	)		—			—			—			—			(500	)
	Distributions to stockholders			(16	)		—			—			—			—			(16	)
	Income tax benefits			113			—			—			—			—			113
	Changes in intercompany balances with affiliates, net			342			1,602			(2,364	)		420			—			—
	Other			(90	)		—			—			—			—			(90	)
	Net cash (used in) provided by financing activities			(151	)		1,313			(2,469	)		(318	)		—			(1,625	)
	Change in cash and cash equivalents			(22	)		—			(271	)		2			—			(291	)
	Cash and cash equivalents at beginning of period			22			—			383			300			—			705
	Cash and cash equivalents at end of period		$	—		$	—		$	112		$	302		$	—		$	414
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	FOR THE YEAR ENDED DECEMBER 31, 2012
	(Dollars in millions)
			HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
			Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
			Issuer									Guarantors
	Cash flows from operating activities:
	Net income (loss)		$	1,588		$	(1,508	)	$	2,428		$	1,166		$	(1,668	)	$	2,006
	Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
	Change in operating assets and liabilities			57			(28	)		(1,927	)		(1,765	)		—			(3,663	)
	Provision for doubtful accounts			—			—			2,144			1,626			—			3,770
	Depreciation and amortization			—			—			821			858			—			1,679
	Income taxes			96			—			—			—			—			96
	Losses (gains) on sales of facilities			—			—			3			(18	)		—			(15	)
	Legal claim costs			—			175			—			—			—			175
	Amortization of deferred loan costs			2			60			—			—			—			62
	Share-based compensation			56			—			—			—			—			56
	Equity in earnings of affiliates			(1,668	)		—			—			—			1,668			—
	Other			—			14			(1	)		(4	)		—			9
	Net cash provided by (used in) operating activities			131			(1,287	)		3,468			1,863			—			4,175
Cash flows from investing activities:
Purchase of property and equipment			—			—			(1,039	)		(823	)		—			(1,862	)
Acquisition of hospitals and health care entities			—			—			(110	)		(148	)		—			(258	)
Disposal of hospitals and health care entities			—			—			2			28			—			30
Change in investments			—			—			(11	)		27			—			16
Other			—			—			(2	)		13			—			11
Net cash used in investing activities			—			—			(1,160	)		(903	)		—			(2,063	)
Cash flows from financing activities:
Issuances of long-term debt			1,000			3,850			—			—			—			4,850
Net change in revolving bank credit facilities			—			(685	)		—			—			—			(685	)
Repayment of long-term debt			—			(2,309	)		(20	)		(112	)		—			(2,441	)
Distributions to noncontrolling interests			—			—			(60	)		(341	)		—			(401	)
Payment of debt issuance costs			(12	)		(50	)		—			—			—			(62	)
Distributions to stockholders			(3,148	)		—			—			—			—			(3,148	)
Income tax benefits			174			—			—			—			—			174
Changes in intercompany balances with affiliates, net			1,938			481			(1,960	)		(459	)		—			—
Other			(61	)		—			—			(6	)		—			(67	)
Net cash (used in) provided by financing activities			(109	)		1,287			(2,040	)		(918	)		—			(1,780	)
Change in cash and cash equivalents			22			—			268			42			—			332
Cash and cash equivalents at beginning of period			—			—			115			258			—			373
Cash and cash equivalents at end of period		$	22		$	—		$	383		$	300		$	—		$	705
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED DECEMBER 31, 2011
(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
Cash flows from operating activities:
Net income (loss)		$	2,453		$	(1,988	)	$	2,430		$	2,478		$	(2,531	)	$	2,842
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Change in operating assets and liabilities			6			71			(1,755	)		(1,275	)		—			(2,953	)
Provision for doubtful accounts			—			—			1,644			1,180			—			2,824
Depreciation and amortization			—			—			777			688			—			1,465
Income taxes			912			—			—			—			—			912
Gains on sales of facilities			—			—			(127	)		(15	)		—			(142	)
Gain on acquisition of controlling interest in equity investment			—			—			—			(1,522	)		—			(1,522	)
Losses on retirement of debt			—			481			—			—			—			481
Amortization of deferred loan costs			—			70			—			—			—			70
Share-based compensation			26			—			—			—			—			26
Pay-in-kind interest			—			(78	)		—			—			—			(78	)
Equity in earnings of affiliates			(2,531	)		—			—			—			2,531			—
Other			—			9			—			(1	)		—			8
Net cash provided by (used in) operating activities			866			(1,435	)		2,969			1,533			—			3,933
Cash flows from investing activities:
Purchase of property and equipment			—			—			(910	)		(769	)		—			(1,679	)
Acquisition of hospitals and health care entities			—			—			(142	)		(1,540	)		—			(1,682	)
Disposal of hospitals and health care entities			—			—			200			81			—			281
Change in investments			—			—			34			46			—			80
Other			—			—			—			5			—			5
Net cash used in investing activities			—			—			(818	)		(2,177	)		—			(2,995	)
Cash flows from financing activities:
Issuances of long-term debt			—			5,500			—			—			—			5,500
Net change in revolving bank credit facilities			—			(449	)		—			—			—			(449	)
Repayment of long-term debt			—			(6,577	)		(17	)		(46	)		—			(6,640	)
Distributions to noncontrolling interests			—			—			(77	)		(301	)		—			(378	)
Payment of debt issuance costs			—			(92	)		—			—			—			(92	)
Issuance of common stock			2,506			—			—			—			—			2,506
Repurchase of common stock			(1,503	)		—			—			—			—			(1,503	)
Distributions to stockholders			(31	)		—			—			—			—			(31	)
Income tax benefits			63			—			—			—			—			63
Changes in intercompany balances with affiliates, net			(1,918	)		3,053			(2,098	)		963			—			—
Other			11			—			—			37			—			48
Net cash provided by (used in) financing activities			(872	)		1,435			(2,192	)		653			—			(976	)
Change in cash and cash equivalents			(6	)		—			(41	)		9			—			(38	)
Cash and cash equivalents at beginning of period			6			—			156			249			—			411
Cash and cash equivalents at end of period		$	—		$	—		$	115		$	258		$	—		$	373
Schedule of Consolidated Statements of Stockholder's Deficit	'
	The Hospital Company Consolidated Statements of Stockholder’s Deficit presentation for the years ended December 31, 2013, 2012 and 2011 are as follows (dollars in millions):
			2013			2012			2011
	Presentation in HCA Holdings, Inc. Consolidated Statements of Stockholders’ Deficit:
	Share-based benefit plans		$	139		$	169		$	35
	Reclassification of certain equity securities with contingent redemption rights			—			—			141
	Other			(6	)		(17	)		36
	Presentation in Healthtrust, Inc. — The Hospital Company Consolidated Statements of Stockholder’s Deficit:
	Distributions from HCA Holdings, Inc., net of contributions to HCA Holdings, Inc.		$	133		$	152		$	212
Schedule of Quarterly Consolidated Financial Information	'
	HCA HOLDINGS, INC.
	QUARTERLY CONSOLIDATED FINANCIAL INFORMATION
	(UNAUDITED)
	(Dollars in millions)
			2013
			First			Second			Third			Fourth
	Revenues		$	8,440		$	8,450		$	8,456		$	8,836
	Net income		$	438	(a)	$	537	(b)	$	467	(c)	$	554	(d)
	Net income attributable to HCA Holdings, Inc.		$	344	(a)	$	423	(b)	$	365	(c)	$	424	(d)
	Basic earnings per share		$	0.77		$	0.95		$	0.82		$	0.96
	Diluted earnings per share		$	0.74		$	0.91		$	0.79		$	0.92
			2012
			First			Second			Third			Fourth
	Revenues		$	8,405		$	8,112		$	8,062		$	8,434
	Net income		$	639	(e)	$	485	(f)	$	455	(g)	$	427	(h)
	Net income attributable to HCA Holdings, Inc.		$	540	(e)	$	391	(f)	$	360	(g)	$	314	(h)
	Basic earnings per share		$	1.23		$	0.89		$	0.82		$	0.71
	Diluted earnings per share		$	1.18		$	0.85		$	0.78		$	0.68
	(a)	First quarter results include $11 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $11 million of loss on retirement of debt (See NOTE 9 of the notes to consolidated financial statements).
	(b)	Second quarter results include $3 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
	(c)	Third quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
	(d)	Fourth quarter results include $2 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
	(e)	First quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
	(f)	Second quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
	(g)	Third quarter results include $5 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements).
	(h)	Fourth quarter results include $6 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $110 million of legal claim costs (See NOTE 10 of the notes to consolidated financial statements).

Accounting_Policies_Additional

Accounting Policies - Additional Information (Detail) (USD $)	1 Months Ended	12 Months Ended			168 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Nov. 22, 2010
		State			State
		Surgery_Center			Surgery_Center
		Hospital			Hospital
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Ownership percentage held by parent	'	'	'	'	'	100.00%
Initial public offering of shares common stock	87,719,300	'	'	'	'	'
Number of owned and operated hospitals	'	165	'	'	165	'
Number of freestanding surgery centers	'	115	'	'	115	'
Number of facilities locations	'	20	'	'	20	'
General and administrative expense	'	$287	$248	$228	'	'
Adjustments to estimated reimbursement filed during respective year	'	41	50	40	'	'
Adjustments to estimated reimbursement filed during previous years	'	68	242	30	'	'
Revenue related to operations in previous year	'	46	'	'	'	'
Percentage of the sum of revenues, uninsured discounts and charity care	'	31.30%	29.50%	27.40%	'	'
Outstanding checks unpresented for payment	'	461	437	'	461	'
Allowance for doubtful accounts percentage of accounts receivable	'	93.00%	93.00%	'	'	'
Allowance for doubtful accounts	'	5,488	4,846	'	5,488	'
Days revenues in accounts receivable	'	'54 days	'51 days	'52 days	'	'
Depreciation expense	'	1,733	1,673	1,461	'	'
Goodwill impairments	'	0	0	0	102	'
Goodwill increased related to acquisitions	'	265	288	'	'	'
Goodwill decrease related to facility sales	'	1	3	'	'	'
Goodwill increase (decrease) related to foreign currency translation and other adjustments	'	-13	3	'	'	'
Acquired identifiable intangible assets	'	113	'	'	'	'
Deferred loan costs	'	542	571	'	542	'
Deferred loan costs, accumulated amortization	'	305	281	'	305	'
Amortization of deferred loan costs	'	55	62	70	'	'
Physician recruiting liability amounts	'	15	15	'	15	'
Maximum amount pay under effective minimum revenue guarantees	'	39	'	'	39	'
Reserves for professional liability risks	'	1,279	1,297	'	1,279	'
Current portion of professional liability risks reserves	'	331	324	'	331	'
Provisions for losses related to professional liability risks	'	314	331	244	'	'
Reserves for professional liability risks cover individual claims	'	2,600	2,700	'	2,600	'
Net payments of professional and general liability claims	'	307	335	'	'	'
Insurance subsidiary ownership percentage	'	100.00%	'	'	100.00%	'
Self-insured retention amount per occurrence	'	5	'	'	'	'
Maximum amount losses per occurrence	'	50	'	'	'	'
Reinsurance for professional liability risks retention level of amount per occurrence	'	15	'	'	'	'
Amounts receivable under reinsurance contracts recorded in other assets	'	19	17	'	19	'
Amounts receivable under reinsurance contracts recorded in other current assets	'	5	32	'	5	'
Electronic health record incentive income	'	216	336	210	'	'
Incentive income, Medicaid	'	33	84	87	'	'
Incentive income, Medicare	'	183	252	123	'	'
Electronic health record deferred incentive income	'	78	113	'	78	'
Investor final fee upon completion of initial public offering of common stock	181	'	'	'	'	'
Percentage of fee	1.00%	'	'	'	'	'
Investors fee related to the initial public offering of common stock, recorded as cost of stock offering	26	'	'	'	'	'
Rural Floor Provision Settlement Effect [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Adjustments to Medicare revenues	'	271	'	'	'	'
Implementation of Revised Supplemental Security Income Ratios [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Adjustments to Medicare revenues	'	75	'	'	'	'
HealthONE [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Other intangible assets	'	'	$0	$269	'	'
IPO [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Initial public offering of shares common stock	87,719,300	'	'	'	'	'
Maximum [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Percentage of income of federal poverty level eligible for charity care	'	200.00%	'	'	'	'
Finite lived intangible asset useful life	'	'15 years	'	'	'	'
Maximum [Member] | Building and Improvements [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Estimated useful lives in years	'	'40 years	'	'	'	'
Maximum [Member] | Equipment [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Estimated useful lives in years	'	'10 years	'	'	'	'
Minimum [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Finite lived intangible asset useful life	'	'3 years	'	'	'	'
Minimum [Member] | Building and Improvements [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Estimated useful lives in years	'	'10 years	'	'	'	'
Minimum [Member] | Equipment [Member]	'	'	'	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Estimated useful lives in years	'	'4 years	'	'	'	'

Accounting_Policies_Schedule_o

Accounting Policies - Schedule of Revenues from Third Party Payers and Uninsured (Detail) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues from third party payers	'	'	'	'	'	'	'	'	$34,109	$33,272	$29,846
Uninsured	'	'	'	'	'	'	'	'	2,677	2,580	1,846
Other	'	'	'	'	'	'	'	'	1,254	931	814
Revenues before provision for doubtful accounts	'	'	'	'	'	'	'	'	38,040	36,783	32,506
Provision for doubtful accounts	'	'	'	'	'	'	'	'	-3,858	-3,770	-2,824
Revenues	8,836	8,456	8,450	8,440	8,434	8,062	8,112	8,405	34,182	33,013	29,682
Revenues from third party payers, ratio	'	'	'	'	'	'	'	'	99.80%	100.70%	100.60%
Uninsured Ratio	'	'	'	'	'	'	'	'	7.80%	7.80%	6.20%
Other Ratio	'	'	'	'	'	'	'	'	3.70%	2.80%	2.70%
Revenues before provision for doubtful accounts, ratio	'	'	'	'	'	'	'	'	111.30%	111.30%	109.50%
Provision for doubtful accounts Ratio	'	'	'	'	'	'	'	'	-11.30%	-11.30%	-9.50%
Revenues ratio from third party payers	'	'	'	'	'	'	'	'	100.00%	100.00%	100.00%
Medicare [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues from third party payers	'	'	'	'	'	'	'	'	7,951	8,292	7,653
Revenues from third party payers, ratio	'	'	'	'	'	'	'	'	23.30%	25.10%	25.80%
Managed Medicare [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues from third party payers	'	'	'	'	'	'	'	'	3,279	2,954	2,442
Revenues from third party payers, ratio	'	'	'	'	'	'	'	'	9.60%	8.90%	8.20%
Medicaid [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues from third party payers	'	'	'	'	'	'	'	'	1,480	1,464	1,845
Revenues from third party payers, ratio	'	'	'	'	'	'	'	'	4.30%	4.40%	6.20%
Managed Medicaid [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues from third party payers	'	'	'	'	'	'	'	'	1,570	1,504	1,265
Revenues from third party payers, ratio	'	'	'	'	'	'	'	'	4.60%	4.60%	4.30%
Managed Care and Other Insurers [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues from third party payers	'	'	'	'	'	'	'	'	18,654	17,998	15,703
Revenues from third party payers, ratio	'	'	'	'	'	'	'	'	54.60%	54.50%	52.90%
International (Managed Care and Other Insurers) [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenues from third party payers	'	'	'	'	'	'	'	'	$1,175	$1,060	$938
Revenues from third party payers, ratio	'	'	'	'	'	'	'	'	3.40%	3.20%	3.20%

Accounting_Policies_Schedule_o1

Accounting Policies - Schedule of Revenue Deductions Related to Uninsured Accounts (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Regulatory Assets [Abstract]	'	'	'
Charity care	$3,497	$3,093	$2,683
Uninsured discounts	8,210	6,978	5,707
Provision for doubtful accounts	3,858	3,770	2,824
Total uncompensated care	$15,565	$13,841	$11,214
Charity care, ratio	22.00%	22.00%	24.00%
Uninsured discounts, ratio	53.00%	51.00%	51.00%
Provision for doubtful accounts, ratio	25.00%	27.00%	25.00%
Total uncompensated care, ratio	100.00%	100.00%	100.00%

Accounting_Policies_Schedule_o2

Accounting Policies - Schedule of Estimated Cost of Uncompensated Care (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accounting Policies [Abstract]	'	'	'
Gross patient charges	$181,141	$165,614	$141,516
Patient care costs (salaries and benefits, supplies, other operating expenses and depreciation and amortization)	29,606	28,533	25,554
Cost-to-charges ratio	16.30%	17.20%	18.10%
Total uncompensated care	15,565	13,841	11,214
Estimated cost of total uncompensated care	$2,537	$2,381	$2,030

ShareBased_Compensation_Additi

Share-Based Compensation - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Weighted Average Fair Value of Stock Options Granted	$16.68	$13.16	$8.53
Total Intrinsic Value of Stock Options	$334,000,000	'	'
Unrecognized Compensation Cost Related to Nonvested Awards	104,000,000	'	'
Value of distribution per share	'	$6.50	'
Value of distribution	'	3,142,000,000	'
Reduction of non vested stock options on exercise price of share-based awards	'	$6.50	'
Share Based Compensation Nonvested Distribution Declared	0	'	0
Restricted Stock Units [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Unrecognized Compensation Cost Related to Nonvested Awards	$185,000,000	'	'
Restricted Stock Units [Member] | 2006 Stock Incentive Plan [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Granted, Stock Options	4,858,800	4,647,400	'
Stock Appreciation Rights (SARs) [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Granted, Stock Options	4,864,000	6,348,000	'
Vested, Stock Options	25,088,200	'	'
Shares Available for Future Grants	32,269,100	'	'

ShareBased_Compensation_Schedu

Share-Based Compensation - Schedule of Fair Value of Each Stock Option Award is Estimated on Grant Date, Using Option Valuation Models (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'	'	'
Risk-free interest rate	1.20%	1.18%	0.89%
Expected volatility	45.00%	50.00%	41.00%
Expected life, in years	'6 years 3 months	'6 years 3 months	'5 years
Expected dividend yield	'	'	'

ShareBased_Compensation_Schedu1

Share-Based Compensation - Schedule of Stock Option Activity (Detail) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock Options outstanding, Weighted Average Exercise Price, Beginning Balance	$11.56	$9.26	$8.58
Granted, Weighted Average Exercise Price	$37.49	$27.03	$23.35
Exercised, Weighted Average Exercise Price	$8.49	$7.60	$6.31
Cancelled, Weighted Average Exercise Price	$25.50	$9.49	$5.88
Stock Options outstanding, Weighted Average Exercise Price, Ending Balance	$15.82	$11.56	$9.26
Options exercisable, Weighted Average Exercise Price	$10.55	'	'
Options outstanding, Weighted Average Remaining Contractual Term	'5 years 4 months 24 days	'	'
Options exercisable, Weighted Average Remaining Contractual Term	'4 years 1 month 6 days	'	'
Options outstanding, Aggregate Intrinsic Value	$1,122	'	'
Options exercisable, Aggregate Intrinsic Value	$947	'	'
Time Based Stock Options and SARs [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock Options Outstanding, Beginning Balance	19,191,000	21,739,000	24,517,000
Granted, Stock Options	2,432,000	3,174,000	644,000
Exercised, Stock Options	-4,498,000	-5,530,000	-3,312,000
Cancelled, Stock Options	-316,000	-192,000	-110,000
Stock Options Outstanding, Ending Balance	16,809,000	19,191,000	21,739,000
Stock Options Exercisable, Ending Balance	11,960,000	'	'
Performance Stock Options and SARs [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock Options Outstanding, Beginning Balance	22,051,000	24,573,000	26,009,000
Granted, Stock Options	2,432,000	3,174,000	644,000
Exercised, Stock Options	-5,843,000	-5,128,000	-1,732,000
Cancelled, Stock Options	-263,000	-568,000	-348,000
Stock Options Outstanding, Ending Balance	18,377,000	22,051,000	24,573,000
Stock Options Exercisable, Ending Balance	13,527,000	'	'
Total Stock Options and Stock SARs [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock Options Outstanding, Beginning Balance	41,242,000	46,312,000	50,526,000
Granted, Stock Options	4,864,000	6,348,000	1,288,000
Exercised, Stock Options	-10,341,000	-10,658,000	-5,044,000
Cancelled, Stock Options	-579,000	-760,000	-458,000
Stock Options Outstanding, Ending Balance	35,186,000	41,242,000	46,312,000
Stock Options Exercisable, Ending Balance	25,487,000	'	'

ShareBased_Compensation_Schedu2

Share-Based Compensation - Schedule of Restricted Stock Units Activity (Detail) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
		Time Based Stock Options and SARs [Member]	Performance Based Stock Options and RSUs [Member]	Restricted Stock Units [Member]	Restricted Stock Units [Member]	Restricted Stock Units [Member]	Restricted Stock Units [Member]	Restricted Stock Units [Member]	Restricted Stock Units [Member]
						Time Based Stock Options and SARs [Member]	Time Based Stock Options and SARs [Member]	Performance Based Stock Options and RSUs [Member]	Performance Based Stock Options and RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'	'
RSUs Outstanding, Beginning Balance	'	'	'	80	'	80	'	'	'
RSUs Outstanding, Granted	4,859	3,305	1,554	4,647	80	3,162	80	1,485	'
RSUs Outstanding, Vested	-1,183	-831	-352	-4	'	-4	'	'	'
RSUs Outstanding, Cancelled	-662	-449	-213	-239	'	-164	'	-75	'
RSUs Outstanding, Ending Balance	7,498	5,099	2,399	4,484	80	3,074	80	1,410	'
Weighted Average Grant Date Fair Value, RSUs, Beginning balance	'	'	'	$30	'	'	'	'	'
Weighted Average Grant Date Fair Value, RSUs, Granted	$37.43	'	'	$26.98	$30	'	'	'	'
Weighted Average Grant Date Fair Value, RSUs, Vested	$27.30	'	'	$30	'	'	'	'	'
Weighted Average Grant Date Fair Value, RSUs, Cancelled	$31.91	'	'	$26.99	'	'	'	'	'
Weighted Average Grant Date Fair Value, RSUs, Ending balance	$33.30	'	'	$27.03	$30	'	'	'	'

Acquisitions_and_Dispositions_1

Acquisitions and Dispositions - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

2 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2012

Oct. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

American Group [Member]

American Group [Member]

American Group [Member]

National Group [Member]

National Group [Member]

National Group [Member]

HealthONE [Member]

HealthONE [Member]

HealthONE [Member]

HealthONE [Member]

HealthONE [Member]

Outsource Group [Member]

Hospitals [Member]

Hospitals [Member]

Hospitals [Member]

Hospitals [Member]

Hospitals [Member]

Other Healthcare Entity [Member]

Other Healthcare Entity [Member]

Other Healthcare Entity [Member]

Other [Member]

Other [Member]

Other [Member]

Real Estate [Member]

Hospitals [Member]

Freestanding Surgery Centers [Member]

American Group [Member]

National Group [Member]

Hospital

Hospital

Hospital

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity interest, ownership percentage by parent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase price of acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,450

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of acquired businesses

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7

12

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of identifiable net assets of acquired entities

'

'

'

'

'

'

'

'

'

'

2,261

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

265

232

68

'

Gain on acquisition of business

'

'

'

'

'

'

'

'

'

'

1,522

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase in noncontrolling interests on business acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Decrease in property and equipment on business acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

26

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase in goodwill on business acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

56

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected tax deductible on the amount of goodwill related to acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

981

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

8,836

8,456

8,450

8,440

8,434

8,062

8,112

8,405

34,182

33,013

29,682

16,487

16,115

13,714

15,968

15,505

14,741

347

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net income

424

365

423

344

314

360

391

540

1,556

1,605

2,465

'

'

'

'

'

'

15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash paid for acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

277

146

58

136

'

'

57

200

96

'

'

'

'

Payment to acquire goodwill

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,317

'

'

'

'

183

58

'

'

'

'

'

'

'

'

'

'

'

Payment to acquire intangible assets

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

113

'

'

'

'

'

'

'

'

'

'

'

'

Number of hospitals acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

Liability assumed on acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

33

'

'

'

'

'

'

'

'

'

'

Pretax gain (loss) on sales of business

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-10

142

'

'

'

'

'

'

15

Proceeds from sale of business

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

33

281

'

'

'

'

'

'

30

Gain (loss) on sale of business after tax

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

($7)

$80

'

'

'

'

'

'

$9

Acquisitions_and_Dispositions_2

Acquisitions and Dispositions - Schedule of Allocation of Purchase Price, Including Assumed Liabilities (Detail) (HealthONE [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
HealthONE [Member]	'	'
Current assets	'	$400
Property and equipment	'	1,014
Identifiable intangible asset (trade name)	0	269
Goodwill	'	2,317
Other assets	'	7
Liabilities	'	152
Noncontrolling interests	'	$123

Acquisitions_and_Dispositions_3

Acquisitions and Dispositions - Schedule of Pro Forma Summary of Operations (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2011
Business Combinations [Abstract]	'
Pro forma revenues	$31,383
Pro forma net income attributable to HCA Holdings, Inc.	$2,507

Income_Taxes_Schedule_of_Provi

Income Taxes - Schedule of Provision for Income Taxes (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Current, Federal	$827	$604	($119)
Current, State	86	58	-12
Current, Foreign	44	43	44
Deferred, Federal	-53	167	714
Deferred, State	20	-8	71
Deferred, Foreign	26	24	21
Provision for income taxes	$950	$888	$719

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Contingency [Line Items]	'	'	'
Reductions in interest related to taxing authority examinations	$4	$53	$100
Reductions in interest related to taxing authority examinations, net of tax	3	33	63
Income before income taxes, Foreign	187	178	173
State net operating loss carryforwards	17	'	'
Liability for unrecognized tax benefits	462	426	'
Unrecognized tax benefits, accrued interest	30	14	'
Deferred tax assets, reductions	13	13	'
Unrecognized tax benefits that would impact effective tax rate	$160	$125	'
State and Local Jurisdiction [Member] | Minimum [Member]	'	'	'
Income Tax Contingency [Line Items]	'	'	'
Net operating loss carryforwards, expiration date	'2014	'	'
State and Local Jurisdiction [Member] | Maximum [Member]	'	'	'
Income Tax Contingency [Line Items]	'	'	'
Net operating loss carryforwards, expiration date	'2033	'	'

Income_Taxes_Schedule_of_Recon

Income Taxes - Schedule of Reconciliation of Federal Statutory Rate to Effective Income Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Federal statutory rate	35.00%	35.00%	35.00%
State income taxes, net of federal tax benefit	2.30%	2.20%	2.00%
Change in liability for uncertain tax positions	0.50%	'	1.00%
Nontaxable gain on acquisition of controlling interest in equity investment	'	'	-13.80%
Tax exempt interest income	-0.20%	-0.20%	-0.20%
Other items, net	0.30%	-1.40%	-1.40%
Effective income tax rate on income applicable to HCA Holdings, Inc.	37.90%	35.60%	22.60%
Income attributable to noncontrolling interests from consolidated partnerships	-5.70%	-4.90%	-2.40%
Effective income tax rate on income before income taxes	32.20%	30.70%	20.20%

Income_Taxes_Schedule_of_Defer

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Income Tax Disclosure [Abstract]	'	'
Depreciation and fixed asset basis differences, Assets	'	'
Allowances for professional liability and other risks, Assets	365	355
Accounts receivable, Assets	423	405
Compensation, Assets	240	237
Other, Assets	638	744
Deferred tax assets	1,666	1,741
Depreciation and fixed asset basis differences, Liabilities	229	292
Allowances for professional liability and other risks, Liabilities	'	'
Accounts receivable, Liabilities	'	'
Compensation, Liabilities	'	'
Other, Liabilities	698	595
Deferred tax liabilities	$927	$887

Income_Taxes_Schedule_of_Activ

Income Taxes - Schedule of Activity Related to Unrecognized Tax Benefits (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]	'	'
Beginning Balance	$425	$445
Additions based on tax positions related to the current year	21	16
Additions for tax positions of prior years	25	92
Reductions for tax positions of prior years	-18	-19
Settlements	-5	-103
Lapse of applicable statutes of limitations	-3	-6
Ending Balance	$445	$425

Earnings_Per_Share_Additional_

Earnings Per Share - Additional Information (Detail)	1 Months Ended
	Nov. 30, 2013	Sep. 30, 2011
Earnings Per Share [Abstract]	'	'
Common stock repurchased	10,656,436	80,771,143

Earnings_Per_Share_Schedule_of

Earnings Per Share - Schedule of Computations of Basic and Diluted Earnings Per Share (Detail) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Share [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Net income attributable to HCA Holdings, Inc	$424	$365	$423	$344	$314	$360	$391	$540	$1,556	$1,605	$2,465
Weighted average common shares outstanding	'	'	'	'	'	'	'	'	445,066	440,178	476,609
Effect of dilutive incremental shares	'	'	'	'	'	'	'	'	16,847	19,225	19,334
Shares used for diluted earnings per share	'	'	'	'	'	'	'	'	461,913	459,403	495,943
Basic earnings per share	$0.96	$0.82	$0.95	$0.77	$0.71	$0.82	$0.89	$1.23	$3.50	$3.65	$5.17
Diluted earnings per share	$0.92	$0.79	$0.91	$0.74	$0.68	$0.78	$0.85	$1.18	$3.37	$3.49	$4.97

Investments_of_Insurance_Subsi2

Investments of Insurance Subsidiaries - Schedule of Investments (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	$500	$552
Unrealized Amounts, Gains	13	24
Unrealized Amounts, Losses	-3	-6
Fair Value	510	570
Amounts classified as current assets	-62	-55
Investment carrying value	448	515
Debt Securities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	498	550
Unrealized Amounts, Gains	11	23
Unrealized Amounts, Losses	-3	-6
Fair Value	506	567
Debt Securities [Member] | States and Municipalities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	385	395
Unrealized Amounts, Gains	11	23
Unrealized Amounts, Losses	-3	'
Fair Value	393	418
Debt Securities [Member] | Auction Rate Securities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	7	74
Unrealized Amounts, Gains	'	'
Unrealized Amounts, Losses	'	-6
Fair Value	7	68
Debt Securities [Member] | Asset-Backed Securities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	12	14
Unrealized Amounts, Gains	'	'
Unrealized Amounts, Losses	'	'
Fair Value	12	14
Debt Securities [Member] | Money Market Funds [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	94	67
Unrealized Amounts, Gains	'	'
Unrealized Amounts, Losses	'	'
Fair Value	94	67
Equity Securities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	2	2
Unrealized Amounts, Gains	2	1
Unrealized Amounts, Losses	'	'
Fair Value	$4	$3

Investments_of_Insurance_Subsi3

Investments of Insurance Subsidiaries - Additional Information (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Amortized Cost And Fair Value Debt Securities [Abstract]	'	'
Investments subject to restrictions	$1	$9
Available for sale securities expected maturity of debt securities	'3 years 9 months 18 days	'
Available for sale securities average scheduled maturity	'5 years 4 months 24 days	'

Investments_of_Insurance_Subsi4

Investments of Insurance Subsidiaries - Schedule of Maturities of Investments (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Due in one year or less, Amortized Cost	$110	'
Due after one year through five years, Amortized Cost	180	'
Due after five years through ten years, Amortized Cost	100	'
Due after ten years, Amortized Cost	89	'
Amortized Cost, Total	479	'
Amortized Cost	498	'
Due in one year or less, Fair Value	110	'
Fair Value	510	570
Due after one year through five years, Fair Value	186	'
Due after five years through ten years, Fair Value	102	'
Due after ten years, Fair Value	89	'
Fair Value, Total	487	'
Fair Value	506	'
Auction Rate Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized Cost	7	'
Fair Value	7	'
Asset-Backed Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized Cost	12	'
Fair Value	$12	'

Financial_Instruments_Schedule

Financial Instruments - Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) (Pay-Fixed Interest Rate Swaps [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Maturity Date, 2014 [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Notional Amount	$500
Fair Value	-5
Pay-fixed interest rate swaps	31-Dec-14
Maturity Date, 2016 [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Notional Amount	3,000
Fair Value	-248
Pay-fixed interest rate swaps	31-Dec-16
Maturity Date, 2017 [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Notional Amount	1,000
Fair Value	($42)
Pay-fixed interest rate swaps	31-Dec-17

Financial_Instruments_Addition

Financial Instruments - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Offsetting [Abstract]	'
Estimated amount reclassified from other comprehensive income to interest expense	$127
Estimated termination value if there is breach of provision related to derivative agreement	$308

Financial_Instruments_Effect_o

Financial Instruments - Effect of Interest Rate and Cross Currency Swaps on Results of Operations (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Cross Currency Swap (Income Taxes and Other Liabilities) [Member] | Other Operating Expenses [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Amount of Gain Recognized in Operations on Derivatives	$13
Interest Rate Swaps [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Amount of Gain Recognized in OCI on Derivatives, Net of Tax	2
Interest Rate Swaps [Member] | Interest Expense [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Amount of Loss Reclassified from Accumulated OCI into Operations	$131

Financial_Instruments_Effect_o1

Financial Instruments - Effect of Interest Rate and Cross Currency Swaps on Results of Operations (Parenthetical) (Detail) (Other Operating Expenses [Member], Cross Currency Swap (Income Taxes and Other Liabilities) [Member])	12 Months Ended
	Dec. 31, 2013
Other Operating Expenses [Member] | Cross Currency Swap (Income Taxes and Other Liabilities) [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Maturity Date for Derivatives Hedging Instrument	'2013-11

Assets_and_Liabilities_Measure2

Assets and Liabilities Measured at Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	$510	$570
Less amounts classified as current assets	-62	-55
Investments of insurance subsidiaries, noncurrent	448	515
Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	295	429
Cross Currency Swap (Income Taxes and Other Liabilities) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	'	13
Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	506	567
Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	393	418
Debt Securities [Member] | Auction Rate Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	7	68
Debt Securities [Member] | Asset-Backed Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	12	14
Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	94	67
Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	4	3
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	97	68
Less amounts classified as current assets	-62	-55
Investments of insurance subsidiaries, noncurrent	35	13
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	'	'
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	94	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | Auction Rate Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | Asset-Backed Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	94	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	3	1
Significant Other Observable Inputs (Level 2) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	405	432
Less amounts classified as current assets	'	'
Investments of insurance subsidiaries, noncurrent	405	432
Significant Other Observable Inputs (Level 2) [Member] | Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	295	429
Significant Other Observable Inputs (Level 2) [Member] | Cross Currency Swap (Income Taxes and Other Liabilities) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	'	13
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	405	432
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	393	418
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | Auction Rate Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | Asset-Backed Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	12	14
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Other Observable Inputs (Level 2) [Member] | Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	8	70
Less amounts classified as current assets	'	'
Investments of insurance subsidiaries, noncurrent	8	70
Significant Unobservable Inputs (Level 3) [Member] | Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	7	68
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | Auction Rate Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	7	68
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | Asset-Backed Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member] | Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	$1	$2

Assets_and_Liabilities_Measure3

Assets and Liabilities Measured at Fair Value - Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Asset, Beginning Balance	$70
Unrealized gains included in other comprehensive income	6
Settlements	-68
Asset, Ending Balance	$8

Assets_and_Liabilities_Measure4

Assets and Liabilities Measured at Fair Value - Additional Information (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fair Value Disclosures [Abstract]	'	'
Estimated fair value of long-term debt	$29,603	$30,781
Carrying amounts of long-term debt	$28,376	$28,930

LongTerm_Debt_Schedule_of_Long

Long-Term Debt - Schedule of Long-Term Debt (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Debt Instrument [Line Items]	'	'
First lien debt	$18,181	$17,539
Total debt (average life of 6.3 years, rates averaging 6.3%)	28,376	28,930
Less amounts due within one year	786	1,435
Long-term debt	27,590	27,495
Senior Secured Asset-Based Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term line of credit	2,440	1,470
Senior Secured Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term line of credit	'	'
Senior Secured Term Loan Facilities [Member]	'	'
Debt Instrument [Line Items]	'	'
Term loans	5,598	5,958
Senior Secured First Lien Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Senior secured first lien notes	9,695	9,688
Other Senior Secured Debt [Member]	'	'
Debt Instrument [Line Items]	'	'
Other senior secured debt (effective interest rate of 6.8%)	448	423
Senior Secured Second Lien Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Senior secured second lien notes	'	197
Senior Unsecured Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Senior unsecured notes	$10,195	$11,194

LongTerm_Debt_Schedule_of_Long1

Long-Term Debt - Schedule of Long-Term Debt (Parenthetical) (Detail)	Dec. 31, 2013
Debt Instrument [Line Items]	'
Total debt average term	'6 years 3 months 18 days
Total debt average rate	6.30%
Senior Secured Asset-Based Revolving Credit Facility [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	1.70%
Senior Secured Term Loan Facilities [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	5.30%
Senior Secured First Lien Notes [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	7.10%
Other Senior Secured Debt [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	6.80%
Senior Unsecured Notes [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	7.20%

LongTerm_Debt_Additional_Infor

Long-Term Debt - Additional Information (Detail) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Mar. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Oct. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Mar. 31, 2013

Nov. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Feb. 29, 2012

Dec. 31, 2013

Oct. 31, 2012

Dec. 31, 2013

Oct. 31, 2012

Dec. 31, 2013

Oct. 31, 2012

Oct. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 06, 2012

Nov. 23, 2010

Dec. 31, 2013

Maximum [Member]

Minimum [Member]

Interest Rate Swaps [Member]

Senior Secured Second Lien Notes Due 2017 [Member]

Senior Secured Term Loan Facilities [Member]

Federal Fund Rate [Member]

Senior Secured First Lien Notes Due 2022 [Member]

Senior Secured First Lien Notes Due 2022 [Member]

Senior Secured Revolving Credit Facility Maturing on November 17, 2015 [Member]

Senior Secured Revolving Credit Facility Maturing on November 17, 2015 [Member]

Senior Secured Revolving Credit Facility Maturing on November 17, 2016 [Member]

Senior Secured Revolving Credit Facility Maturing on November 17, 2016 [Member]

Senior Secured First Lien Notes Due 2023 [Member]

Senior Secured First Lien Notes Due 2023 [Member]

Senior Unsecured Notes Due 2023 [Member]

Asset-Based Revolving Credit Facility Maturing on September 30, 2016 [Member]

Senior Secured Term Loan A-2 Facility Maturing on May 2, 2016 [Member]

Senior Secured Term Loan A-3 Facility Maturing on February 2, 2016 [Member]

Senior Secured Term Loan B-3 Facility Maturing on May 1, 2018 [Member]

Senior Secured Term Loan B-2 Facility Maturing on March 31, 2017 [Member]

Senior Secured First Lien Notes Due 2019 [Member]

Senior Secured First Lien Notes Due 2020 [Member]

Senior Secured First Lien Notes Due 2020 [Member]

Senior Secured First Lien Notes Due 2020 [Member]

Senior secured first lien indebtedness [Member]

Maturities Ranging Two Thousand Fourteen To Two Thousand Thirty Three [Member]

Maturities Ranging Two Thousand Fourteen To Two Thousand Thirty Three [Member]

Maturities Ranging Two Thousand Fourteen To Two Thousand Thirty Three [Member]

Maturities Ranging 2014 To 2025 [Member]

Maturities Ranging 2014 To 2025 [Member]

Maturities Ranging 2014 To 2025 [Member]

Maturities Ranging 2015 To 2095 [Member]

Maturities Ranging 2015 To 2095 [Member]

Maturities Ranging 2015 To 2095 [Member]

Senior Unsecured Notes Due 2021 [Member]

Senior Unsecured Notes Due 2021 [Member]

Senior Unsecured Notes Due 2021 [Member]

Senior Unsecured Notes Due 2021 [Member]

Senior Unsecured Notes Unamortized Debt Discounts [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Redemption of aggregate principal amount

'

'

'

'

'

'

'

'

'

$201,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument, stated interest

'

'

'

'

'

'

'

'

'

9.88%

'

'

5.88%

5.88%

'

'

'

'

4.75%

4.75%

5.88%

'

'

'

'

'

8.50%

7.25%

7.88%

6.50%

'

'

'

'

'

'

'

'

'

'

'

6.25%

6.25%

7.75%

'

Percentage of redemption of principal amount

'

'

'

'

'

'

'

'

'

104.94%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Pretax loss on retirement of debt

-17,000,000

-11,000,000

-17,000,000

'

-481,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loan facility amount matured

'

'

'

'

'

'

'

'

'

'

329,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument, principal amount

'

'

'

'

'

2,500,000,000

'

'

'

'

'

'

1,350,000,000

1,350,000,000

'

'

'

'

1,250,000,000

1,250,000,000

1,250,000,000

'

'

'

'

'

1,500,000,000

1,400,000,000

1,250,000,000

3,000,000,000

'

6,541,000,000

'

'

246,000,000

'

'

'

'

'

1,000,000,000

1,000,000,000

1,000,000,000

1,525,000,000

'

Long-term line of credit

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000,000

2,000,000,000

2,000,000,000

'

'

'

2,500,000,000

512,000,000

724,000,000

2,367,000,000

1,995,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument maturity date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17-Nov-15

'

17-Nov-16

'

'

'

'

30-Sep-16

2-May-16

2-Feb-16

1-May-18

31-Mar-17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of senior secured credit facility over eligible accounts receivable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of credit outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

2,440,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument basis spread

'

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument, unamortized discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

55,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

Capital leases and other secured debt

'

'

448,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notional amount, total

'

'

'

'

'

'

'

'

4,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debentures, principal amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

886,000,000

'

'

'

'

'

'

'

Senior unsecured notes

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,525,000,000

'

'

'

'

Debt instrument, maturities range

'

'

'

'

'

'

'2018

'2015

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2033

'2014

'

'2025

'2014

'

'2095

'2015

'

'

'

'

'

Maturity of long-term debt in 2015

'

'

1,065,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maturity of long-term debt in 2016

'

'

2,282,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maturity of long-term debt in 2017

'

'

2,028,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maturity of long-term debt in 2018

'

'

$2,803,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Contingencies_and_Legal_Claim_1

Contingencies and Legal Claim Costs - Additional Information (Detail) (USD $)	0 Months Ended	3 Months Ended	12 Months Ended		0 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Oct. 28, 2011	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2003	Jan. 24, 2013	Dec. 31, 2013	Jul. 31, 2012
	Cases		Hospital		Pending Litigation [Member]	Pending Litigation [Member]	FLORIDA [Member]
					Health Care Foundation of Greater Kansas City [Member]	Health Care Foundation of Greater Kansas City [Member]	Hospital
Schedule Of Activities Related To Claims Filed [Line Items]	'	'	'	'	'	'	'
Number of owned and operated hospitals reviewed	'	'	95	'	'	'	8
Number of claims filed	3	'	'	'	'	'	'
Capital commitments in connection with purchase of hospitals	'	'	'	$450	'	'	'
Legal claim costs	'	175	'	'	'	'	'
Judgment award by the court	'	'	'	'	162	'	'
Period of agreed capital commitments	'	'	'5 years	'	'	'	'
Number of year under court-supervisor accounting for expenditures following the purchase	'	'	'10 years	'	'	'	'
Plaintiff attorneys fees award	'	'	'	'	'	$12	'

Leases_Schedule_of_Commitments

Leases - Schedule of Commitments Relating to Noncancellable Operating Leases (Detail) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Leases [Abstract]	'
2014	$293
2015	267
2016	215
2017	175
2018	132
Thereafter	740
Operating leases future minimum payments due, gross	1,822
Less sublease income	-30
Commitments relating to noncancellable operating leases	$1,792

Capital_Stock_Additional_Infor

Capital Stock - Additional Information (Detail) (USD $)	1 Months Ended			12 Months Ended
	Nov. 30, 2013	Sep. 30, 2011	Mar. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Capital Stock [Line Items]	'	'	'	'	'	'
Common stock, shares authorized	'	'	'	1,800,000,000	1,800,000,000	'
Initial public offering of shares common stock	'	'	87,719,300	'	'	'
Initial public offering of shares of common stock, price per share	'	'	$30	'	'	'
Proceeds from issuance of initial public offering	'	'	$2,506,000,000	'	'	'
Repurchase of common stock	10,656,436	80,771,143	'	'	'	'
Repurchase of common stock, per share	$46.92	$18.61	'	'	'	'
Shares repurchased as percentage of total shares outstanding	'	15.60%	'	'	'	'
Value of distribution per share	'	'	'	'	$6.50	'
Value of distribution	'	'	'	'	3,142,000,000	'
Reduction of non vested stock options on exercise price of share-based awards	'	'	'	'	$6.50	'
Share Based Compensation Nonvested Distribution Declared	'	'	'	$0	'	$0
Minimum [Member]	'	'	'	'	'	'
Capital Stock [Line Items]	'	'	'	'	'	'
Number of directors as per the amended and restated by-laws	'	'	'	3	'	'

Employee_Benefit_Plans_Additio

Employee Benefit Plans - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Contribution Benefit Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Cost of defined benefit plans	$374	$371	$322
Restoration Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Number of hours of service required to qualify for the plan	'1,000 or more hours	'	'
Noncontributory and nonqualified plan, benefit expense	29	20	25
Noncontributory and nonqualified plan, accrued benefits liabilities	137	120	'
Supplemental Executive Retirement Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Defined benefit plan cost	43	51	33
Defined benefit plan obligation	214	242	'
Defined Benefit Pension Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Defined benefit plan cost	37	49	39
Defined benefit plan obligation	$81	$196	'
Subsequent to March 31, 2008 [Member] | Defined Contribution Benefit Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Percentage of employer contribution to match participant contribution in defined contribution plan, net	100.00%	'	'
Subsequent to March 31, 2008 [Member] | Defined Contribution Benefit Plans [Member] | Minimum [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Percentage of employer contribution to match participant contribution in defined contribution plan	3.00%	'	'
Subsequent to March 31, 2008 [Member] | Defined Contribution Benefit Plans [Member] | Maximum [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Percentage of employer contribution to match participant contribution in defined contribution plan	9.00%	'	'

Segment_and_Geographic_Informa2

Segment and Geographic Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013
	Hospital
Segment Reporting Information [Line Items]	'
Number of geographically organized groups	2
Number of owned and operated hospitals	165
Reorganization Group [Member] | National Group [Member]	'
Segment Reporting Information [Line Items]	'
Number of owned and operated hospitals	82
Reorganization Group [Member] | American Group [Member]	'
Segment Reporting Information [Line Items]	'
Number of owned and operated hospitals	77
Reorganization Group [Member] | Corporate and Other [Member]	'
Segment Reporting Information [Line Items]	'
Number of owned and operated hospitals	6

Segment_and_Geographic_Informa3

Segment and Geographic Information - Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA, Depreciation and Amortization and Assets (Detail) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2013

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

$8,836

$8,456

$8,450

$8,440

$8,434

$8,062

$8,112

$8,405

$34,182

$33,013

$29,682

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-29

-36

-258

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

6,574

6,531

6,061

Depreciation and amortization

'

'

'

'

'

'

'

'

'

1,753

1,679

1,465

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

6,574

6,531

6,061

Depreciation and amortization

'

'

'

'

'

'

'

'

'

1,753

1,679

1,465

Interest expense

'

'

'

'

'

'

'

'

'

1,848

1,798

2,037

Losses (gains) on sales of facilities

'

-2

1

-3

11

-6

-5

1

1

10

-15

-142

Losses on retirement of debt

17

'

'

'

11

'

'

'

'

17

'

481

Legal claim costs

'

'

'

'

'

110

'

'

'

'

175

'

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

-1,522

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

181

Income before income taxes

'

'

'

'

'

'

'

'

'

2,946

2,894

3,561

Assets

'

28,831

'

'

'

28,075

'

'

'

28,831

28,075

'

Goodwill and other intangible assets, Beginning Balance

'

'

'

'

5,539

'

'

'

'

5,539

'

'

Goodwill and other intangible assets, Acquisitions

'

'

'

'

'

'

'

'

'

378

'

'

Goodwill and other intangible assets, Dispositions

'

'

'

'

'

'

'

'

'

-1

'

'

Goodwill and other intangible assets, Foreign currency translation and other

'

'

'

'

'

'

'

'

'

-13

3

'

Goodwill and other intangible assets, Ending Balance

'

5,903

'

'

'

5,539

'

'

'

5,903

5,539

'

National Group [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

15,968

15,505

14,741

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-9

-9

-7

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

3,301

3,325

3,052

Depreciation and amortization

'

'

'

'

'

'

'

'

'

718

694

639

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

3,301

3,325

3,052

Depreciation and amortization

'

'

'

'

'

'

'

'

'

718

694

639

Assets

'

10,206

'

'

'

9,451

'

'

'

10,206

9,451

'

Goodwill and other intangible assets, Beginning Balance

'

'

'

'

1,035

'

'

'

'

1,035

'

'

Goodwill and other intangible assets, Acquisitions

'

'

'

'

'

'

'

'

'

68

'

'

Goodwill and other intangible assets, Dispositions

'

'

'

'

'

'

'

'

'

'

'

'

Goodwill and other intangible assets, Foreign currency translation and other

'

'

'

'

'

'

'

'

'

1

'

'

Goodwill and other intangible assets, Ending Balance

'

1,104

'

'

'

1,035

'

'

'

1,104

1,035

'

American Group [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

16,487

16,115

13,714

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-24

-28

-251

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

3,662

3,575

3,141

Depreciation and amortization

'

'

'

'

'

'

'

'

'

835

816

680

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

3,662

3,575

3,141

Depreciation and amortization

'

'

'

'

'

'

'

'

'

835

816

680

Assets

'

13,911

'

'

'

13,744

'

'

'

13,911

13,744

'

Goodwill and other intangible assets, Beginning Balance

'

'

'

'

4,189

'

'

'

'

4,189

'

'

Goodwill and other intangible assets, Acquisitions

'

'

'

'

'

'

'

'

'

13

'

'

Goodwill and other intangible assets, Dispositions

'

'

'

'

'

'

'

'

'

-1

'

'

Goodwill and other intangible assets, Foreign currency translation and other

'

'

'

'

'

'

'

'

'

-11

'

'

Goodwill and other intangible assets, Ending Balance

'

4,190

'

'

'

4,189

'

'

'

4,190

4,189

'

Corporate and Other [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

1,727

1,393

1,227

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

4

1

'

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

-389

-369

-132

Depreciation and amortization

'

'

'

'

'

'

'

'

'

200

169

146

Adjusted segment EBITDA

'

'

'

'

'

'

'

'

'

-389

-369

-132

Depreciation and amortization

'

'

'

'

'

'

'

'

'

200

169

146

Assets

'

4,714

'

'

'

4,880

'

'

'

4,714

4,880

'

Goodwill and other intangible assets, Beginning Balance

'

'

'

'

315

'

'

'

'

315

'

'

Goodwill and other intangible assets, Acquisitions

'

'

'

'

'

'

'

'

'

297

'

'

Goodwill and other intangible assets, Dispositions

'

'

'

'

'

'

'

'

'

'

'

'

Goodwill and other intangible assets, Foreign currency translation and other

'

'

'

'

'

'

'

'

'

-3

'

'

Goodwill and other intangible assets, Ending Balance

'

$609

'

'

'

$315

'

'

'

$609

$315

'

Other_Comprehensive_Loss_Compo

Other Comprehensive Loss - Components of Accumulated Other Comprehensive Loss (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity [Abstract]	'	'	'
Unrealized gains on available-for-sale securities, beginning balance	$11	$7	$6
Unrealized gains on available-for-sale securities, net of income taxes	-4	4	1
Unrealized gains on available-for-sale securities, ending balance	7	11	7
Foreign currency translation adjustments, beginning balance	-1	-25	-19
Foreign currency translation adjustments	12	24	-6
Foreign currency translation adjustments, ending balance	11	-1	-25
Defined benefit plans, beginning balance	-196	-169	-143
Defined benefit plans	84	-56	-42
Defined benefit plans, (income) expense reclassified into operations from other comprehensive income	24	29	16
Defined benefit plans, ending balance	-88	-196	-169
Change in fair value of derivative instruments, beginning balance	-271	-253	-272
Change in fair value of derivative instruments	2	-96	-197
Change in fair value of derivatives instruments, (income) expense reclassified into operations from other comprehensive income	82	78	216
Change in fair value of derivative instruments, ending balance	-187	-271	-253
Accumulated other comprehensive income (loss), net of tax, beginning balance	-457	-440	-428
Unrealized gains on available-for-sale securities, net of income taxes	-4	4	1
Foreign currency translation adjustments	12	24	-6
Defined benefit plans	84	-56	-42
Change in fair value of derivative instruments, net of income tax benefit	2	-96	-197
Expense reclassified into operations from other comprehensive income, Total	106	107	232
Accumulated other comprehensive income (loss), net of tax, Ending balance	($257)	($457)	($440)

Other_Comprehensive_Loss_Compo1

Other Comprehensive Loss - Components of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity [Abstract]	'	'	'
Unrealized gains on available-for-sale securities, tax portion	($3)	$2	$1
Foreign currency translation adjustments, income (taxes)	6	13	-3
Defined benefit plans, income tax benefit	-50	33	25
Change in fair value of derivative instruments, income tax benefit	1	-55	-114
Defined benefit plans, Expense reclassified into operations from other comprehensive income, Income tax benefits	14	17	9
Change in fair value of derivative instruments, Expense reclassified into operations from other comprehensive income, Income tax benefits	$49	$44	$125

Accrued_Expenses_and_Allowance2

Accrued Expenses and Allowance for Doubtful Accounts - Summary of Other Accrued Expenses (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Payables And Accruals [Abstract]	'	'
Professional liability risks	$331	$324
Interest	392	409
Taxes other than income	252	235
Legal claim costs	189	175
Other	749	706
Other accrued expenses	$1,913	$1,849

Accrued_Expenses_and_Allowance3

Accrued Expenses and Allowance for Doubtful Accounts - Summary of Allowance of Doubtful Accounts (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Payables And Accruals [Abstract]	'	'	'
Balance at Beginning of Year	$4,846	$4,106	$3,939
Provision for doubtful accounts	3,858	3,770	2,824
Accounts Written off, Net of Recoveries	-3,216	-3,030	-2,657
Balance at End of Year	$5,488	$4,846	$4,106

Supplemental_Condensed_Consoli2

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Additional Information (Detail) (USD $)	Oct. 31, 2012	Nov. 22, 2010	Dec. 31, 2013	Dec. 31, 2012	Dec. 06, 2012	Nov. 23, 2010
In Millions, unless otherwise specified			Senior Unsecured Notes Due 2021 [Member]	Senior Unsecured Notes Due 2021 [Member]	Senior Unsecured Notes Due 2021 [Member]	Senior Unsecured Notes Due 2021 [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'	'	'
Debt instrument, principal amount	$2,500	'	$1,000	$1,000	$1,000	$1,525
Debt instrument, stated interest	'	'	'	6.25%	6.25%	7.75%
Ownership percentage held by parent	'	100.00%	'	'	'	'

Supplemental_Condensed_Consoli3

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Condensed Consolidating Comprehensive Income Statement (Detail) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2013

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Supplemental Condensed Consolidating Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues before provision for doubtful accounts

'

'

'

'

'

'

'

'

'

$38,040

$36,783

$32,506

Provision for doubtful accounts

'

'

'

'

'

'

'

'

'

3,858

3,770

2,824

Revenues

'

8,836

8,456

8,450

8,440

8,434

8,062

8,112

8,405

34,182

33,013

29,682

Salaries and benefits

'

'

'

'

'

'

'

'

'

15,646

15,089

13,440

Supplies

'

'

'

'

'

'

'

'

'

5,970

5,717

5,179

Other operating expenses

'

'

'

'

'

'

'

'

'

6,237

6,048

5,470

Electronic health record incentive income

'

'

'

'

'

'

'

'

'

-216

-336

-210

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-29

-36

-258

Depreciation and amortization

'

'

'

'

'

'

'

'

'

1,753

1,679

1,465

Interest expense

'

'

'

'

'

'

'

'

'

1,848

1,798

2,037

Losses (gains) on sales of facilities

'

-2

1

-3

11

-6

-5

1

1

10

-15

-142

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

-1,522

Legal claim costs

'

'

'

'

'

110

'

'

'

'

175

'

Loss on retirement of debt

17

'

'

'

11

'

'

'

'

17

'

481

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

181

Management fees

'

'

'

'

'

'

'

'

'

'

'

'

Total expenses including equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

31,236

30,119

26,121

Income (loss) before income taxes

'

'

'

'

'

'

'

'

'

2,946

2,894

3,561

Provision (benefit) for income taxes

'

'

'

'

'

'

'

'

'

950

888

719

Net income (loss)

'

554

467

537

438

427

455

485

639

1,996

2,006

2,842

Net income attributable to noncontrolling interests

'

'

'

'

'

'

'

'

'

440

401

377

Net income (loss) attributable to HCA Holdings, Inc.

'

424

365

423

344

314

360

391

540

1,556

1,605

2,465

Comprehensive income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

1,756

1,588

2,453

HCA Holdings, Inc. Issuer [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Supplemental Condensed Consolidating Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues before provision for doubtful accounts

'

'

'

'

'

'

'

'

'

'

'

'

Provision for doubtful accounts

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

'

'

'

Salaries and benefits

'

'

'

'

'

'

'

'

'

'

'

'

Supplies

'

'

'

'

'

'

'

'

'

'

'

'

Other operating expenses

'

'

'

'

'

'

'

'

'

8

3

'

Electronic health record incentive income

'

'

'

'

'

'

'

'

'

'

'

'

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-1,875

-1,668

-2,531

Depreciation and amortization

'

'

'

'

'

'

'

'

'

'

'

'

Interest expense

'

'

'

'

'

'

'

'

'

184

123

120

Losses (gains) on sales of facilities

'

'

'

'

'

'

'

'

'

'

'

'

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

'

Legal claim costs

'

'

'

'

'

'

'

'

'

'

'

'

Loss on retirement of debt

'

'

'

'

'

'

'

'

'

'

'

'

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

'

Management fees

'

'

'

'

'

'

'

'

'

'

'

'

Total expenses including equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-1,683

-1,542

-2,411

Income (loss) before income taxes

'

'

'

'

'

'

'

'

'

1,683

1,542

2,411

Provision (benefit) for income taxes

'

'

'

'

'

'

'

'

'

-73

-46

-42

Net income (loss)

'

'

'

'

'

'

'

'

'

1,756

1,588

2,453

Net income attributable to noncontrolling interests

'

'

'

'

'

'

'

'

'

'

'

'

Net income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

1,756

1,588

2,453

Comprehensive income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

1,756

1,588

2,453

HCA Inc. Issuer [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Supplemental Condensed Consolidating Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues before provision for doubtful accounts

'

'

'

'

'

'

'

'

'

'

'

'

Provision for doubtful accounts

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

'

'

'

Salaries and benefits

'

'

'

'

'

'

'

'

'

'

'

'

Supplies

'

'

'

'

'

'

'

'

'

'

'

'

Other operating expenses

'

'

'

'

'

'

'

'

'

-2

5

4

Electronic health record incentive income

'

'

'

'

'

'

'

'

'

'

'

'

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

'

'

'

Depreciation and amortization

'

'

'

'

'

'

'

'

'

'

'

'

Interest expense

'

'

'

'

'

'

'

'

'

2,253

2,167

2,390

Losses (gains) on sales of facilities

'

'

'

'

'

'

'

'

'

'

'

'

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

'

Legal claim costs

'

'

'

'

'

'

'

'

'

'

175

'

Loss on retirement of debt

'

'

'

'

'

'

'

'

'

17

'

481

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

181

Management fees

'

'

'

'

'

'

'

'

'

'

'

'

Total expenses including equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

2,268

2,347

3,056

Income (loss) before income taxes

'

'

'

'

'

'

'

'

'

-2,268

-2,347

-3,056

Provision (benefit) for income taxes

'

'

'

'

'

'

'

'

'

-860

-839

-1,068

Net income (loss)

'

'

'

'

'

'

'

'

'

-1,408

-1,508

-1,988

Net income attributable to noncontrolling interests

'

'

'

'

'

'

'

'

'

'

'

'

Net income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

-1,408

-1,508

-1,988

Comprehensive income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

-1,324

-1,526

-1,969

Subsidiary Guarantors [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Supplemental Condensed Consolidating Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues before provision for doubtful accounts

'

'

'

'

'

'

'

'

'

20,042

19,415

18,126

Provision for doubtful accounts

'

'

'

'

'

'

'

'

'

2,262

2,144

1,644

Revenues

'

'

'

'

'

'

'

'

'

17,780

17,271

16,482

Salaries and benefits

'

'

'

'

'

'

'

'

'

8,387

7,959

7,584

Supplies

'

'

'

'

'

'

'

'

'

3,158

2,995

2,851

Other operating expenses

'

'

'

'

'

'

'

'

'

2,998

3,013

2,741

Electronic health record incentive income

'

'

'

'

'

'

'

'

'

-142

-219

-126

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-2

-5

-86

Depreciation and amortization

'

'

'

'

'

'

'

'

'

855

821

777

Interest expense

'

'

'

'

'

'

'

'

'

-523

-468

-342

Losses (gains) on sales of facilities

'

'

'

'

'

'

'

'

'

20

3

-127

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

'

Legal claim costs

'

'

'

'

'

'

'

'

'

'

'

'

Loss on retirement of debt

'

'

'

'

'

'

'

'

'

'

'

'

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

'

Management fees

'

'

'

'

'

'

'

'

'

-632

-569

-491

Total expenses including equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

14,119

13,530

12,781

Income (loss) before income taxes

'

'

'

'

'

'

'

'

'

3,661

3,741

3,701

Provision (benefit) for income taxes

'

'

'

'

'

'

'

'

'

1,362

1,313

1,271

Net income (loss)

'

'

'

'

'

'

'

'

'

2,299

2,428

2,430

Net income attributable to noncontrolling interests

'

'

'

'

'

'

'

'

'

69

62

63

Net income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

2,230

2,366

2,367

Comprehensive income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

2,338

2,339

2,341

Subsidiary Non-Guarantors [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Supplemental Condensed Consolidating Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues before provision for doubtful accounts

'

'

'

'

'

'

'

'

'

17,998

17,368

14,380

Provision for doubtful accounts

'

'

'

'

'

'

'

'

'

1,596

1,626

1,180

Revenues

'

'

'

'

'

'

'

'

'

16,402

15,742

13,200

Salaries and benefits

'

'

'

'

'

'

'

'

'

7,259

7,130

5,856

Supplies

'

'

'

'

'

'

'

'

'

2,812

2,722

2,328

Other operating expenses

'

'

'

'

'

'

'

'

'

3,233

3,027

2,725

Electronic health record incentive income

'

'

'

'

'

'

'

'

'

-74

-117

-84

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

-27

-31

-172

Depreciation and amortization

'

'

'

'

'

'

'

'

'

898

858

688

Interest expense

'

'

'

'

'

'

'

'

'

-66

-24

-131

Losses (gains) on sales of facilities

'

'

'

'

'

'

'

'

'

-10

-18

-15

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

-1,522

Legal claim costs

'

'

'

'

'

'

'

'

'

'

'

'

Loss on retirement of debt

'

'

'

'

'

'

'

'

'

'

'

'

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

'

Management fees

'

'

'

'

'

'

'

'

'

632

569

491

Total expenses including equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

14,657

14,116

10,164

Income (loss) before income taxes

'

'

'

'

'

'

'

'

'

1,745

1,626

3,036

Provision (benefit) for income taxes

'

'

'

'

'

'

'

'

'

521

460

558

Net income (loss)

'

'

'

'

'

'

'

'

'

1,224

1,166

2,478

Net income attributable to noncontrolling interests

'

'

'

'

'

'

'

'

'

371

339

314

Net income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

853

827

2,164

Comprehensive income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

861

855

2,159

Eliminations [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Supplemental Condensed Consolidating Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues before provision for doubtful accounts

'

'

'

'

'

'

'

'

'

'

'

'

Provision for doubtful accounts

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

'

'

'

Salaries and benefits

'

'

'

'

'

'

'

'

'

'

'

'

Supplies

'

'

'

'

'

'

'

'

'

'

'

'

Other operating expenses

'

'

'

'

'

'

'

'

'

'

'

'

Electronic health record incentive income

'

'

'

'

'

'

'

'

'

'

'

'

Equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

1,875

1,668

2,531

Depreciation and amortization

'

'

'

'

'

'

'

'

'

'

'

'

Interest expense

'

'

'

'

'

'

'

'

'

'

'

'

Losses (gains) on sales of facilities

'

'

'

'

'

'

'

'

'

'

'

'

Gain on acquisition of controlling interest in equity investment

'

'

'

'

'

'

'

'

'

'

'

'

Legal claim costs

'

'

'

'

'

'

'

'

'

'

'

'

Loss on retirement of debt

'

'

'

'

'

'

'

'

'

'

'

'

Termination of management agreement

'

'

'

'

'

'

'

'

'

'

'

'

Management fees

'

'

'

'

'

'

'

'

'

'

'

'

Total expenses including equity in earnings of affiliates

'

'

'

'

'

'

'

'

'

1,875

1,668

2,531

Income (loss) before income taxes

'

'

'

'

'

'

'

'

'

-1,875

-1,668

-2,531

Provision (benefit) for income taxes

'

'

'

'

'

'

'

'

'

'

'

'

Net income (loss)

'

'

'

'

'

'

'

'

'

-1,875

-1,668

-2,531

Net income attributable to noncontrolling interests

'

'

'

'

'

'

'

'

'

'

'

'

Net income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

-1,875

-1,668

-2,531

Comprehensive income (loss) attributable to HCA Holdings, Inc.

'

'

'

'

'

'

'

'

'

($1,875)

($1,668)

($2,531)

Supplemental_Condensed_Consoli4

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Condensed Consolidating Balance Sheet (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified
Current assets:	'	'	'	'
Cash and cash equivalents	$414	$705	$373	$411
Accounts receivable, net	5,208	4,672	'	'
Inventories	1,179	1,086	'	'
Deferred income taxes	489	385	'	'
Other	747	915	'	'
Total current assets	8,037	7,763	'	'
Property and equipment, net	13,619	13,185	'	'
Investments of insurance subsidiaries	448	515	'	'
Investments in and advances to affiliates	121	104	'	'
Goodwill and other intangible assets	5,903	5,539	'	'
Deferred loan costs	237	290	'	'
Other	466	679	'	'
Total assets	28,831	28,075	'	'
Current liabilities:	'	'	'	'
Accounts payable	1,803	1,768	'	'
Accrued salaries	1,193	1,120	'	'
Other accrued expenses	1,913	1,849	'	'
Long-term debt due within one year	786	1,435	'	'
Total current liabilities	5,695	6,172	'	'
Long-term debt	27,590	27,495	'	'
Intercompany balances	'	'	'	'
Professional liability risks	949	973	'	'
Income taxes and other liabilities	1,525	1,776	'	'
Total liabilities	35,759	36,416	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-8,270	-9,660	'	'
Noncontrolling interests	1,342	1,319	'	'
Total stockholders' deficit	-6,928	-8,341	-7,014	-10,794
Total liabilities and stockholders' deficit	28,831	28,075	'	'
HCA Holdings, Inc. Issuer [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	'	22	'	6
Accounts receivable, net	'	'	'	'
Inventories	'	'	'	'
Deferred income taxes	489	385	'	'
Other	'	122	'	'
Total current assets	489	529	'	'
Property and equipment, net	'	'	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	20,356	18,481	'	'
Goodwill and other intangible assets	'	'	'	'
Deferred loan costs	30	32	'	'
Other	250	469	'	'
Total assets	21,125	19,511	'	'
Current liabilities:	'	'	'	'
Accounts payable	1	'	'	'
Accrued salaries	'	'	'	'
Other accrued expenses	272	30	'	'
Long-term debt due within one year	'	'	'	'
Total current liabilities	273	30	'	'
Long-term debt	2,525	2,525	'	'
Intercompany balances	26,107	26,131	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	490	485	'	'
Total liabilities	29,395	29,171	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-8,270	-9,660	'	'
Noncontrolling interests	'	'	'	'
Total stockholders' deficit	-8,270	-9,660	'	'
Total liabilities and stockholders' deficit	21,125	19,511	'	'
HCA Inc. Issuer [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	'	'	'	'
Accounts receivable, net	'	'	'	'
Inventories	'	'	'	'
Deferred income taxes	'	'	'	'
Other	'	'	'	'
Total current assets	'	'	'	'
Property and equipment, net	'	'	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	'	'	'	'
Goodwill and other intangible assets	'	'	'	'
Deferred loan costs	207	258	'	'
Other	'	'	'	'
Total assets	207	258	'	'
Current liabilities:	'	'	'	'
Accounts payable	'	'	'	'
Accrued salaries	'	'	'	'
Other accrued expenses	353	567	'	'
Long-term debt due within one year	702	1,360	'	'
Total current liabilities	1,055	1,927	'	'
Long-term debt	24,701	24,304	'	'
Intercompany balances	-10,513	-12,407	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	296	442	'	'
Total liabilities	15,539	14,266	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-15,332	-14,008	'	'
Noncontrolling interests	'	'	'	'
Total stockholders' deficit	-15,332	-14,008	'	'
Total liabilities and stockholders' deficit	207	258	'	'
Subsidiary Guarantors [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	112	383	115	156
Accounts receivable, net	2,565	2,448	'	'
Inventories	692	629	'	'
Deferred income taxes	'	'	'	'
Other	301	342	'	'
Total current assets	3,670	3,802	'	'
Property and equipment, net	7,504	7,417	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	13	16	'	'
Goodwill and other intangible assets	1,695	1,697	'	'
Deferred loan costs	'	'	'	'
Other	48	31	'	'
Total assets	12,930	12,963	'	'
Current liabilities:	'	'	'	'
Accounts payable	1,169	1,203	'	'
Accrued salaries	694	638	'	'
Other accrued expenses	464	464	'	'
Long-term debt due within one year	45	39	'	'
Total current liabilities	2,372	2,344	'	'
Long-term debt	181	173	'	'
Intercompany balances	-19,428	-17,130	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	521	629	'	'
Total liabilities	-16,354	-13,984	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	29,185	26,847	'	'
Noncontrolling interests	99	100	'	'
Total stockholders' deficit	29,284	26,947	'	'
Total liabilities and stockholders' deficit	12,930	12,963	'	'
Subsidiary Non-Guarantors [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	302	300	258	249
Accounts receivable, net	2,643	2,224	'	'
Inventories	487	457	'	'
Deferred income taxes	'	'	'	'
Other	446	451	'	'
Total current assets	3,878	3,432	'	'
Property and equipment, net	6,115	5,768	'	'
Investments of insurance subsidiaries	448	515	'	'
Investments in and advances to affiliates	108	88	'	'
Goodwill and other intangible assets	4,208	3,842	'	'
Deferred loan costs	'	'	'	'
Other	168	179	'	'
Total assets	14,925	13,824	'	'
Current liabilities:	'	'	'	'
Accounts payable	633	565	'	'
Accrued salaries	499	482	'	'
Other accrued expenses	824	788	'	'
Long-term debt due within one year	39	36	'	'
Total current liabilities	1,995	1,871	'	'
Long-term debt	183	493	'	'
Intercompany balances	3,834	3,406	'	'
Professional liability risks	949	973	'	'
Income taxes and other liabilities	218	220	'	'
Total liabilities	7,179	6,963	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	6,503	5,642	'	'
Noncontrolling interests	1,243	1,219	'	'
Total stockholders' deficit	7,746	6,861	'	'
Total liabilities and stockholders' deficit	14,925	13,824	'	'
Eliminations [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	'	'	'	'
Accounts receivable, net	'	'	'	'
Inventories	'	'	'	'
Deferred income taxes	'	'	'	'
Other	'	'	'	'
Total current assets	'	'	'	'
Property and equipment, net	'	'	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	-20,356	-18,481	'	'
Goodwill and other intangible assets	'	'	'	'
Deferred loan costs	'	'	'	'
Other	'	'	'	'
Total assets	-20,356	-18,481	'	'
Current liabilities:	'	'	'	'
Accounts payable	'	'	'	'
Accrued salaries	'	'	'	'
Other accrued expenses	'	'	'	'
Long-term debt due within one year	'	'	'	'
Total current liabilities	'	'	'	'
Long-term debt	'	'	'	'
Intercompany balances	'	'	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	'	'	'	'
Total liabilities	'	'	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-20,356	-18,481	'	'
Noncontrolling interests	'	'	'	'
Total stockholders' deficit	-20,356	-18,481	'	'
Total liabilities and stockholders' deficit	($20,356)	($18,481)	'	'

Supplemental_Condensed_Consoli5

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net income (loss)	$1,996	$2,006	$2,842
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'	'
Change in operating assets and liabilities	-4,272	-3,663	-2,953
Provision for doubtful accounts	3,858	3,770	2,824
Depreciation and amortization	1,753	1,679	1,465
Income taxes	143	96	912
Gains on sales of facilities	10	-15	-142
Gain on acquisition of controlling interest in equity investment	'	'	-1,522
Legal claim costs	'	175	'
Loss on retirement of debt	17	'	481
Amortization of deferred loan costs	55	62	70
Share-based compensation	113	56	26
Pay-in-kind interest	'	'	-78
Equity in earnings of affiliates	-29	-36	-258
Other	7	9	8
Net cash provided by (used in) operating activities	3,680	4,175	3,933
Cash flows from investing activities:	'	'	'
Purchase of property and equipment	-1,943	-1,862	-1,679
Acquisition of hospitals and health care entities	-481	-258	-1,682
Disposal of hospitals and health care entities	33	30	281
Change in investments	36	16	80
Other	9	11	5
Net cash used in investing activities	-2,346	-2,063	-2,995
Cash flows from financing activities:	'	'	'
Issuances of long-term debt	'	4,850	5,500
Net change in revolving bank credit facilities	970	-685	-449
Repayment of long-term debt	-1,662	-2,441	-6,640
Distributions to noncontrolling interests	-435	-401	-378
Payment of debt issuance costs	-5	-62	-92
Issuance of common stock	'	'	2,506
Repurchase of common stock	-500	'	-1,503
Distributions to stockholders	-16	-3,148	-31
Income tax benefits	113	174	63
Changes in intercompany balances with affiliates, net	'	'	'
Other	-90	-67	48
Net cash (used in) provided by financing activities	-1,625	-1,780	-976
Change in cash and cash equivalents	-291	332	-38
Cash and cash equivalents at beginning of period	705	373	411
Cash and cash equivalents at end of period	414	705	373
HCA Holdings, Inc. Issuer [Member]	'	'	'
Cash flows from operating activities:	'	'	'
Net income (loss)	1,756	1,588	2,453
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'	'
Change in operating assets and liabilities	-11	57	6
Provision for doubtful accounts	'	'	'
Depreciation and amortization	'	'	'
Income taxes	143	96	912
Gains on sales of facilities	'	'	'
Gain on acquisition of controlling interest in equity investment	'	'	'
Legal claim costs	'	'	'
Loss on retirement of debt	'	'	'
Amortization of deferred loan costs	3	2	'
Share-based compensation	113	56	26
Pay-in-kind interest	'	'	'
Equity in earnings of affiliates	-1,875	-1,668	-2,531
Other	'	'	'
Net cash provided by (used in) operating activities	129	131	866
Cash flows from investing activities:	'	'	'
Purchase of property and equipment	'	'	'
Acquisition of hospitals and health care entities	'	'	'
Disposal of hospitals and health care entities	'	'	'
Change in investments	'	'	'
Other	'	'	'
Net cash used in investing activities	'	'	'
Cash flows from financing activities:	'	'	'
Issuances of long-term debt	'	1,000	'
Net change in revolving bank credit facilities	'	'	'
Repayment of long-term debt	'	'	'
Distributions to noncontrolling interests	'	'	'
Payment of debt issuance costs	'	-12	'
Issuance of common stock	'	'	2,506
Repurchase of common stock	-500	'	-1,503
Distributions to stockholders	-16	-3,148	-31
Income tax benefits	113	174	63
Changes in intercompany balances with affiliates, net	342	1,938	-1,918
Other	-90	-61	11
Net cash (used in) provided by financing activities	-151	-109	-872
Change in cash and cash equivalents	-22	22	-6
Cash and cash equivalents at beginning of period	22	'	6
Cash and cash equivalents at end of period	'	22	'
HCA Inc. Issuer [Member]	'	'	'
Cash flows from operating activities:	'	'	'
Net income (loss)	-1,408	-1,508	-1,988
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'	'
Change in operating assets and liabilities	17	-28	71
Provision for doubtful accounts	'	'	'
Depreciation and amortization	'	'	'
Income taxes	'	'	'
Gains on sales of facilities	'	'	'
Gain on acquisition of controlling interest in equity investment	'	'	'
Legal claim costs	'	175	'
Loss on retirement of debt	17	'	481
Amortization of deferred loan costs	52	60	70
Share-based compensation	'	'	'
Pay-in-kind interest	'	'	-78
Equity in earnings of affiliates	'	'	'
Other	9	14	9
Net cash provided by (used in) operating activities	-1,313	-1,287	-1,435
Cash flows from investing activities:	'	'	'
Purchase of property and equipment	'	'	'
Acquisition of hospitals and health care entities	'	'	'
Disposal of hospitals and health care entities	'	'	'
Change in investments	'	'	'
Other	'	'	'
Net cash used in investing activities	'	'	'
Cash flows from financing activities:	'	'	'
Issuances of long-term debt	'	3,850	5,500
Net change in revolving bank credit facilities	970	-685	-449
Repayment of long-term debt	-1,254	-2,309	-6,577
Distributions to noncontrolling interests	'	'	'
Payment of debt issuance costs	-5	-50	-92
Issuance of common stock	'	'	'
Repurchase of common stock	'	'	'
Distributions to stockholders	'	'	'
Income tax benefits	'	'	'
Changes in intercompany balances with affiliates, net	1,602	481	3,053
Other	'	'	'
Net cash (used in) provided by financing activities	1,313	1,287	1,435
Change in cash and cash equivalents	'	'	'
Cash and cash equivalents at beginning of period	'	'	'
Cash and cash equivalents at end of period	'	'	'
Subsidiary Guarantors [Member]	'	'	'
Cash flows from operating activities:	'	'	'
Net income (loss)	2,299	2,428	2,430
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'	'
Change in operating assets and liabilities	-2,320	-1,927	-1,755
Provision for doubtful accounts	2,262	2,144	1,644
Depreciation and amortization	855	821	777
Income taxes	'	'	'
Gains on sales of facilities	20	3	-127
Gain on acquisition of controlling interest in equity investment	'	'	'
Legal claim costs	'	'	'
Loss on retirement of debt	'	'	'
Amortization of deferred loan costs	'	'	'
Share-based compensation	'	'	'
Pay-in-kind interest	'	'	'
Equity in earnings of affiliates	-2	-5	-86
Other	2	-1	'
Net cash provided by (used in) operating activities	3,118	3,468	2,969
Cash flows from investing activities:	'	'	'
Purchase of property and equipment	-921	-1,039	-910
Acquisition of hospitals and health care entities	'	-110	-142
Disposal of hospitals and health care entities	17	2	200
Change in investments	-16	-11	34
Other	'	-2	'
Net cash used in investing activities	-920	-1,160	-818
Cash flows from financing activities:	'	'	'
Issuances of long-term debt	'	'	'
Net change in revolving bank credit facilities	'	'	'
Repayment of long-term debt	-34	-20	-17
Distributions to noncontrolling interests	-71	-60	-77
Payment of debt issuance costs	'	'	'
Issuance of common stock	'	'	'
Repurchase of common stock	'	'	'
Distributions to stockholders	'	'	'
Income tax benefits	'	'	'
Changes in intercompany balances with affiliates, net	-2,364	-1,960	-2,098
Other	'	'	'
Net cash (used in) provided by financing activities	-2,469	-2,040	-2,192
Change in cash and cash equivalents	-271	268	-41
Cash and cash equivalents at beginning of period	383	115	156
Cash and cash equivalents at end of period	112	383	115
Subsidiary Non-Guarantors [Member]	'	'	'
Cash flows from operating activities:	'	'	'
Net income (loss)	1,224	1,166	2,478
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'	'
Change in operating assets and liabilities	-1,958	-1,765	-1,275
Provision for doubtful accounts	1,596	1,626	1,180
Depreciation and amortization	898	858	688
Income taxes	'	'	'
Gains on sales of facilities	-10	-18	-15
Gain on acquisition of controlling interest in equity investment	'	'	-1,522
Legal claim costs	'	'	'
Loss on retirement of debt	'	'	'
Amortization of deferred loan costs	'	'	'
Share-based compensation	'	'	'
Pay-in-kind interest	'	'	'
Equity in earnings of affiliates	-27	-31	-172
Other	-4	-4	-1
Net cash provided by (used in) operating activities	1,746	1,863	1,533
Cash flows from investing activities:	'	'	'
Purchase of property and equipment	-1,022	-823	-769
Acquisition of hospitals and health care entities	-481	-148	-1,540
Disposal of hospitals and health care entities	16	28	81
Change in investments	52	27	46
Other	9	13	5
Net cash used in investing activities	-1,426	-903	-2,177
Cash flows from financing activities:	'	'	'
Issuances of long-term debt	'	'	'
Net change in revolving bank credit facilities	'	'	'
Repayment of long-term debt	-374	-112	-46
Distributions to noncontrolling interests	-364	-341	-301
Payment of debt issuance costs	'	'	'
Issuance of common stock	'	'	'
Repurchase of common stock	'	'	'
Distributions to stockholders	'	'	'
Income tax benefits	'	'	'
Changes in intercompany balances with affiliates, net	420	-459	963
Other	'	-6	37
Net cash (used in) provided by financing activities	-318	-918	653
Change in cash and cash equivalents	2	42	9
Cash and cash equivalents at beginning of period	300	258	249
Cash and cash equivalents at end of period	302	300	258
Eliminations [Member]	'	'	'
Cash flows from operating activities:	'	'	'
Net income (loss)	-1,875	-1,668	-2,531
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'	'
Change in operating assets and liabilities	'	'	'
Provision for doubtful accounts	'	'	'
Depreciation and amortization	'	'	'
Income taxes	'	'	'
Gains on sales of facilities	'	'	'
Gain on acquisition of controlling interest in equity investment	'	'	'
Legal claim costs	'	'	'
Loss on retirement of debt	'	'	'
Amortization of deferred loan costs	'	'	'
Share-based compensation	'	'	'
Pay-in-kind interest	'	'	'
Equity in earnings of affiliates	1,875	1,668	2,531
Other	'	'	'
Net cash provided by (used in) operating activities	'	'	'
Cash flows from investing activities:	'	'	'
Purchase of property and equipment	'	'	'
Acquisition of hospitals and health care entities	'	'	'
Disposal of hospitals and health care entities	'	'	'
Change in investments	'	'	'
Other	'	'	'
Net cash used in investing activities	'	'	'
Cash flows from financing activities:	'	'	'
Issuances of long-term debt	'	'	'
Net change in revolving bank credit facilities	'	'	'
Repayment of long-term debt	'	'	'
Distributions to noncontrolling interests	'	'	'
Payment of debt issuance costs	'	'	'
Issuance of common stock	'	'	'
Repurchase of common stock	'	'	'
Distributions to stockholders	'	'	'
Income tax benefits	'	'	'
Changes in intercompany balances with affiliates, net	'	'	'
Other	'	'	'
Net cash (used in) provided by financing activities	'	'	'
Change in cash and cash equivalents	'	'	'
Cash and cash equivalents at beginning of period	'	'	'
Cash and cash equivalents at end of period	'	'	'

Supplemental_Condensed_Consoli6

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Consolidated Statements of Stockholder's Deficit (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based benefit plans	$139	$169	$35
Reclassification of certain equity securities with contingent redemption rights	'	'	141
Other	-13	-28	-56
Healthtrust, Inc. [Member]	'	'	'
Share-based benefit plans	139	169	35
Reclassification of certain equity securities with contingent redemption rights	'	'	141
Other	-6	-17	36
Distributions from HCA Holdings, Inc., net of contributions to HCA Holdings, Inc.	$133	$152	$212

Supplemental_Condensed_Consoli7

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Quarterly Consolidated Financial Information (Detail) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stockholders Equity Excluding Portion Attributable To Subsidiaries Noncontrolling Interest [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Revenues	$8,836	$8,456	$8,450	$8,440	$8,434	$8,062	$8,112	$8,405	$34,182	$33,013	$29,682
Net income	554	467	537	438	427	455	485	639	1,996	2,006	2,842
Net income attributable to HCA Holdings, Inc.	$424	$365	$423	$344	$314	$360	$391	$540	$1,556	$1,605	$2,465
Basic earnings per share	$0.96	$0.82	$0.95	$0.77	$0.71	$0.82	$0.89	$1.23	$3.50	$3.65	$5.17
Diluted earnings per share	$0.92	$0.79	$0.91	$0.74	$0.68	$0.78	$0.85	$1.18	$3.37	$3.49	$4.97

Supplemental_Condensed_Consoli8

Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Quarterly Consolidated Financial Information (Parenthetical) (Detail) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2013

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Stockholders Equity Excluding Portion Attributable To Subsidiaries Noncontrolling Interest [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Losses (gains) on sales of facilities

'

$2

($1)

$3

($11)

$6

$5

($1)

($1)

($10)

$15

$142

Losses on retirement of debt

-17

'

'

'

-11

'

'

'

'

-17

'

-481

Legal claim costs

'

'

'

'

'

$110

'

'

'

'

$175

'